Processing 00000000.tx.1: Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse Jean-Michel Itier1,, Pablo Ibez2,, Mara Angeles Mena3, Nacer Abbas2,, Charles Cohen-Salmon4, Georg Andrees Bohme5, Michel Laville5, Jeremy Pratt5, Olga Corti2, Laurent Pradier5, Gwnelle Ret1, Chantal Joubert4, Magali Periquet2, Francisco Araujo5, Julia Negroni4, Mara Jos Casarejos3, Santiago Canals3, Rosa Solano3, Alba Serrano6, Eva Gallego6, Marina Snchez6, Patrice Denfle1, Jess Benavides5, Gnter Tremp1, Thomas A. 

Phrase: "Parkin gene inactivation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0598496:Gene Inactivation [Genetic Function]
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   734   C1418270:parkin gene [Gene or Genome]
   734   C2983548:Parkin Gene [Gene or Genome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "behaviour"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "dopamine neurotransmission in the mouse Jean-Michel Itier1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0027793:Neurotransmission [Cell Function]

Phrase: ", Pablo Ibez2,"

Phrase: ", Mara Angeles Mena3,"

Phrase: "Nacer Abbas2,"

Phrase: ", Charles Cohen-Salmon4,"

Phrase: "Georg Andrees Bohme5,"

Phrase: "Michel Laville5,"

Phrase: "Jeremy Pratt5,"

Phrase: "Olga Corti2,"

Phrase: "Laurent Pradier5,"

Phrase: "Gwnelle Ret1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413420:RET1 [Gene or Genome]

Phrase: "Chantal Joubert4,"

Phrase: "Magali Periquet2,"

Phrase: "Francisco Araujo5,"

Phrase: "Julia Negroni4,"

Phrase: "Mara Jos Casarejos3,"

Phrase: "Santiago Canals3,"

Phrase: "Rosa Solano3,"

Phrase: "Alba Serrano6,"

Phrase: "Eva Gallego6,"

Phrase: "Marina Snchez6,"

Phrase: "Patrice Denfle1,"

Phrase: "Jess Benavides5,"

Phrase: "Gnter Tremp1,"

Phrase: "Thomas A."
Processing 00000000.tx.2: Rooney5,*, Alexis Brice2,7 and Justo Garca de Ybenes6 1Functional Genomics Department, Aventis Pharma SA, 13 Quai Jules Guesde, F-94400 Vitry-sur-Seine, France, 2INSERM U289, Groupe Hopitalier Piti-Salptrire, 47, Bd de l'Hpital, 75651 Paris Cedex 13, France, 3Department of Research, Hospital Ramon y Cajal, Carretera de Colmenar km. 

Phrase: "Rooney5,"

Phrase: "*,"

Phrase: "Alexis Brice2,"

Phrase: "7"

Phrase: "and"

Phrase: "Justo Garca de Ybenes6 1Functional Genomics Department,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1704729:Department [Organization]

Phrase: "Aventis Pharma SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0036243:SA [Geographic Area]
   827   C1539696:SA [Gene or Genome]
   827   C1825840:SA [Gene or Genome]
   827   C3539736:Sa [Spatial Concept]

Phrase: "13 Quai Jules Guesde,"

Phrase: "F-94400 Vitry-sur-Seine,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "2INSERM U289,"

Phrase: "Groupe Hopitalier Piti-Salptrire,"

Phrase: "47,"

Phrase: "Bd de l'Hpital,"

Phrase: "75651 Paris Cedex 13,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0030561:Paris [Geographic Area]
   812   C0331677:Paris [Plant]
   812   C0591239:Cedex [Antibiotic,Organic Chemical]
   812   C1824032:PARIS [Gene or Genome]
   779 E C1824369:PARI [Gene or Genome]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "3Department of Research,"

Phrase: "Hospital Ramon y Cajal,"

Phrase: "Carretera de Colmenar km."
Processing 00000000.tx.3: 9,100, 28034 Madrid, Spain, 4CNRS UMR 7593, Hopitalier Piti-Salptrire, 47, Bd de l'Hpital, 75651 Paris Cedex 13, France, 5CNS Department, Aventis Pharma SA, 13 Quai Jules Guesde, F-94400 Vitry-sur-Seine, France, 6Department of Neurology, Fundacin Jimnez Daz, Universidad Autnoma de Madrid, Avda. de Reyes Catlicos, 2. 

Phrase: "9,100,"

Phrase: "28034 Madrid,"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "4CNRS UMR 7593,"

Phrase: "Hopitalier Piti-Salptrire,"

Phrase: "47,"

Phrase: "Bd de l'Hpital,"

Phrase: "75651 Paris Cedex 13,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0030561:Paris [Geographic Area]
   812   C0331677:Paris [Plant]
   812   C0591239:Cedex [Antibiotic,Organic Chemical]
   812   C1824032:PARIS [Gene or Genome]
   779 E C1824369:PARI [Gene or Genome]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "5CNS Department,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704729:Department [Organization]

Phrase: "Aventis Pharma SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0036243:SA [Geographic Area]
   827   C1539696:SA [Gene or Genome]
   827   C1825840:SA [Gene or Genome]
   827   C3539736:Sa [Spatial Concept]

Phrase: "13 Quai Jules Guesde,"

Phrase: "F-94400 Vitry-sur-Seine,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "6Department of Neurology,"

Phrase: "Fundacin Jimnez Daz,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0067356:daz [Organic Chemical]
   827   C1539219:DAZ [Gene or Genome]

Phrase: "Universidad Autnoma de Madrid,"

Phrase: "Avda. de Reyes Catlicos,"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.4: 28040 Madrid, Spain and 7Dpartement de Gntique, Cytogntique et Embryologie, Groupe Hopitalier Piti-Salptrire, AP-HP, 47, Bd de l'Hpital, 75651 Paris Cedex 13, France Received April 10, 2003; 

Phrase: "28040 Madrid,"

Phrase: "Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "and"

Phrase: "7Dpartement de Gntique,"

Phrase: "Cytogntique et Embryologie,"

Phrase: "Groupe Hopitalier Piti-Salptrire,"

Phrase: "AP-HP,"

Phrase: "47,"

Phrase: "Bd de l'Hpital,"

Phrase: "75651 Paris Cedex 13,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0030561:Paris [Geographic Area]
   812   C0331677:Paris [Plant]
   812   C0591239:Cedex [Antibiotic,Organic Chemical]
   812   C1824032:PARIS [Gene or Genome]
   779 E C1824369:PARI [Gene or Genome]

Phrase: "France Received April 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016674:France [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.5: Revised June 13, 2003; 

Phrase: "Revised June 13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.6: Accepted July 10, 2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Mutations of the parkin gene are the most frequent cause of early onset autosomal recessive parkinsonism (EO-AR). 

Phrase: "Accepted July 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mutations of the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "the most frequent cause of early onset autosomal recessive parkinsonism (EO-AR)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0015127:cause [Functional Concept]
   739   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.7: Here we show that inactivation of the parkin gene in mice results in motor and cognitive deficits, inhibition of amphetamine-induced dopamine release and inhibition of glutamate neurotransmission. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that inactivation of the parkin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0598496:Gene Inactivation [Genetic Function]
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "results in motor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1274040:Result [Functional Concept]
   790   C1513492:Motor [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C1705994:Motor [Manufactured Object]
   790   C2825142:Result [Finding]

Phrase: "and"

Phrase: "cognitive deficits,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "inhibition of amphetamine-induced dopamine release"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "inhibition of glutamate neurotransmission."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.8: The levels of dopamine are increased in the limbic brain areas of parkin mutant mice and there is a shift towards increased metabolism of dopamine by MAO. 

Phrase: "The levels of dopamine"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in the limbic brain areas of parkin mutant mice"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   741   C1521713:Mouse Brain [Tissue]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0205146:areas [Spatial Concept]
   739   C0205217:Increased [Quantitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1418270:PARKIN [Gene or Genome]
   739   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   706 E C0017446:Area [Geographic Area]

Phrase: "and"

Phrase: "there"

Phrase: "is"

Phrase: "a shift towards increased metabolism of dopamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "by MAO."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.9: Although there was no evidence for a reduction of nigrostriatal dopamine neurons in the parkin mutant mice, the level of dopamine transporter protein was reduced in these animals, suggesting a decreased density of dopamine terminals, or adaptative changes in the nigrostriatal dopamine system. 

Phrase: "Although"

Phrase: "there"

Phrase: "was"

Phrase: "no evidence for a reduction of nigrostriatal dopamine neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the parkin mutant mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "the level of dopamine transporter protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "reduced in these animals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003062:Animals [Animal]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a decreased density of dopamine terminals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1265608:Decreased density [Finding]
   753   C0178587:density [Quantitative Concept]

Phrase: "or"

Phrase: "adaptative changes in the nigrostriatal dopamine system."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.10: GSH levels were increased in the striatum and fetal mesencephalic neurons from parkin mutant mice, suggesting that a compensatory mechanism may protect dopamine neurons from neuronal death. 

Phrase: "GSH levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1260386:GSH [Disease or Syndrome]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "increased in the striatum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0010097:Striatum [Body Part, Organ, or Organ Component]
   770   C0162512:Striatum [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "fetal mesencephalic neurons from parkin mutant mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a compensatory mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "protect"

Phrase: "dopamine neurons from neuronal death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1512035:dopamine neurons [Cell]
   781   C2754100:neuron death [Cell Function]
   760   C0027882:Neurons [Cell]
Processing 00000000.tx.11: These parkin mutant mice provide a valuable tool to better understand the preclinical deficits observed in patients with PD and to characterize the mechanisms leading to the degeneration of dopamine neurons that could provide new strategies for neuroprotection.  

Phrase: "These parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a valuable tool to better"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0332272:Better [Qualitative Concept]
   812   C0336791:Tool [Manufactured Object]
   812   C2827396:Tool [Manufactured Object]
   779 E C0205170:Well [Qualitative Concept]
   779 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the preclinical deficits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "observed in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "with PD"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "leading to the degeneration of dopamine neurons"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   778   C1512035:dopamine neurons [Cell]
   774   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   748   C0011164:Degeneration [Pathologic Function]
   748   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   748   C0027882:Neurons [Cell]
   748   C0332152:Leading [Temporal Concept]
   748   C1522538:Leading [Functional Concept]
   748   C1880269:Degeneration [Functional Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "could"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "new strategies for neuroprotection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679199:strategies [Mental Process]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinson's Disease (PD) is the second most frequent neurodegenerative disorder with a prevalence of 0.20.3% in the population of Europe and North America (1,2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's Disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "the second most frequent neurodegenerative disorder with a prevalence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   762   C0683921:disorder prevalence [Quantitative Concept]
   742   C0012634:Disorder [Disease or Syndrome]

Phrase: "of 0.20.3%"

Phrase: "in the population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "of Europe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]

Phrase: "and"

Phrase: "North America"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028405:North America [Geographic Area]
   928 E C0425358:NORTH AMERICAN [Finding]
   928 E C2700615:North American [Population Group]
   861   C0002454:America [Geographic Area]
   861   C1709269:North [Spatial Concept]
   789 E C0596070:American [Population Group]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Clinically, PD is best characterized by akinesia or bradykinesia, rigidity, resting tremor and postural abnormalities (3,4). 

Phrase: "Clinically,"

Phrase: "PD"

Phrase: "is"

Phrase: "best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "characterized by akinesia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085623:Akinesia [Disease or Syndrome]
   790   C1880022:Characterized [Activity]

Phrase: "or"

Phrase: "bradykinesia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "rigidity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0026837:Rigidity, NOS [Sign or Symptom]
  1000   C0700109:rigidity [Natural Phenomenon or Process]
   928 E C0231517:Rigid [Individual Behavior]
   928 E C1882952:RIGID [Phenomenon or Process]

Phrase: "resting tremor"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0234379:Resting Tremor [Sign or Symptom]
   861   C0035253:Resting [Daily or Recreational Activity]
   861   C0040822:Tremor [Sign or Symptom]
   861   C1512899:resting [Cell]
   861   C1963252:Tremor [Finding]
   827 E C1622890:ResT [Molecular Function]

Phrase: "and"

Phrase: "postural abnormalities"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   947   C0231471:POSTURE ABNORMALITY [Finding]
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.14: In addition, other neurological deficits, such as peculiar personality traits, cognitive and autonomic dysfunction, depression and sleep disorders often take place (3). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "other neurological deficits,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0521654:Neurological deficit [Finding]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "such as peculiar personality traits,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0233849:Personality Traits [Finding]
   827   C0599883:traits [Organism Attribute]
   827   C1427926:TRAITS [Gene or Genome]

Phrase: "cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516691:Cognitive [Functional Concept]

Phrase: "and"

Phrase: "autonomic dysfunction,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0741307:Autonomic dysfunction [Pathologic Function]
   861   C0004388:Autonomic [Body System]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "depression"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "and"

Phrase: "sleep disorders often"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0037317:sleep disorders [Sign or Symptom]
   901   C0851578:Sleep Disorders [Disease or Syndrome]
   827   C0012634:Disorders [Disease or Syndrome]
   827   C0037313:Sleep [Organism Function]
   755 E C0013144:Sleepy [Finding]
   727 E C2830004:SLEEPINESS [Finding]

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: The major pathological hallmark of PD is the degeneration of dopaminergic neurons of the substantia nigra, predominantly the ventrolateral portion of the pars compacta that innervates the dorsal striatum. 

Phrase: "The major pathological hallmark of PD"

Phrase: "is"

Phrase: "the degeneration of dopaminergic neurons of the substantia nigra,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   742   C0011164:Degeneration [Pathologic Function]
   742   C1880269:Degeneration [Functional Concept]

Phrase: "predominantly"

Phrase: "the ventrolateral portion of the pars compacta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "that"

Phrase: "innervates"

Phrase: "the dorsal striatum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2333957:Dorsal striatum [Body Part, Organ, or Organ Component]
   861   C0010097:Striatum [Body Part, Organ, or Organ Component]
   861   C0162512:Striatum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.16: Other monoamine brain nuclei are also damaged, but to a lesser extent than in the substantia nigra. 

Phrase: "Other monoamine brain nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1706993:Brain nucleus [Body Part, Organ, or Organ Component]
   793   C0007610:Nucleus [Cell Component]

Phrase: "are"

Phrase: "also"

Phrase: "damaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0010957:Damage [Injury or Poisoning]
   966   C1883709:Damage [Functional Concept]

Phrase: ","

Phrase: "but to a lesser extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]

Phrase: "than"

Phrase: "in the substantia nigra."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.17: Most PD patients present intracellular eosinophillic inclusions, known as Lewy bodies (5). 

Phrase: "Most PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "intracellular eosinophillic inclusions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: "known as Lewy bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0205309:Known [Qualitative Concept]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.18: These inclusions are immunoreactive for several proteins, such as -synuclein and ubiquitin, but are not exclusive to PD since they have been observed in other neurological disorders (6,7). 

Phrase: "These inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "are"

Phrase: "immunoreactive for several proteins,"

Phrase: "such as -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "are"

Phrase: "not exclusive to PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1548966:Exclusive [Idea or Concept]

Phrase: "since"

Phrase: "they"

Phrase: "have"

Phrase: "been"

Phrase: "observed in other neurological disorders"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0027765:Neurological Disorders [Disease or Syndrome]
   760   C0012634:Disorders [Disease or Syndrome]
   760   C0205494:Neurological [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C2707261:Neurological [Clinical Attribute]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.19: Most cases of PD are sporadic and have been associated with a number of risk factors, including exposure to pesticides, drinking well water, and recent industrialization. 

Phrase: "Most cases of PD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "associated with a number of risk factors,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0035648:risk factors [Quantitative Concept]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1553898:risk factors [Idea or Concept]
   757   C0960756:factor A [Organic Chemical]
   748   C0035647:Risk [Qualitative Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714   C1521761:Factor [Functional Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "exposure to pesticides,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "drinking"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001948:drinking [Individual Behavior]
  1000   C0684271:Drinking [Organism Function]
   966 E C0452428:Drink [Food]

Phrase: "well water,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0205170:Well [Qualitative Concept]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   861   C3146287:Well [Manufactured Object]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "recent industrialization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021266:Industrialization [Occupational Activity]
Processing 00000000.tx.20: This suggests that the pathogenesis of the disease may be related to excessive oxidative stress, lack of free radical scavenging products or abnormalities of mitochondrial energy production (8,9). 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the pathogenesis of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]

Phrase: "may"

Phrase: "be"

Phrase: "related to excessive oxidative stress,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0442802:Excessive [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "lack of free radical scavenging products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "or"

Phrase: "abnormalities of mitochondrial energy production"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.21: Indeed, blockade of the mitochondrial respiratory chain or generation of oxidative stress by different pharmacological tools has been used to generate most of the experimental models of PD in laboratory animals (1013). 

Phrase: "Indeed,"

Phrase: "blockade of the mitochondrial respiratory chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332206:Blockade [Functional Concept]
   753   C3540676:Blockade [Pharmacologic Substance]

Phrase: "or"

Phrase: "generation of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "by different pharmacological tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0336791:Tool [Manufactured Object]
   793   C2827396:Tool [Manufactured Object]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "most of the experimental models of PD in laboratory animals"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0887965:Experimental Animal Models [Animal]
   761   C0887966:Laboratory Animal Models [Animal]
   760   C0003064:Animals, Laboratory [Animal]
           experimental animal
   760   C0086272:Models, Experimental [Intellectual Product]
   757   C0599779:animals models [Animal]
   739   C0003062:Animals [Animal]
   739   C0022877:Laboratory [Manufactured Object,Organization]
   739   C0205393:Most [Quantitative Concept]
   739   C1517586:Experimental [Qualitative Concept]
   739   C3161035:Models [Intellectual Product]
   739   C3244292:laboratory [Functional Concept]

Phrase: "(1013"

Phrase: ")."
Processing 00000000.tx.22: In addition to the sporadic forms of PD, familial aggregation is present in up to 25% of PD cases. 

Phrase: "In addition to the sporadic forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "of PD,"

Phrase: "familial aggregation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0015576:familial [Family Group]
   861   C0241888:Familial [Functional Concept]
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]
   789 E C1704727:Family [Conceptual Entity]

Phrase: "is"

Phrase: "present in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0150312:Present [Quantitative Concept]
   833   C0449450:Present [Idea or Concept]

Phrase: "up to 25%"

Phrase: "of PD cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.23: A subset of these families correspond to monogenic forms of PD; 

Phrase: "A subset of these families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515021:Subset [Classification]

Phrase: "correspond to monogenic forms of PD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: ";"
Processing 00000000.tx.24: a few families with mutations in genes encoding for -synuclein (14) and Nurr1 (15) are associated with autosomal dominant forms of the disease. 

Phrase: "a few families with mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015576:Families [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "in genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding for -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1547699:Encoding [Idea or Concept]
   790   C2700640:Encoding [Activity]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "Nurr1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417836:NURR1 [Gene or Genome]

Phrase: "(15"

Phrase: ")"

Phrase: "are"

Phrase: "associated with autosomal dominant forms of the disease."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0443147:Autosomal dominant [Intellectual Product]
   767   C0243083:associated disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C0596142:autosomal [Cell Component]
   744   C1527180:Dominant [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1522492:Form [Functional Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.25: However, the majority of familial cases are associated with mutations of the parkin gene (16), which causes the most common form of autosomal recessive parkinsonism (17) and accounts for approximately 15% of the isolated cases with onset before the age of 45 (18). 

Phrase: "However,"

Phrase: "the majority of familial cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "associated with mutations of the parkin gene"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1418270:parkin gene [Gene or Genome]
           PARKIN
   778   C2983548:Parkin Gene [Gene or Genome]
   774   C0596611:gene mutations [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0026882:Mutations [Genetic Function]
   748   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the most common form of autosomal recessive parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "accounts for approximately 15% of the isolated cases"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C1853237:Isolated cases [Finding]
   744   C0205409:Isolated [Functional Concept]
   744   C0332232:Approximately [Qualitative Concept]
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   744   C1548221:Isolated [Idea or Concept]
   744   C1551359:account [Idea or Concept]
   744   C2741673:Account # [Clinical Attribute]
   744   C2981730:Account [Classification]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "with onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "before the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 45"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.26: In most families with PD related to parkin gene mutations, the disease onset is before age 40 and the clinical response to L-DOPA is good (16,19,20). 

Phrase: "In most families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with PD"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "to parkin gene mutations,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0596611:gene mutations [Genetic Function]
   861   C1418270:parkin gene [Gene or Genome]
   861   C2983548:Parkin Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the disease onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0277793:disease onset [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "before age 40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0001779:Age [Organism Attribute]
   827   C0332152:Before [Temporal Concept]
   827   C0439509:/40 [Temporal Concept]
   827   C1705850:Before [Intellectual Product]

Phrase: "and"

Phrase: "the clinical response to L-DOPA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "good"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205170:Good [Qualitative Concept]

Phrase: "(16,"

Phrase: "19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.27: The majority of patients with homozygous or combined heterozygous mutations of the parkin gene have severe loss of nigral dopaminergic neurons, but without Lewy bodies (2124). 

Phrase: "The majority of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "with homozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygous [Organism Attribute]

Phrase: "or"

Phrase: "combined heterozygous mutations of the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "severe loss of nigral dopaminergic neurons,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   858   C3550005:Loss of dopaminergic neurons [Finding]
   820   C0598940:Loss of neurons [Finding]
           neuron loss
   753   C1517945:Loss [Quantitative Concept]
   742 E C1850496:Neuronal loss [Finding]

Phrase: "but without Lewy bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "(2124"

Phrase: ")."
Processing 00000000.tx.28: However, PD patients with parkin mutations can also display atypical phenotypes of late onset, autosomal dominant transmission and Lewy bodies in their brain (17,2527). 

Phrase: "However,"

Phrase: "PD patients with parkin mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "can"

Phrase: "also"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "atypical phenotypes of late onset, autosomal dominant transmission"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0031437:Phenotypes [Organism Attribute]
   711 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "Lewy bodies in their brain"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0085200:Lewy Bodies [Cell Component]
   760   C0242821:bodies [Human]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "(17,"

Phrase: "2527"

Phrase: ")."
Processing 00000000.tx.29: Age at onset of parkinsonism related to parkin mutations is extremely variable, even within the same family or among carriers of the same mutation (20,28). 

Phrase: "Age at onset of parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "to parkin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "extremely variable, even within the same family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0015576:Family [Family Group]
   748   C0439828:Variable [Qualitative Concept]
   748   C0445247:Same [Qualitative Concept]
   748   C1704727:Family [Conceptual Entity]

Phrase: "or among carriers of the same mutation"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   757   C2985478:Mutation Carrier [Human]
   748   C0007294:carriers [Finding]
   748   C0026882:Mutation [Genetic Function]
   748   C0445247:Same [Qualitative Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   714 E C0560175:Carrier [Finding]
   714 E C1706209:Carrier [Medical Device]
   714 E C3273162:Carrier [Intellectual Product]

Phrase: "(20,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.30: In addition, a single parkin mutation is detected in some patients (29), suggesting that this situation could represent a risk factor for PD. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a single parkin mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "detected in some patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this situation"

Phrase: "could"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a risk factor for PD."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0035648:Risk factor [Quantitative Concept]
   797   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   797   C0960756:factor A [Organic Chemical]
   760   C0035647:Risk [Qualitative Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.31: Therefore, the reduction of parkin protein function, and not only total absence of parkin function or a dominant negative effect of specific mutations, is enough to produce parkinsonism in some individuals. 

Phrase: "Therefore,"

Phrase: "the reduction of parkin protein function,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "not only total absence of parkin function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "a dominant negative effect of specific mutations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "enough to"

Phrase: "produce"

Phrase: "parkinsonism in some individuals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.32: The pathogenic impact of parkin mutations may also be modulated by other factors. 

Phrase: "The pathogenic impact of parkin mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "modulated by other factors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443264:Modulated [Spatial Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.33: Parkin is encoded by a gene containing 12 exons. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "encoded by a gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017337:Gene [Gene or Genome]
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "12 exons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.34: Many different mutations, including deletions and multiplications of one or several exons, point mutations that alter the open reading frame producing premature stop codons and truncated proteins or changes of a single amino acid in critical regions of the protein have been identified in all exons, including exon 3 (17,19). 

Phrase: "Many different mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "multiplications of one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2911648:Multiplication [Quantitative Concept]

Phrase: "or"

Phrase: "several exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the open reading frame"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0079941:Open Reading Frame [Gene or Genome]
   901   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   827   C0034754:Reading [Daily or Recreational Activity]
   827   C0175566:Open [Spatial Concept]
   827   C0180979:Frame [Medical Device]
   827   C1705179:Reading [Finding]
   827   C1705858:Frame [Manufactured Object]
   755 E C0547049:Openness [Spatial Concept]

Phrase: "producing"

Phrase: "premature stop codons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242612:Premature Stop Codon [Nucleotide Sequence]
   901   C0242611:Stop Codon [Nucleotide Sequence]
   827   C0009221:Codon [Nucleotide Sequence]
   827   C1095825:Codon [Plant]

Phrase: "and"

Phrase: "truncated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "changes of a single amino acid"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   820   C1953353:Amino acid change [Finding]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0205171:Single [Quantitative Concept]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "in critical regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "identified in all exons,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "exon 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(17,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.35: Parkin is a protein of 465 amino acids with a ubiquitin homology domain at the N terminal, and two ring fingers plus one in between ring sequence towards the C terminal. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a protein of 465 amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with a ubiquitin homology domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1334043:Homology [Gene or Genome]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C2697616:Homology [Qualitative Concept]
   827   C3541951:Domain [Intellectual Product]

Phrase: "at the N terminal,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "two ring fingers plus one in between ring sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   762   C0230398:fingers ring [Body Part, Organ, or Organ Component]
   742   C0016129:Fingers [Body Location or Region]
   742   C0521164:Ring [Spatial Concept]
   742   C0549188:fingers [Quantitative Concept]
   742   C1260969:Ring [Medical Device]
   742   C1705184:Ring [Medical Device]
   731 E C1521759:Ring Finger [Cell Component]
   708 E C1281584:Finger [Body Part, Organ, or Organ Component]

Phrase: "towards the C terminal."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1707271:C-Terminal [Amino Acid Sequence]
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.36: As with many RING-finger-containing proteins, parkin acts as an E3 ubiquitin protein ligase and has been shown to bind to and ubiquitinate a number of specific protein substrates, including Cdcrel-1 (30), Pael-R (31), synphilin-1 (32) and glycosylated -synuclein (33). 

Phrase: "As with many RING-finger-containing proteins,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   788   C1313794:RING Finger Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   778   C1521759:Ring Finger [Cell Component]
   748   C0016129:Finger [Body Location or Region]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332256:Containing [Functional Concept]
   748   C0521164:Ring [Spatial Concept]
   748   C1260969:Ring [Medical Device]
   748   C1281584:Finger [Body Part, Organ, or Organ Component]
   748   C1705184:Ring [Medical Device]
   748   C2700400:Containing [Activity]

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "acts as an E3 ubiquitin protein ligase"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   840   C0077678:Ubiquitin-Protein Ligase E3 [Amino Acid, Peptide, or Protein,Enzyme]
           ubiquitin-protein ligase
           E3 Ubiquitin Ligase
           E3 Ligase
   814   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1442769:ubiquitin-protein ligase [Gene or Genome]
   804   C1418270:E3 ubiquitin ligase [Gene or Genome]
   748   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1145667:Bind [Activity]
   833   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "ubiquitinate"

Phrase: "a number of specific protein substrates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Cdcrel-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "Pael-R (31"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205090:R- [Spatial Concept]
   827   C0450355:31 [Intellectual Product]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: "glycosylated -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.37: To date, the mechanism(s) by which parkin mutations and deregulation of parkin substrates lead to dopamine neuronal loss and the onset of parkinsonian symptoms is unknown. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s) by which parkin mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0026882:Mutations [Genetic Function]
   760   C1418270:PARKIN [Gene or Genome]
   760   C2603362:S' [Clinical Attribute]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "deregulation of parkin substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880287:Deregulation [Activity]

Phrase: "lead to dopamine neuronal loss"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C1850496:Neuronal loss [Finding]
   770 E C0598940:neuron loss [Finding]
   770   C1512035:dopamine neuron [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1517945:Loss [Quantitative Concept]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the onset of parkinsonian symptoms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.38: To further understand the mechanisms by which mutations in parkin lead to the onset of parkinsonism, we have generated a transgenic animal model in which the parkin gene has been inactivated. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the mechanisms by which mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "in parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "lead to the onset of parkinsonism,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0242422:Parkinsonism [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "have"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a transgenic animal model in which"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0003069:Transgenic Animal [Animal]
   790   C0599779:Animal Model [Animal]
   783   C1519606:Transgenic Model [Experimental Model of Disease]
   753   C0003062:Animal [Animal]
   753   C3161035:Model [Intellectual Product]

Phrase: "the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "inactivated."
Processing 00000000.tx.39: Here we report the construction of a parkin mutant mouse and a characterization of the phenotype resulting from preventing the functional expression of the parkin protein.  

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the construction of a parkin mutant mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "a characterization of the phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "resulting from preventing"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0678226:resulting [Functional Concept]
   756   C0309872:PREVENT [Pharmacologic Substance]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "the functional expression of the parkin protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.40: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Absence of parkin protein in parkin exon 3 deleted mice A 12kb fragment containing mouse parkin exon 3 was isolated from the 129SV genomic phage library. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Absence of parkin protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in parkin exon 3 deleted mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "A 12kb fragment containing mouse parkin exon 3"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   795   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0025914:Mouse [Mammal]
   795   C0025929:mouse [Mammal]
   795   C0026809:Mouse [Mammal]
   795   C0332255:fragment [Functional Concept]
   795   C0332256:Containing [Functional Concept]
   795   C1418270:PARKIN [Gene or Genome]
   795   C1708096:Fragment [Qualitative Concept]
   795   C2700400:Containing [Activity]
   795   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "isolated from the 129SV genomic phage library."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   774   C0017430:Genomic Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0004651:Phage [Virus]
   748   C0017428:Genomic [Gene or Genome]
   748   C0023621:Library [Manufactured Object,Organization]
   748   C0205409:Isolated [Functional Concept]
   748   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0887950:genomic [Biomedical Occupation or Discipline]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.41: A targeting vector was assembled to replace the 3' end of exon 3 and a substantial part of intron 4 by a neomycin-resistance cassette (Fig.1A). 

Phrase: "A targeting vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "assembled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706853:Assemble [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "the 3' end of exon 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444930:End [Spatial Concept]
   753   C2746065:End [Temporal Concept]

Phrase: "and"

Phrase: "a substantial part of intron 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "by a neomycin-resistance cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450240:Cassette [Medical Device]
   827   C1706210:Cassette [Manufactured Object]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.42: The successful deletion was confirmed at the genome level by Southern blot (Fig.1B). 

Phrase: "The successful deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "was"

Phrase: "confirmed at the genome level"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0017428:Genome [Gene or Genome]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1547707:Level [Geographic Area]
   760   C2338314:Genome [Conceptual Entity]
   760   C2946261:Level [Pharmacologic Substance]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "by Southern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005862:Southern Blot [Molecular Biology Research Technique]
  1000   C1148472:Blot, Southern [Laboratory or Test Result]
   861   C1710133:Southern [Spatial Concept]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.43: Northern blot analysis revealed that the tree parkin mRNA disappeared in the mutant mice and is replaced by a single new band. 

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the tree parkin mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "disappeared in the mutant mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "is"

Phrase: "replaced by a single new band."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C1299987:Replaced by [Functional Concept]
           replaced
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0175723:Band [Medical Device]
   753   C0205171:Single [Quantitative Concept]
   753   C0205314:New [Temporal Concept]
   753   C0439645:Band [Spatial Concept]
   753   C0559956:Replaced [Functional Concept]
   753   C1521913:band [Cell Component]
   719 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.44: Using parkin exon 2, 3 or 4 as a probe, we demonstrated a splice between exon 2 and 4 and skipping of exon 3 in the parkin mRNA present in the mutant mice (Fig.1C). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "parkin exon 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "or"

Phrase: "4 as a probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0182400:Probe [Medical Device]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "a splice between exon 2"

Phrase: "and"

Phrase: "4"

Phrase: "and"

Phrase: "skipping of exon 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0560435:skipping [Finding]

Phrase: "in the parkin mRNA present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0150312:Present [Quantitative Concept]
   827   C0449450:Present [Idea or Concept]

Phrase: "in the mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(Fig.1C"

Phrase: ")."
Processing 00000000.tx.45: This result was confirmed by RTPCR experiments and sequencing of the amplification products (data not shown). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "was"

Phrase: "confirmed by RTPCR experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0681814:Experiments [Research Activity]
   770   C0750484:Confirmed [Idea or Concept]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "sequencing of the amplification products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1441475:Amplification/Sequencing [Laboratory Procedure]
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.46: The consequence of such aberrant splicing in this putative coding mRNA is the change of the ORF from position codon 57 and the appearance of a stop codon at position 105. 

Phrase: "The consequence of such aberrant splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "in this putative coding mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "the change of the ORF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0025320:The change [Physiologic Function]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "from position codon 57"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0009221:Codon [Nucleotide Sequence]
   827   C0733755:Position [Spatial Concept]
   827   C1095825:Codon [Plant]
   755 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "the appearance of a stop codon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]

Phrase: "at position 105."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.47: Germ line transmission was obtained with chimeric mice. 

Phrase: "Germ line transmission"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C1521797:Transmission [Natural Phenomenon or Process]
   734   C0017473:Germ Line [Cell]

Phrase: "was"

Phrase: "obtained with chimeric mice."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0008109:chimeric [Organism]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.48: Mice carrying the homozygous mutation were viable and fertile. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the homozygous mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: "and"

Phrase: "fertile."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0015895:Fertile [Organism Function]
   928 E C0200069:Fertility [Diagnostic Procedure]
   928 E C2986895:Fertility [Idea or Concept]
Processing 00000000.tx.49: Studies of mortality in the colony showed no excess mortality when compared with wild-type animals reared in parallel and mutant mice had the same average litter size as wild type mice (7.60.6 versus 8.30.6 young/litter; n=32 and 24, respectively). 

Phrase: "Studies of mortality"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "in the colony"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439158:colony [Quantitative Concept]
  1000   C1947989:Colony [Cell]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no excess mortality"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079320:Mortality, Excess [Quantitative Concept]
   861   C0026565:Mortality [Quantitative Concept]
   861   C0026566:mortality [Quantitative Concept]

Phrase: "when"

Phrase: "compared with wild-type animals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1883559:Wild Type [Organism Attribute]
   797   C0003070:Animals, Wild [Animal]
   760   C0003062:Animals [Animal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "reared"

Phrase: "in parallel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "and"

Phrase: "mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "the same average litter size as wild type mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0023881:Litter Size [Quantitative Concept]
   742   C0456389:size [Spatial Concept]

Phrase: "(7.60.6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1423717:7-60 [Gene or Genome]

Phrase: "versus"

Phrase: "8.30.6 young/litter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1299950:Litter [Manufactured Object]

Phrase: "; n=32"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "24,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.50: View larger version (30K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.51: Inactivation of the parkin gene. 

Phrase: "Inactivation of the parkin gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0598496:Gene Inactivation [Genetic Function]
   760   C0544461:Inactivation [Cell or Molecular Dysfunction]
Processing 00000000.tx.52: (A) The strategy for inactivating the parkin gene in the mouse. 

Phrase: "(A)"

Phrase: "The strategy for inactivating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679199:strategy [Mental Process]

Phrase: "the parkin gene in the mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1418270:parkin gene [Gene or Genome]
   790   C2983548:Parkin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.53: The 1097bp encompassing the 3' end of exon 3 and 5' end of intron 3 were deleted. 

Phrase: "The 1097bp"

Phrase: "encompassing"

Phrase: "the 3' end of exon 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444930:End [Spatial Concept]
   753   C2746065:End [Temporal Concept]

Phrase: "and"

Phrase: "5' end of intron 3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0444930:End [Spatial Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "deleted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]
Processing 00000000.tx.54: (B) Southern blot of genomic DNA from wild type and parkin mutant mice. 

Phrase: "(B) Southern blot of genomic DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005862:Southern Blot [Molecular Biology Research Technique]
   790   C1148472:Blot, Southern [Laboratory or Test Result]
   753   C1710133:Southern [Spatial Concept]

Phrase: "from wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "parkin mutant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.55: The 6kb and the 5kb bands indicate the presence of the wild-type and the mutated parkin allele, respectively. 

Phrase: "The 6kb"

Phrase: "and"

Phrase: "the 5kb bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "indicate"

Phrase: "the presence of the wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the mutated parkin allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.56: (C) Northern blot: total RNA from wild-type or parkin mutant mice brain were hybridized with a probe corresponding to parkin gene exon 2, 3 or 4. 

Phrase: "(C) Northern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0005861:Northern Blot [Molecular Biology Research Technique]
   901   C1621557:Northern Blot [Research Device]
   827   C1709269:Northern [Spatial Concept]

Phrase: ":"

Phrase: "total RNA from wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "parkin mutant mice brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1521713:Mouse Brain [Tissue]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "hybridized with a probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0182400:Probe [Medical Device]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]

Phrase: "corresponding"

Phrase: "to parkin gene exon 2,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C1418270:parkin gene [Gene or Genome]
           PARKIN
   840   C2983548:Parkin Gene [Gene or Genome]
   804   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0017337:Gene [Gene or Genome]
   804   C1883351:To [Qualitative Concept]
   804   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "or"

Phrase: "4."
Processing 00000000.tx.57: (D) Demonstration of the absence of parkin protein by western blot analysis. 

Phrase: "("

Phrase: "D)"

Phrase: "Demonstration of the absence of parkin protein"

Phrase: "by western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]
Processing 00000000.tx.58: Brain extract from wild-type or parkin mutant mice was used with an anti-parkin antibody.  

Phrase: "Brain extract from wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2828366:Extract [Substance]

Phrase: "or"

Phrase: "parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "used with an anti-parkin antibody."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1273517:used [Finding]
   753   C1418270:PARKIN [Gene or Genome]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.59: Western blots using an antibody raised against amino acids 7192 of the parkin protein indicated that the 4850kDa band, corresponding to the parkin protein, had disappeared in the parkin mutant mice (Fig.1D). 

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "raised against amino acids 7192 of the parkin protein"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   781   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0001128:Acids [Chemical]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0442818:Raised [Quantitative Concept]
   742   C1418270:PARKIN [Gene or Genome]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the 4850kDa band,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "corresponding to the parkin protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "had"

Phrase: "disappeared in the parkin mutant mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1418270:PARKIN [Gene or Genome]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.60: These mutants can therefore be considered to have lost their ability to produce the parkin protein. 

Phrase: "These mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "therefore"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "produce"

Phrase: "the parkin protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.61: Clinical phenotype and brain morphology Transgenic parkin mice appeared to be normal with no modification of behaviour or handicap. 

Phrase: "Clinical phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "brain morphology Transgenic parkin mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0025936:Mice, Transgenic [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "normal with no modification of behaviour"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0233512:Normal behavior [Social Behavior]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "handicap."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231172:Handicap [Finding]
Processing 00000000.tx.62: The oldest homozygous transgenic mice, of both mixed (C57BL6/129SV) and pure (129SV) background, did not show any overt behavioural changes up to 24 months of age. 

Phrase: "The oldest homozygous transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "of both"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "(C57BL6/129SV"

Phrase: ")"

Phrase: "and"

Phrase: "pure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2247561:PurE [Molecular Function]
   928 E C1882508:Purity [Quantitative Concept]

Phrase: "(129SV"

Phrase: ")"

Phrase: "background,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any overt behavioural changes up to 24 months of age."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0542299:Behavioral changes [Individual Behavior]
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   706 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.63: No differences in brain morphology, brain weight and brain size were observed and there was no evidence of muscle degeneration (data not shown). 

Phrase: "No differences in brain morphology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "brain weight"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0870228:brain weight [Quantitative Concept]
   861   C0005910:weight [Organism Attribute]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0043100:Weight [Quantitative Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1705104:Weight [Idea or Concept]

Phrase: "and"

Phrase: "brain size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0870226:brain size [Quantitative Concept]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0456389:size [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "no evidence of muscle degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.64: These findings are in contrast to those found in Drosophila parkin mutants that display a reduced lifespan, male sterility and muscle degeneration (34). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are in contrast to those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1551058:Are [Quantitative Concept]
   760   C1979874:Contrast [Qualitative Concept]

Phrase: "found in Drosophila parkin mutants"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0013138:Drosophila [Eukaryote]
   760   C0150312:Found [Quantitative Concept]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C1028876:Drosophila [Fungus]
   760   C1418270:PARKIN [Gene or Genome]
   760   C1504613:Drosophila [Eukaryote]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a reduced lifespan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0870809:life span [Group Attribute]

Phrase: "male sterility"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0917731:Male sterility [Finding]
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C0678108:Sterility [Pathologic Function]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]
   789 E C0232920:Sterile [Qualitative Concept]

Phrase: "and"

Phrase: "muscle degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0234958:MUSCLE DEGENERATION [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.65: Histological sections of the brain at the levels of the striatum, hippocampus, brain stem and cerebellum stained with haematoxylin and eosin also did not reveal any changes (data not shown). 

Phrase: "Histological sections of the brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "at the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of the striatum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "stained with haematoxylin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "eosin also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "any changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.66: However, body weight was reduced from weaning to 500 days of age in both male and female parkin mutant mice (Fig.2) and body temperature, measured rectally, was reduced in parkin mutant mice at 4 months (37.20.2C in parkin mutant mice versus 38.50.16C in wild-type mice, P<0.001, n=14). 

Phrase: "However,"

Phrase: "body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "was"

Phrase: "reduced from weaning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0043084:Weaning [Organism Function]
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "to 500 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "in both male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "female parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "body temperature,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0005903:Body Temperature [Organism Attribute]
           temperature
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "rectally,"

Phrase: "was"

Phrase: "reduced in parkin mutant mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "at 4 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "(37.20.2C in parkin mutant mice"

Phrase: "versus"

Phrase: "38.50.16C in wild-type mice,"

Phrase: "P<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n=14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.67: View larger version (35K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.68: Parkin mutant mice have decreased body weight. 

Phrase: "Parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "decreased body weight."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0043096:Decreased body weight [Finding]
           Decreased weight
   901   C0005910:Body Weight [Organism Attribute]
           weight
   901   C1305866:body weight [Diagnostic Procedure]
           weight
   827   C0043100:Weight [Quantitative Concept]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1705104:Weight [Idea or Concept]
   743 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.69: Evolution of body weight for wild type (open bars, n=11) and parkin mutant (hatched bars, n=14) mice. 

Phrase: "Evolution of body weight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015219:Evolution [Genetic Function]

Phrase: "for wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(open bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "n=11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "parkin mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(hatched bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "n=14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.70: *P<0.05; 

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.71: **P<0.01; 

Phrase: "*"

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.72: ***P<0.001 versus wild-type mice, Student's t-test.  

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "wild-type mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "Student's t-test."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]
Processing 00000000.tx.73: Protein markers of dopaminergic neurons Tyrosine hydroxylase (TH) immunoreactivity in the substantia nigra and striatum of female mice was similar in wild type and parkin mutant mice at 15 months of age. 

Phrase: "Protein markers of dopaminergic neurons Tyrosine hydroxylase (TH) immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0005516:Marker [Clinical Attribute]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "striatum of female mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1521998:Mouse Striatum [Tissue]
   770   C0010097:Striatum [Body Part, Organ, or Organ Component]
   770   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "similar in wild type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "parkin mutant mice at 15 months of age."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
Processing 00000000.tx.74: Quantitative analysis showed no statistically significant difference in the number of TH-positive perikaria in the substantia nigra or in TH optical density in the striatum between the two groups (Fig.3AF). 

Phrase: "Quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no statistically significant difference in the number of TH-positive perikaria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1705241:*Difference [Quantitative Concept]
   736   C1705242:Difference [Qualitative Concept]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "or in TH optical density"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0439164:Optical density [Quantitative Concept]
   790   C1268822:Optical density [Clinical Attribute]
   790   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]
   753   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0178587:density [Quantitative Concept]

Phrase: "in the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "between the two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(Fig.3AF"

Phrase: ")."
Processing 00000000.tx.75: No differences in TH staining were observed up to 24 months of age (data not shown). 

Phrase: "No differences in TH staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "observed up to 24 months of age (data"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   767   C1510828:Age-Months [Organism Attribute]
   744   C0001779:Age [Organism Attribute]
   744   C0439231:months [Temporal Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1511726:Data [Idea or Concept]
   744   C3245479:data [Medical Device]
   711 E C0439507:/month [Temporal Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.76: This lack of effect on TH staining was confirmed by western blot where no differences in the levels of TH protein were observed between male parkin mutant mice and controls at 15 months of age in the striatum (Fig.3G and H) or in the limbic region, diencephalon and brain stem (data not shown). 

Phrase: "This lack of effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "on TH staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]

Phrase: "was"

Phrase: "confirmed by western blot where"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1705493:Western [Spatial Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "no differences in the levels of TH protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "observed between male parkin mutant mice"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0024554:Male [Finding]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0086582:male [Population Group]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1441672:Observed [Functional Concept]
   753   C1706180:Male [Qualitative Concept]
   753   C1706428:Male [Qualitative Concept]
   753   C1706429:Male [Organism Attribute]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "controls at 15 months of age"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C1510828:Age-Months [Organism Attribute]
   753   C0001779:Age [Organism Attribute]
   753   C0243148:control [Qualitative Concept]
   753   C0439231:months [Temporal Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0439507:/month [Temporal Concept]

Phrase: "in the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "(Fig.3G"

Phrase: "and"

Phrase: "H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "or in the limbic region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "diencephalon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012144:Diencephalon [Body Part, Organ, or Organ Component]
  1000   C1281065:Diencephalon [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.77: In addition, there was no difference in -synuclein, ubiquitin, synapsin, synaptophysin, Map2 and Neu N staining in mutant mice at 24 months of age (data not shown). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "there"

Phrase: "was"

Phrase: "no difference in -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synapsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085252:synapsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synaptophysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "Map2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417006:MAP2 [Gene or Genome]
  1000   C1424480:MAP2 [Gene or Genome]

Phrase: "and"

Phrase: "Neu N staining in mutant mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "at 24 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.78: By contrast, although immunohistochemical examination of dopamine transporter (DAT) staining in wild-type and mutant mice at 15 months of age showed no significant differences (data not shown), the levels of DAT and VMAT2, measured by western blot, were significantly reduced in the striatum of parkin mutant mice (Fig.3G and H). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "although"

Phrase: "immunohistochemical examination of dopamine transporter (DAT) staining"

Phrase: "in wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant mice at 15 months of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the levels of DAT"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "VMAT2,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
   923   C1529240:Vesicular Monoamine Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3539788:Monoamine Transporter [Amino Acid, Peptide, or Protein]
   812   C0205378:Vesicular [Qualitative Concept]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0599682:monoamine [Organic Chemical]
   741 E C0333262:VESICLES [Acquired Abnormality]
   741 E C1622418:vesicle [Cell Component]

Phrase: "measured by western blot,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C1705493:Western [Spatial Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced in the striatum of parkin mutant mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   750   C1521998:Mouse Striatum [Tissue]
   744   C0010097:Striatum [Body Part, Organ, or Organ Component]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0162512:Striatum [Body Part, Organ, or Organ Component]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1418270:PARKIN [Gene or Genome]
   744   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig.3G"

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.79: View larger version (56K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(56K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.80: Protein markers of dopamine neurons. 

Phrase: "Protein markers of dopamine neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.81: (A) Representative photomicographs of TH immunoreactivity in the striatum of a 15-month-old female wild-type mouse. 

Phrase: "(A) Representative photomicographs of TH immunoreactivity"

Phrase: "in the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "of a 15-month-old female wild-type mouse."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   845   C1520150:Wild Type Mouse [Mammal]
   818   C1883559:Wild Type [Organism Attribute]
   795   C0025914:Mouse [Mammal]
   795   C0025929:mouse [Mammal]
   795   C0026809:Mouse [Mammal]
   795   C0332307:Type [Qualitative Concept]
   795   C0445392:Wild [Intellectual Product]
   795   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.82: (B) Representative photomicographs of TH immunoreactivity in the striatum of a 15-month-old female parkin mutant mouse. 

Phrase: "(B) Representative photomicographs of TH immunoreactivity"

Phrase: "in the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "of a 15-month-old female parkin mutant mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mouse [Mammal]
   795   C0025929:mouse [Mammal]
   795   C0026809:Mouse [Mammal]
Processing 00000000.tx.83: (C) TH immunoreactivity in the substantia nigra of wild-type mouse. 

Phrase: "(C) TH immunoreactivity in the substantia nigra"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597879:immunoreactivity [Molecular Function]

Phrase: "of wild-type mouse."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.84: (D) TH immunoreactivity in the substantia nigra of parkin mutant mice. 

Phrase: "("

Phrase: "D)"

Phrase: "TH immunoreactivity in the substantia nigra of parkin mutant mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.85: (E) Magnification of TH immunostaining in the substantia nigra in wild-type mice. 

Phrase: "(E) Magnification of TH immunostaining"

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "in wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.86: (F) Magnification of TH immunostaining in the substantia nigra in parkin mutant mice (original magnificationx50). 

Phrase: "(F) Magnification of TH immunostaining"

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "in parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(original magnificationx50"

Phrase: ")."
Processing 00000000.tx.87: Bar indicates 500m for the striatum and 200m for the substantia nigra. 

Phrase: "Bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "indicates"

Phrase: "500m for the striatum"

Phrase: "and"

Phrase: "200m for the substantia nigra."
Processing 00000000.tx.88: TH cell counts and OD-values in wild type and mutant mice were compared using an unpaired t-test. 

Phrase: "TH cell counts"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007584:Counts, Cell [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0439157:counts [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C0750480:Count [Activity]
   779 E C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "OD-values in wild type"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1550401:Value type [Idea or Concept]
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an unpaired t-test."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1710574:Unpaired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.89: A value of P<0.05 was considered statistically significant. 

Phrase: "A value of P<0.05"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.90: (G) Representative western blots of tyrosine hydroxylase, dopamine transporter and vesicular monoamine transporter proteins in mice striatum (13 from wild type and 46 from parkin mutant mice). 

Phrase: "(G) Representative western blots of tyrosine hydroxylase,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0949466:Western Blots [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]
   745 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "dopamine transporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "vesicular monoamine transporter proteins in mice striatum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1529240:Vesicular Monoamine Transporter Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(13 from wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "46 from parkin mutant mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.91: -Actin was used as charge control. 

Phrase: "-Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "used as charge control."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007961:Charge [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1706211:Charge [Organism Attribute]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.92: (H) Data represent the ratio TH, DAT and VMAT2/-actin in mice striatum. 

Phrase: "(H) Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the ratio TH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]
   827   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "DAT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "VMAT2/-actin in mice striatum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.93: Values are expressed as the meanSEM (n=6 animals in each group). 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as the meanSEM"

Phrase: "(n=6 animals in each group"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1642385:Animal group [Group]
   753   C0003062:Animals [Animal]

Phrase: ")."
Processing 00000000.tx.94: Statistical analysis was performed by ANOVA, followed by Student's t-test. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by ANOVA,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "followed by Student's t-test."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.95: *P<0.05, **P<0.01 parkin mutant versus wild-type mice.  

Phrase: "*P<0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "*P<0.01 parkin mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "versus"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.96: Deficits in learning and exploration in parkin mutant mice Parkin mutant mice display reduced exploratory behaviour in unfamiliar environments (Fig.4A) and decreased spontaneous alternation in the exploration of the unknown arm of a T-maze (Fig.4B), a test used to reveal deficits in working memory. 

Phrase: "Deficits in learning"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2987487:deficits [Qualitative Concept]
   756 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "and"

Phrase: "exploration in parkin mutant mice Parkin mutant mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1280903:Exploration [Therapeutic or Preventive Procedure]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "reduced exploratory behaviour in unfamiliar environments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015328:Exploratory Behavior [Individual Behavior]
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "decreased spontaneous alternation in the exploration of the unknown arm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0919661:alternation [Pathologic Function]

Phrase: "of a T-maze"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0083355:MAZE [Therapeutic or Preventive Procedure]
   827   C0870866:maze [Manufactured Object]
   734   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "a test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "deficits in working memory."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0233794:Memory Deficits [Mental or Behavioral Dysfunction]
   770   C2987487:deficits [Qualitative Concept]
   737 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.97: This indicates that mutant mice are less willing to explore and/or less able to remember what they had recently explored. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "less willing to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0600109:Willing [Finding]
   793 E C0042950:Will [Mental Process]

Phrase: "explore"

Phrase: "and/or"

Phrase: "less able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085732:Able [Organism Attribute]
   790   C1299581:Able [Finding]

Phrase: "remember"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679062:remember [Mental Process]

Phrase: "what they"

Phrase: "had"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "explored."
Processing 00000000.tx.98: In the hanging thread test no differences were observed between wild-type and mutant mice with respect to maximal hanging time (Fig.4C), or the number of animals refusing the test during the first trial (data not shown), which could indicate no differences in muscular tonus between both groups. 

Phrase: "In the hanging thread test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "no differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed between wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1441672:Observed [Functional Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant mice with respect to maximal hanging time"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the number of animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "refusing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0017095:Refuse [Environmental Effect of Humans]
   966   C1705116:Refuse [Activity]

Phrase: "the test during the first trial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "could"

Phrase: "indicate"

Phrase: "no differences in muscular tonus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between both groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.99: However, during re-exposure to the test 3 months later, the number of animals rejecting the challenge was greater in the wild-type than in the mutant group (Fig.4C). 

Phrase: "However,"

Phrase: "during re-exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
   861   C2986904:RE [Idea or Concept]

Phrase: "to the test 3 months later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439231:months [Temporal Concept]
   779 E C0439507:/month [Temporal Concept]

Phrase: "the number of animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "rejecting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548437:Reject [Idea or Concept]
   966   C2700401:Reject [Activity]

Phrase: "the challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0798503:Challenge [Clinical Attribute]
  1000   C0805586:Challenge [Health Care Activity]
  1000   C3274764:Challenge [Conceptual Entity]

Phrase: "was"

Phrase: "greater in the wild-type"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "than"

Phrase: "in the mutant group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: This could be interpreted as abnormal learning by the mutant mice, although other explanations, such as a more submissive character are also possible. 

Phrase: "This"

Phrase: "could"

Phrase: "be"

Phrase: "interpreted as abnormal learning"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0013621:learning [Educational Activity]
   770   C0023185:Learning [Mental Process]
   770   C0205161:Abnormal [Qualitative Concept]
   770   C1285553:interpreted [Functional Concept]
   770   C2347472:% Abnormal [Quantitative Concept]
   770   C2699333:ABNORMAL [Intellectual Product]

Phrase: "by the mutant mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "although"

Phrase: "other explanations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681841:Explanations [Intellectual Product]

Phrase: "such as a more submissive character"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007952:Character [Mental Process]
   827   C0486537:Character [Organism Attribute]
   827   C2350015:Character [Qualitative Concept]

Phrase: "are"

Phrase: "also possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.101: View larger version (27K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.102: Parkin mutant mice have motor and cognitive deficits. 

Phrase: "Parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "motor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513492:Motor [Functional Concept]
  1000   C1705994:Motor [Manufactured Object]

Phrase: "and"

Phrase: "cognitive deficits."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.103: (A) Open field activity in 170-day-old wild-type (open bars, n=14) and parkin mutant (striped bars, n=14) male mice over two consecutive periods of 3min immediately following the introduction of the mouse into the motility cage reveals a reduced exploratory behaviour during the first period of testing without changes in the motor activity during the second period. 

Phrase: "(A) Open field activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "in 170-day-old wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1550423:Day type [Idea or Concept]
   840   C1883559:Wild Type [Organism Attribute]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "(open bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "n=14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "parkin mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(striped bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "n=14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "male mice over two consecutive periods of 3min immediately"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the introduction of the mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1293116:Introduction [Health Care Activity]
   760   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "into the motility cage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337189:Cage [Manufactured Object]
   861   C0441239:Cage [Medical Device]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a reduced exploratory behaviour during the first period of testing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015328:Exploratory Behavior [Individual Behavior]
   739   C0004927:Behavior [Individual Behavior]
   739   C2707008:Behavior [Clinical Attribute]

Phrase: "without changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in the motor activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0026606:Motor Activity [Daily or Recreational Activity]
  1000   C1321502:motor activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "during the second period."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.104: **P<0.01 versus wild-type mice (Student's t-test). 

Phrase: "*"

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: (B) Alternance in a T maze: male 140-day-old wild-type (open bars, n=10) and parkin mutant (hatched bars, n=14) mice were allowed 3min to explore the maze when one of its arms were blocked. 

Phrase: "(B) Alternance in a T maze"

Phrase: ":"

Phrase: "male 140-day-old wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C1550423:Day type [Idea or Concept]
   827   C1883559:Wild Type [Organism Attribute]
   799   C0332307:Type [Qualitative Concept]
   799   C0445392:Wild [Intellectual Product]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "(open bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "n=10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "parkin mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(hatched bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "n=14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "3min to"

Phrase: "explore"

Phrase: "the maze"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083355:MAZE [Therapeutic or Preventive Procedure]
  1000   C0870866:maze [Manufactured Object]

Phrase: "when"

Phrase: "one of its arms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "were"

Phrase: "blocked."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.106: The next day animals were returned to the maze with both arms open. 

Phrase: "The next day animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "returned to the maze"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0332156:Return to [Qualitative Concept]
           Return
   770   C0083355:MAZE [Therapeutic or Preventive Procedure]
   770   C0870866:maze [Manufactured Object]

Phrase: "with both arms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0206655:ARMS [Neoplastic Process]
  1000   C0446516:Arm [Body Location or Region]
  1000   C1269078:Arm [Body Part, Organ, or Organ Component]
  1000   C1269612:Arm [Body Location or Region]
  1000   C2681631:ARMS [Gene or Genome]
   944 E C0445456:Brachial [Spatial Concept]

Phrase: "open."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]
Processing 00000000.tx.107: The first arm to be visited was noted. 

Phrase: "The first arm to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0446516:Arm [Body Location or Region]
   827   C1269078:Arm [Body Part, Organ, or Organ Component]
   827   C1269612:Arm [Body Location or Region]
   771 E C0445456:Brachial [Spatial Concept]
   743 E C0206655:ARMS [Neoplastic Process]
   743 E C2681631:ARMS [Gene or Genome]

Phrase: "be"

Phrase: "visited"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0545082:Visit [Behavior]
   966   C1512346:visit [Health Care Activity]
   966   C2826704:VISIT [Intellectual Product]

Phrase: "was"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.108: Wild-type mice showed a higher probability of visiting the previously unknown arm than the parkin mutant mice. 

Phrase: "Wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a higher probability of visiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033204:Probability [Quantitative Concept]

Phrase: "the previously unknown arm than the parkin mutant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0446516:Arm [Body Location or Region]
   742   C1269078:Arm [Body Part, Organ, or Organ Component]
   742   C1269612:Arm [Body Location or Region]
Processing 00000000.tx.109: *P<0.05 (Fisher's exact test). 

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(Fisher's exact test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0325045:Fisher [Mammal]
   827   C0392366:test [Intellectual Product]
   827   C2828393:Exact [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.110: (C) Hanging thread test: the data show the longest time that animals of 12 months of age managed to hang on to the taught string (best of three trials). 

Phrase: "(C) Hanging thread test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   812   C1710394:Thread [Manufactured Object]
   812   C1882475:Thread [Intellectual Product]

Phrase: ":"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the longest time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "that animals of 12 months of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003062:Animals [Animal]

Phrase: "managed to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1273870:Managed [Occupational Activity]

Phrase: "hang on to the taught string"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0183652:string [Medical Device]
   753   C0348054:Taught [Qualitative Concept]
   753   C0544691:hang [Injury or Poisoning]
   753   C1547402:String [Idea or Concept]
   753   C1823998:HANG [Gene or Genome]
   753   C3540771:String [Intellectual Product]
   719 E C0039401:teach [Educational Activity]

Phrase: "(best of three trials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522427:Best [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.111: There was no difference between hanging times achieved by naive wild-type (open bars) and mutant mice (hatched bars) and no difference between the number of animals refusing to try the test (n=3/28 wild-type versus 3/25 mutant). 

Phrase: "There"

Phrase: "was"

Phrase: "no difference between hanging times"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1442103:Time Difference [Temporal Concept]
   781   C1547049:*Time Difference [Quantitative Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "achieved by naive wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(open bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(hatched bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "no difference between the number of animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "refusing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0017095:Refuse [Environmental Effect of Humans]
   966   C1705116:Refuse [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "try"

Phrase: "the test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "(n=3/28 wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1883559:Wild Type [Organism Attribute]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "versus"

Phrase: "3/25 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: ")."
Processing 00000000.tx.112: However, when animals were re-exposed to the test 3 months later, a significantly higher proportion of wild-type animals refused to grip the string. 

Phrase: "However,"

Phrase: "when"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "re-exposed to the test 3 months later,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0332157:Exposed to [Clinical Attribute]
           Exposed
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C0439231:months [Temporal Concept]
   744   C2986904:RE [Idea or Concept]
   711 E C0439507:/month [Temporal Concept]

Phrase: "a significantly higher proportion of wild-type animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709707:Proportion [Quantitative Concept]

Phrase: "refused"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1548564:Refused [Idea or Concept]
  1000   C1705116:Refused [Activity]
   966 E C0017095:Refuse [Environmental Effect of Humans]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "grip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021400:GRIP [Disease or Syndrome]
  1000   C0220843:Grip [Organism Function]

Phrase: "the string."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0183652:string [Medical Device]
  1000   C1547402:String [Idea or Concept]
  1000   C3540771:String [Intellectual Product]
   900 E C1704523:Stringiness [Finding]
Processing 00000000.tx.113: *P<0.05 (Fischer's exact test). 

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(Fischer's exact test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: (D) Basal motor activity in control wild-type (open bar) and parkin mutant mice (shaded bar) at 6 months of age. 

Phrase: "("

Phrase: "D)"

Phrase: "Basal motor activity in control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0026606:Motor Activity [Daily or Recreational Activity]
   806   C1321502:motor activity [Molecular Function]
   762   C1706449:Active Control [Research Activity]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(open bar)"

Phrase: "and"

Phrase: "parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(shaded bar) at 6 months of age."
Processing 00000000.tx.115: Motor activity was decreased in the parkin mutant mice. 

Phrase: "Motor activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0026606:Motor Activity [Daily or Recreational Activity]
  1000   C1321502:motor activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "decreased in the parkin mutant mice."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1418270:PARKIN [Gene or Genome]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.116: ***P<0.001 (Student's t-test). 

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.117: (E) Amphetamine-induced motor activity in control wild type (shaded diamond) and parkin mutant mice (open triangle) at 6 months of age. 

Phrase: "(E) Amphetamine-induced motor activity in control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0026606:Motor Activity [Daily or Recreational Activity]
   778   C1321502:motor activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   738   C1706449:Active Control [Research Activity]

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(shaded diamond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0057717:Diamond [Element, Ion, or Isotope]
   861   C1706341:Diamond [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(open triangle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:Triangle [Conceptual Entity]

Phrase: ")"

Phrase: "at 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.118: The data show the cumulative amount of motor activity at 6 months of age in mice treated with amphetamine (0.55mg/kg, i.p.) over a period of 1h before and after treatment with amphetamine and the meanSEM of the counts observed during the periods of 5min expressed as a percentage of baseline for each group. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the cumulative amount of motor activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "at 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "treated with amphetamine"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(0.55mg/kg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]

Phrase: "i.p.) over a period of 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "before"

Phrase: "and after treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0001758:After-Treatment [Health Care Activity]
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1515981:And [Idea or Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with amphetamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the meanSEM of the counts"

Phrase: "observed during the periods of 5min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1441672:Observed [Functional Concept]
   719   C0439531:/period [Temporal Concept]
   719   C1948053:Period [Temporal Concept]

Phrase: "expressed as a percentage of baseline"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0168634:baseline [Biomedical or Dental Material]
   753   C0439165:Percentage [Quantitative Concept]
   753   C1442488:Baseline [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "for each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.119: Amphetamine (0.5mg/kg) reduced motor activity to a similar extent in both mutant and wild-type groups. 

Phrase: "Amphetamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(0.5mg/kg) reduced motor activity to a similar extent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0026606:Motor Activity [Daily or Recreational Activity]
   760   C1321502:motor activity [Molecular Function]
   757   C0086439:Reduced Activity [Sign or Symptom]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "in both mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "wild-type groups."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.120: Amphetamine (1 and 5mg/kg) increased motor activity in wild-type, but not in mutant mice. 

Phrase: "Amphetamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "5mg/kg) increased motor activity in wild-type,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0474395:Increased motor activity, NOS [Finding]
           increased activity
   770   C0026606:Motor Activity [Daily or Recreational Activity]
   770   C1321502:motor activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "not in mutant mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   770   C1518422:Not [Functional Concept]
Processing 00000000.tx.121: Motor activity was evaluated in groups of five animals. 

Phrase: "Motor activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0026606:Motor Activity [Daily or Recreational Activity]
  1000   C1321502:motor activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "evaluated in groups of five animals."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C1642385:Animal group [Group]
   753   C0003062:Animals [Animal]
   753   C0205451:Five [Quantitative Concept]
   753   C0220825:Evaluated [Functional Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
Processing 00000000.tx.122: ***P<0.001 (Student's t-test).  

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: Spontaneous and amphetamine-induced motor activity Amphetamine (0.5mg/kg) reduced locomotor activity in both mutant and wild type mice, and the percentage reduction with respect to the baseline was similar for both groups (Fig.4E). 

Phrase: "Spontaneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205359:Spontaneous [Functional Concept]

Phrase: "and"

Phrase: "amphetamine-induced motor activity Amphetamine"

Phrase: "(0.5mg/kg) reduced locomotor activity in both mutant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0026606:Locomotor Activity [Daily or Recreational Activity]
   762   C0086439:Reduced Activity [Sign or Symptom]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "wild type mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the percentage reduction with respect to the baseline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "similar for both groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: Spontaneous motor activity in familiar environments was reduced in parkin mutant mice at 6 months of age (Fig.4D). 

Phrase: "Spontaneous motor activity in familiar environments"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0026606:Motor Activity [Daily or Recreational Activity]
   790   C1321502:motor activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0205359:Spontaneous [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1513492:Motor [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]
   753   C1705994:Motor [Manufactured Object]

Phrase: "was"

Phrase: "reduced in parkin mutant mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "at 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age (Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.125: Amphetamine (15mg/kg) significantly increased motor activation in wild-type, but not in parkin mutant mice (Fig.4E). 

Phrase: "Amphetamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(15mg/kg) significantly increased motor activation in wild-type,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]

Phrase: "but"

Phrase: "not in parkin mutant mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1418270:PARKIN [Gene or Genome]
   760   C1518422:Not [Functional Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: Since amphetamine is thought to release newly formed, mostly cytoplasmic, catecholamines, rather than vesicular catecholamines, these findings suggest that deregulation of parkin function alters the handling of intracytoplasmic neurotransmitters. 

Phrase: "Since"

Phrase: "amphetamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750546:newly [Idea or Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ","

Phrase: "mostly cytoplasmic, catecholamines,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0007412:Catecholamines [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   793 E C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "rather than"

Phrase: "vesicular catecholamines,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007412:Catecholamines [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827 E C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that deregulation of parkin function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880287:Deregulation [Activity]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the handling of intracytoplasmic neurotransmitters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018578:Handling [Behavior]
   760   C1832073:Handling [Finding]
Processing 00000000.tx.127: Monoamine metabolism in parkin mutant mice The levels of 5-HT and 5-HIAA in the striatum, limbic system, diencephalon and brainstem were similar in both wild type and mutant animals at 11 months of age (Table 1 and Fig.5AD), suggesting that the metabolism of 5-HT is not altered by parkin dysfunction. 

Phrase: "Monoamine metabolism in parkin mutant mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "The levels of 5-HT"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0456951:Level 5 [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "5-HIAA in the striatum,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   869   C0020361:5-Hydroxy-indoleacetic acid [Organic Chemical]
   800   C0936060:Indoleacetic acid [Hormone,Organic Chemical]
   770   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   770   C0000985:Acetic acid [Organic Chemical]
   744   C0001128:Acid [Chemical]
   744   C0021236:indole [Organic Chemical,Pharmacologic Substance]
   744   C0021242:Indole [Organic Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]

Phrase: "limbic system,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0023715:Limbic System [Body System]
  1000   C1283887:Limbic system [Body System]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "diencephalon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012144:Diencephalon [Body Part, Organ, or Organ Component]
  1000   C1281065:Diencephalon [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "brainstem"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "similar in both wild type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "mutant animals at 11 months of age (Table 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "Fig.5AD"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the metabolism of 5-HT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by parkin dysfunction."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0392747:Altered [Functional Concept]
   770   C1418270:PARKIN [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.128: The endogenous levels of dopamine were increased in the limbic regions of parkin mutant mice and the ratios of DOPAC/DA and DOPAC/3-MT were also increased in mutant mice (Table 1 and Fig.5AD). 

Phrase: "The endogenous levels of dopamine"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "increased in the limbic regions of parkin mutant mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1418270:PARKIN [Gene or Genome]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0017446:Region [Geographic Area]
   708   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "the ratios of DOPAC/DA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "DOPAC/3-MT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0886584:Methyl tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "increased in mutant mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig.5AD"

Phrase: ")."
Processing 00000000.tx.129: Increased dopamine levels and increased dopamine metabolism to DOPAC via monoamino oxidase (MAO), an enzyme considered to be mostly intraneuronal, and to 3-MT via catechol-ortho-methyl-tranferase (COMT), an enzyme considered mostly extraneuronal, suggests that parkin dysfunction impairs the release of dopamine and increases intraneuronal dopamine metabolism via MAO. 

Phrase: "Increased dopamine levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "increased dopamine metabolism to DOPAC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1154437:dopamine metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "via monoamino oxidase (MAO),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "an enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mostly intraneuronal,"

Phrase: "and to 3-MT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C0066300:methyl-3-tyrosine [Amino Acid, Peptide, or Protein]
   806   C0886584:Methyl tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1515981:And [Idea or Concept]

Phrase: "via catechol-ortho-methyl-tranferase (COMT),"

Phrase: "an enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "mostly extraneuronal,"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "impairs"

Phrase: "the release of dopamine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "intraneuronal dopamine metabolism via MAO."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1154437:dopamine metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.130: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.131: Monoamine metabolism in limbic system, striatum, diencephalon and brain stem of wild-type and knockout mice for parkin  View larger version (34K): [in this window] [in a new window]  Figure 5. 

Phrase: "Monoamine metabolism in limbic system,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "striatum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "diencephalon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012144:Diencephalon [Body Part, Organ, or Organ Component]
  1000   C1281065:Diencephalon [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "brain stem of wild-type"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
   806   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0242767:Stem [Plant]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "knockout mice for parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0206745:Knock-out Mice [Mammal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.132: Monoamine metabolism in parkin mutant mice is shifted towards the H2O2 producing MAO pathway, and a compensatory increase in GSH levels. 

Phrase: "Monoamine metabolism in parkin mutant mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "shifted towards the H2O2 producing MAO pathway,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0333051:shifted [Functional Concept]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   711 E C2347509:Shift [Phenomenon or Process]

Phrase: "and"

Phrase: "a compensatory increase in GSH levels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]
Processing 00000000.tx.133: (A) Monoamine and metabolites in limbic system. 

Phrase: "(A) Monoamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599682:monoamine [Organic Chemical]

Phrase: "and"

Phrase: "metabolites in limbic system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0870883:Metabolites [Biologically Active Substance]
   770   C2698672:METABOLITES [Regulation or Law]
Processing 00000000.tx.134: (B) Monoamine and metabolites in the striatum. 

Phrase: "(B) Monoamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599682:monoamine [Organic Chemical]

Phrase: "and"

Phrase: "metabolites in the striatum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0870883:Metabolites [Biologically Active Substance]
   770   C2698672:METABOLITES [Regulation or Law]
Processing 00000000.tx.135: (C) Monoamine and metabolites in the diencephalon. 

Phrase: "(C) Monoamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599682:monoamine [Organic Chemical]

Phrase: "and"

Phrase: "metabolites in the diencephalon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0870883:Metabolites [Biologically Active Substance]
   770   C2698672:METABOLITES [Regulation or Law]
Processing 00000000.tx.136: (D) Monoamine and metabolites in the brain stem. 

Phrase: "("

Phrase: "D)"

Phrase: "Monoamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599682:monoamine [Organic Chemical]

Phrase: "and"

Phrase: "metabolites in the brain stem."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0870883:Metabolites [Biologically Active Substance]
   760   C2698672:METABOLITES [Regulation or Law]
Processing 00000000.tx.137: (E) GSH levels in striatum. 

Phrase: "(E) GSH levels in striatum."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1260386:GSH [Disease or Syndrome]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.138: (F) GSH levels in fetal ventral mid brain neuronal cultures. 

Phrase: "(F) GSH levels in fetal ventral mid brain neuronal cultures."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   739   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0441889:Levels [Qualitative Concept]
   739   C1260386:GSH [Disease or Syndrome]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.139: Wild-type and parkin mutant mice at 11 months of age. 

Phrase: "Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "parkin mutant mice at 11 months of age."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
Processing 00000000.tx.140: (AD) Results were calculated as ng/g of fresh tissue and then expressed as a ratio. 

Phrase: "(AD) Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "calculated as ng/g of fresh tissue"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1519521:Fresh Tissue [Tissue]
   778   C1627892:ng/g [Quantitative Concept]
   748   C0040300:Tissue [Tissue]
   748   C0439267:g% [Quantitative Concept]
   748   C0443224:Fresh [Qualitative Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1547928:Tissue [Intellectual Product]
   748   C2827486:Fresh [Body Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "expressed as a ratio."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.141: (E) Results are expressed as mg GSH/g of fresh tissue. 

Phrase: "(E) Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as mg GSH/g of fresh tissue."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C1519521:Fresh Tissue [Tissue]
   767   C1300563:mg/g [Quantitative Concept]
   744   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040300:Tissue [Tissue]
   744   C0439267:g% [Quantitative Concept]
   744   C0439269:mg% [Quantitative Concept]
   744   C0443224:Fresh [Qualitative Concept]
   744   C1260386:GSH [Disease or Syndrome]
   744   C1547928:Tissue [Intellectual Product]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C2827486:Fresh [Body Substance]
Processing 00000000.tx.142: (F) Results are expresed as ng GSH/mg protein. 

Phrase: "(F) Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expresed as ng GSH/mg protein."
Processing 00000000.tx.143: Values are the meanSEM (n=69). 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the meanSEM"

Phrase: "(n=69"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0450388:69 [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.144: Statistical analysis was performed by one-way analysis of variance, followed by the NewmanKleus multiple comparision test. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by one-way analysis of variance,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   897   C1709320:One-way Analysis of Variance [Quantitative Concept]
   814   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   778   C1550369:Performed By [Qualitative Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205447:One [Quantitative Concept]
   748   C0884358:Performed [Functional Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "followed by the NewmanKleus multiple comparision test."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C0439064:Multiple [Quantitative Concept]
   714 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.145: *P<0.05; 

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.146: **P<0.01, ***P<0.001.  

Phrase: "*"

Phrase: "*P<0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.147: To determine which cellular compartment of dopamine is shifted to intraneuronal oxidation, we investigated the turnover of catecholamines after inhibition of their synthesis by -methyl-tyrosine (-MT). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which cellular compartment of dopamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "is"

Phrase: "shifted to intraneuronal oxidation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030011:Oxidation [Molecular Function]
   770   C0333051:shifted [Functional Concept]
   737 E C2347509:Shift [Phenomenon or Process]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the turnover of catecholamines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031227:turnover [Quantitative Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]

Phrase: "after inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of their synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]

Phrase: "by -methyl-tyrosine (-MT)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0886584:Methyl tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.148: The rate of depletion of catecholamines in -MT-treated animals was similar in both mutant and wild-type animals (data not shown), suggesting that the turnover is similar in both groups. 

Phrase: "The rate of depletion of catecholamines in -MT-treated animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0871208:Rate [Activity]
   738   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "similar in both mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "wild-type animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003070:Animals, Wild [Animal]
   827   C0003062:Animals [Animal]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031227:turnover [Quantitative Concept]
  1000   C0243127:turnover [Functional Concept]
  1000   C0443331:Turnover [Health Care Activity]

Phrase: "is"

Phrase: "similar in both groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.149: Since the short term effects of -MT on catecholamines are mostly related to the turnover of the newly synthesized intracytoplasmic pool of catecholamines, rather than the vesicular pool of catecholamines, our data suggest that the increased production of DOPAC in the absence of parkin is not mediated by changes in dopamine turnover, but due to intracytoplasmatic dopamine being unprotected against metabolism by MAO. 

Phrase: "Since"

Phrase: "the short term effects of -MT on catecholamines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0886584:Methyl tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "are"

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "related to the turnover of the newly"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0031227:turnover [Quantitative Concept]
   748   C0243127:turnover [Functional Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0443331:Turnover [Health Care Activity]
   748   C0445223:Related [Finding]
   748   C0750546:newly [Idea or Concept]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "intracytoplasmic pool of catecholamines,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0337051:Pool [Geographic Area]
   770   C1509144:pool [Clinical Attribute]
   770   C2349200:Pool [Functional Concept]

Phrase: "rather than"

Phrase: "the vesicular pool of catecholamines,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0337051:Pool [Geographic Area]
   760   C1509144:pool [Clinical Attribute]
   760   C2349200:Pool [Functional Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the increased production of DOPAC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediated by changes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in dopamine turnover,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "but due to intracytoplasmatic dopamine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C3146286:Due [Idea or Concept]

Phrase: "being"

Phrase: "unprotected against metabolism"

Phrase: "by MAO."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.150: The increased dopamine metabolism by MAO was associated with an increase in the levels of reduced GSH in the striatum (Fig.5E), the brain area with the highest levels of dopamine, but not in other brain areas (data not shown). 

Phrase: "The increased dopamine metabolism by MAO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1154437:dopamine metabolism [Molecular Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]

Phrase: "was"

Phrase: "associated with an increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0442805:Increase [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of reduced GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1260386:GSH [Disease or Syndrome]

Phrase: "in the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "(Fig.5E"

Phrase: ")"

Phrase: ","

Phrase: "the brain area with the highest levels of dopamine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0017446:Area [Geographic Area]
   742   C0205146:Area [Spatial Concept]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "not in other brain areas"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0205146:areas [Spatial Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1518422:Not [Functional Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.151: There were no significant differences in the GSSG levels (data not shown). 

Phrase: "There"

Phrase: "were"

Phrase: "no significant differences in the GSSG levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.152: To further evaluate the changes of GSH in dopamine rich areas, we measured GSH levels in neuronal enriched cultured cells from ventral fetal mid brain. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the changes of GSH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C0025320:The change [Physiologic Function]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in dopamine rich areas,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "GSH levels in neuronal enriched cultured cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1260386:GSH [Disease or Syndrome]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "from ventral fetal mid brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0440731:Fetal brain [Embryonic Structure]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.153: We found that there was an increase of GSH levels in dopamine rich areas of parkin mutant mice from the fetal period (Fig.5F). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that there"

Phrase: "was"

Phrase: "an increase of GSH levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in dopamine rich areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]

Phrase: "of parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "from the fetal period"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0580204:Fetal period [Temporal Concept]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "(Fig.5F"

Phrase: ")."
Processing 00000000.tx.154: [3H]-DA release and [3H]-DA uptake in fetal midbrain neuronal-enriched cultures Both basal release of [3H]-DA and K+-evoked [3H]-DA release, which is mainly an index of vesicular dopamine release, were similar in neuronal cultures from wild type and parkin mutant mice (Fig.6A). 

Phrase: "[3H]-DA release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "3H]-DA uptake in fetal midbrain neuronal-enriched cultures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1657587:dopamine uptake [Cell Function]
   742   C0243144:Uptake [Physiologic Function]
   742   C0347980:% uptake [Quantitative Concept]

Phrase: "Both basal release of [3H]-DA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   804   C1442460:3H [Temporal Concept]

Phrase: "and"

Phrase: "K+-evoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1444748:Evoked [Qualitative Concept]

Phrase: "[3H]-DA release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "mainly"

Phrase: "an index of vesicular dopamine release,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0918012:Index [Intellectual Product]
   753   C1552854:index [Idea or Concept]
   753   C1637833:% index [Quantitative Concept]

Phrase: "were"

Phrase: "similar in neuronal cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "from wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Fig.6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.155: However, amphetamine-induced [3H]-DA release, which is mainly an index of newly synthesized neurotransmitter release, was significantly decreased in neuronal cultures from parkin mutant mice compared to wild-type (Fig.6A). 

Phrase: "However,"

Phrase: "amphetamine-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[3H]-DA release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "mainly"

Phrase: "an index of newly synthesized neurotransmitter release,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0918012:Index [Intellectual Product]
   748   C1552854:index [Idea or Concept]
   748   C1637833:% index [Quantitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased in neuronal cultures"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0010453:Cultures [Idea or Concept]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "from parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "compared to wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "(Fig.6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.156: [3H]-DA uptake was also significantly decreased in fetal midbrain cultures from parkin mutant mice compared with wild type (Fig.6B). 

Phrase: "[3H]-DA uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1657587:dopamine uptake [Cell Function]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "also significantly"

Phrase: "decreased in fetal midbrain"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0015965:Fetal [Embryonic Structure]
   770   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C0521457:Fetal [Functional Concept]
   770   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "cultures from parkin mutant mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0010453:Culture [Idea or Concept]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1418270:PARKIN [Gene or Genome]
   760   C2242979:Culture [Laboratory Procedure]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "compared with wild type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "(Fig.6B"

Phrase: ")."
Processing 00000000.tx.157: This data is in agreement with the reduction of DAT protein levels, suggesting that there is a decrease in both dopamine transporter protein expression and function in parkin mutant mice. 

Phrase: "This data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with the reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of DAT protein levels,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "a decrease in both dopamine transporter protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "function in parkin mutant mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.158: View larger version (35K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.159: Parkin mutant mice have normal basal spontaneous release of [3H]-dopamine and KCl-induced release of [3H]-dopamine, but reduced amphetamine-induced release of [3H]-dopamine as well as reduced [3H]-dopamine uptake. 

Phrase: "Parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "normal basal spontaneous release of [3H]-dopamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   795   C1442460:3H [Temporal Concept]

Phrase: "and"

Phrase: "KCl-induced release of [3H]-dopamine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   799   C1442460:3H [Temporal Concept]

Phrase: "but"

Phrase: "reduced amphetamine-induced release of [3H]-dopamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   795   C1442460:3H [Temporal Concept]

Phrase: "as well as"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "[3H]-dopamine uptake."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1657587:dopamine uptake [Cell Function]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.160: (A) [3H]-DA release in 7 DIV-old cultures from fetal (E13) midbrain mice are the meanSEM (n=46). 

Phrase: "(A) [3H]-DA release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in 7 DIV-old cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "from fetal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015965:Fetal [Embryonic Structure]
  1000   C0521457:Fetal [Functional Concept]

Phrase: "(E13"

Phrase: ")"

Phrase: "midbrain mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "the meanSEM"

Phrase: "(n=46"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.161: Statistical analysis was performed by one-way analysis of variance followed by the NewmanKeuls multiple comparison test. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by one-way analysis of variance"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   897   C1709320:One-way Analysis of Variance [Quantitative Concept]
   814   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   778   C1550369:Performed By [Qualitative Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205447:One [Quantitative Concept]
   748   C0884358:Performed [Functional Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "followed by the NewmanKeuls multiple comparison test."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C0439064:Multiple [Quantitative Concept]
   748   C1707455:Comparison [Activity]
   714 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.162: ***P<0.001 for amphetamine-induced [3H]-DA release in parkin mutant versus wild-type mice. 

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001 for amphetamine-induced"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2603361:P' [Clinical Attribute]

Phrase: "[3H]-DA release in parkin mutant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "versus"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.163: (B) [3H]-DA uptake in 7 DIV-old cultures from fetal (E13) midbrain mice are the meanSEM (n=12). 

Phrase: "(B) [3H]-DA uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1657587:dopamine uptake [Cell Function]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "in 7 DIV-old cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "from fetal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015965:Fetal [Embryonic Structure]
  1000   C0521457:Fetal [Functional Concept]

Phrase: "(E13"

Phrase: ")"

Phrase: "midbrain mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "the meanSEM"

Phrase: "(n=12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.164: Statistical analysis was performed by one-way analysis of variance followed by the NewmanKeuls multiple comparison test. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by one-way analysis of variance"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   897   C1709320:One-way Analysis of Variance [Quantitative Concept]
   814   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   778   C1550369:Performed By [Qualitative Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205447:One [Quantitative Concept]
   748   C0884358:Performed [Functional Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "followed by the NewmanKeuls multiple comparison test."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C0439064:Multiple [Quantitative Concept]
   748   C1707455:Comparison [Activity]
   714 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.165: ***P<0.001 parkin mutant versus wild-type mice.  

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001 parkin mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "versus"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.166: Deficits in glutamate synaptic transmission in parkin mutant mice The deficits in dopamine neurotransmission prompted us to examine the effects of parkin deletion on the pre- and postsynaptic properties of other synaptic systems. 

Phrase: "Deficits in glutamate synaptic transmission"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "in parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "The deficits in dopamine neurotransmission"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effects of parkin deletion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the pre-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332152:Pre [Temporal Concept]
  1000   C0740175:Pre [Qualitative Concept]
  1000   C2257086:PRE [Genetic Function]

Phrase: "and"

Phrase: "postsynaptic properties of other synaptic systems."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]
Processing 00000000.tx.167: To this end, we examined glutamatergic synaptic transmission in hippocampal slices from wild type and parkin mutant mice. 

Phrase: "To this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "glutamatergic synaptic transmission in hippocampal slices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1523698:synaptic transmission, glutamatergic [Cell Function]
   790   C0027793:Synaptic Transmission [Cell Function]
   753   C0040722:transmission [Idea or Concept]
   753   C0242781:Transmission [Pathologic Function]
   753   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "from wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "parkin mutant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.168: First, we analyzed basal synaptic transmission by applying isolated stimuli of increasing intensity to the Schaffer collaterals. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "basal synaptic transmission by applying isolated stimuli of increasing intensity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0027793:Synaptic Transmission [Cell Function]
   739   C0040722:transmission [Idea or Concept]
   739   C0242781:Transmission [Pathologic Function]
   739   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "to the Schaffer collaterals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C3544403:Schaffer collateral [Cell Component]
   827   C1275670:Collateral [Body Part, Organ, or Organ Component]
   827   C1948058:Collateral [Spatial Concept]
Processing 00000000.tx.169: The shape of the resulting glutamatergic extracellular field excitatory post-synaptic potentials (EPSPs) appeared identical in slices from parkin mutant mice and wild-type controls. 

Phrase: "The shape of the resulting glutamatergic extracellular field excitatory post-synaptic potentials (EPSPs)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0332479:Shape [Spatial Concept]
   736   C0348078:shape [Qualitative Concept]
   736   C0522512:Shape [Spatial Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "identical in slices"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "from parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "wild-type controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.170: There was also no evidence for abnormal excitability, such as traces of repeated action-potential firing. 

Phrase: "There"

Phrase: "was"

Phrase: "also"

Phrase: "no evidence for abnormal excitability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "such as traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "of repeated action-potential firing."
Processing 00000000.tx.171: However, the amplitude of the EPSPs was smaller in the parkin mutant mice (Fig.7A and B). 

Phrase: "However,"

Phrase: "the amplitude of the EPSPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "smaller in the parkin mutant mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0547044:Smaller [Qualitative Concept]
   753   C0700321:Smaller [Quantitative Concept]

Phrase: "(Fig.7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.172: View larger version (23K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.173: Parkin mutant mice have deficits in glutamate transmission at hippocampal Schaeffer collateral-CA1 synapses. 

Phrase: "Parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "deficits in glutamate transmission"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C2987487:deficits [Qualitative Concept]
   737 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "at hippocampal Schaeffer collateral-CA1 synapses."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0039062:Synapses [Body Space or Junction]
   771 E C0598501:Synapsis [Cell Function]
   771 E C1633000:Synapsis [Plant]
Processing 00000000.tx.174: (A) Superimposed representative tracings of EPSPs elicited by stimulation of increasing strength in a slice prepared from a wild-type mice (+/+, upper panel) and a parkin mutant mice (-/-, lower panel). 

Phrase: "(A)"

Phrase: "Superimposed"

Phrase: "representative tracings of EPSPs"

Phrase: "elicited by stimulation of increasing strength"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0449265:Elicited by [Qualitative Concept]
           elicited
   753   C0237897:Strength [Quantitative Concept]
   753   C0442808:Increasing [Functional Concept]
   753   C0808080:Strength [Idea or Concept]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1705922:Strength [Qualitative Concept]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in a slice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519355:Slice [Substance]

Phrase: "prepared from a wild-type mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   799   C1520150:Wild Type Mouse [Mammal]
   790   C1883559:Wild Type [Organism Attribute]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   719   C1521827:Prepare [Functional Concept]

Phrase: "(+/+,"

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "a parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(-/-,"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.175: (B) Mean (SEM) amplitude of the EPSPs plotted as a function of stimulus intensity showing the significantly smaller EPSPs size in parkin mutant animals (closed triangles, n=7 slices from four male mutant mice) with respect to wild-type controls (open circles, n=8, four male mice). 

Phrase: "(B) Mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0444504:Mean [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]

Phrase: "(SEM) amplitude of the EPSPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2346753:Amplitude [Spatial Concept]

Phrase: "plotted as a function of stimulus intensity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0237686:Stimulus Intensity [Quantitative Concept]
   774   C0234402:Stimulus, function [Phenomenon or Process]
           Stimulus
   748   C0031843:function [Physiologic Function]
   748   C0522510:Intensity [Qualitative Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the significantly smaller EPSPs size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C0748864:small size [Finding]
   791   C0456389:size [Spatial Concept]

Phrase: "in parkin mutant animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "(closed triangles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:triangles [Conceptual Entity]

Phrase: "n=7 slices from four male mutant mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1519355:Slice [Substance]

Phrase: ")"

Phrase: "with respect to wild-type controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(open circles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: "n=8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "four male mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: ")."
Processing 00000000.tx.176: The decreased EPSP amplitudes in parkin mutant mice were highly significant versus stimulation intensity data over the nine levels of intensities tested (F1,116=23.42; P<0.001). 

Phrase: "The decreased EPSP amplitudes in parkin mutant mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C2346753:Amplitude [Spatial Concept]

Phrase: "were"

Phrase: "highly significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1299395:Highly significant [Qualitative Concept]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "versus"

Phrase: "stimulation intensity data over the nine levels of intensities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1511726:Data [Idea or Concept]
   742   C3245479:data [Medical Device]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(F1,116"

Phrase: "=23.42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "; P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.177: Bonferoni post-tests indicated that the average size of the EPSPs were significantly different at 200A (23770 and 556128V, meanSEM for mutant and wild-type, respectively, P<0.05) and 225A (32390 and 694150V, P<0.05). 

Phrase: "Bonferoni"

Phrase: "post-tests"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   827 E C0039593:Test [Functional Concept]
   789 E C1514253:Postal [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the average size of the EPSPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0456389:size [Spatial Concept]

Phrase: "were"

Phrase: "significantly different at 200A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "(23770"

Phrase: "and"

Phrase: "556128V,"

Phrase: "meanSEM for mutant"

Phrase: "and"

Phrase: "wild-type, respectively,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "225A"

Phrase: "(32390"

Phrase: "and"

Phrase: "694150V,"

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.178: (C) Magnitude of paired-pulse facilitation. 

Phrase: "(C) Magnitude of paired-pulse facilitation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449286:magnitude [Quantitative Concept]
   753   C1704240:Magnitude [Quantitative Concept]
Processing 00000000.tx.179: Plot of the mean (SEM) percentage increase of the second EPSP with respect to the first EPSP as a function of interstimulation interval (same symbols and number of replicates as in B). 

Phrase: "Plot of the mean"

Phrase: "(SEM) percentage increase of the second EPSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "with respect to the first EPSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524913:EPSP [Organ or Tissue Function]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of interstimulation interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: "(same symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "and"

Phrase: "number of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0237753:*Number [Quantitative Concept]
   833   C0449788:Number [Quantitative Concept]

Phrase: "replicates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "as in B"

Phrase: ")."
Processing 00000000.tx.180: In parkin mutant mice there was a significant increase on the facilitation ratios (F1,78=7.795; P<0.01), but there was no significant difference in the average PPF ratios at any of the five paired-pulse intervals tested. 

Phrase: "In parkin mutant mice there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "a significant increase on the facilitation ratios"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "(F1,78"

Phrase: "=7.795"

Phrase: "; P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in the average PPF ratios"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1879649:Average Difference [Research Activity]
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "at any"

Phrase: "of the five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "paired-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Paired [Qualitative Concept]

Phrase: "pulse intervals"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0232117:PULSE [Clinical Attribute]
   861   C0391850:Pulse [Physiologic Function]
   861   C1272706:intervals [Temporal Concept]
   861   C1947910:Pulse [Phenomenon or Process]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]
   777 E C0034107:Pulses [Health Care Activity]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.181: (D) Enhanced facilitation upon repeated low frequency stimulation. 

Phrase: "("

Phrase: "D)"

Phrase: "Enhanced facilitation upon repeated low frequency stimulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0234112:Facilitation [Organ or Tissue Function]
Processing 00000000.tx.182: Amplitudes (meanSEM) of successive EPSPs in a burst of 30 applied 70 ms apart (i.e. at 14Hz) normalized with respect to the amplitude of the first EPSP of the burst (same symbols and replicates as in B). 

Phrase: "Amplitudes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2346753:Amplitude [Spatial Concept]

Phrase: "(meanSEM"

Phrase: ")"

Phrase: "of successive EPSPs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   829   C0234121:Excitatory potential [Organ or Tissue Function]
   818   C0205855:Synaptic Potentials [Organ or Tissue Function]
   795   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   795   C0687676:Post [Temporal Concept]
   795   C1521738:Field [Conceptual Entity]
   795   C1704687:Post [Manufactured Object]
   795   C2346620:Field [Conceptual Entity]
   795   C2349184:Field [Conceptual Entity]
   795   C3245505:potentials [Qualitative Concept]
   795   C3539073:FIELD [Spatial Concept]
   724 E C1514253:Postal [Functional Concept]

Phrase: "in a burst"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439818:burst [Qualitative Concept]
  1000   C1881705:BURST [Phenomenon or Process]

Phrase: "of 30"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "70 ms apart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at 14Hz"

Phrase: ")"

Phrase: "normalized with respect to the amplitude of the first EPSP of the burst"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   735   C0205435:First [Quantitative Concept]
   735   C0439818:burst [Qualitative Concept]
   735   C0524913:EPSP [Organ or Tissue Function]
   735   C0679133:respect [Social Behavior]
   735   C1279901:First [Qualitative Concept]
   735   C1881705:BURST [Phenomenon or Process]
   735   C1882115:Normalized [Research Activity]
   735   C2346753:Amplitude [Spatial Concept]

Phrase: "(same symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "and"

Phrase: "replicates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "as in B"

Phrase: ")."
Processing 00000000.tx.183: There was a significant increase in normalized EPSP amplitude in parkin mutant mice in the ANOVA (F1,390=36.81, P<0.001 compared with wild-type. 

Phrase: "There"

Phrase: "was"

Phrase: "a significant increase in normalized EPSP amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "in the ANOVA (F1,390"

Phrase: "=36.81,"

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with wild-type."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1707455:Compared [Activity]
Processing 00000000.tx.184: (E) Normal LTP in both wild-type and parkin mutant mice. 

Phrase: "(E) Normal LTP in both wild-type"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   790   C2984294:Long-term potentiation [Functional Concept]
   764   C0443252:Long-term [Temporal Concept]
   762   C1710371:Term Type [Idea or Concept]
   742   C0205166:Long [Qualitative Concept]
   742   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   742   C1515273:Term [Temporal Concept]
   742   C1705313:Term [Idea or Concept]
   742   C1706317:Long [Qualitative Concept]
   742   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "parkin mutant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.185: Plot of the mean (SEM) amplitude of the EPSPs versus time. 

Phrase: "Plot of the mean"

Phrase: "(SEM) amplitude of the EPSPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2346753:Amplitude [Spatial Concept]

Phrase: "versus"

Phrase: "time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.186: Data were normalized for each slice with respect to the average amplitude recorded during baseline. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "normalized for each slice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1519355:Slice [Substance]
   770   C1882115:Normalized [Research Activity]

Phrase: "with respect to the average amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "recorded during baseline."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0168634:baseline [Biomedical or Dental Material]
   790   C1442488:Baseline [Quantitative Concept]
   756   C0034869:Record [Intellectual Product]
Processing 00000000.tx.187: Shown in insert are representative superimposed tracings taken before and after LTP induction (theta-burst stimulation, arrow) in wild-type mice (+/+) and a parkin mutant mice (-/-).  

Phrase: "Shown in insert"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441587:Insert [Health Care Activity]
   790   C1743766:Insert [Medical Device]
   790   C1883719:Insert [Functional Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative superimposed tracings"

Phrase: "taken before"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "and after LTP induction"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   833   C2984294:Long-term potentiation [Functional Concept]
   790   C0443252:Long-term [Temporal Concept]
   753   C0205166:Long [Qualitative Concept]
   753   C0205263:Induction [Functional Concept]
   753   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
   753   C1515273:Term [Temporal Concept]
   753   C1515981:And [Idea or Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2826302:TERM [Intellectual Product]

Phrase: "(theta-burst stimulation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0439101:Theta [Intellectual Product]
   827   C0439818:burst [Qualitative Concept]
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1422662:THETA [Gene or Genome]
   827   C1881705:BURST [Phenomenon or Process]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "in wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(+/+"

Phrase: ")"

Phrase: "and"

Phrase: "a parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(-/-"

Phrase: ")."
Processing 00000000.tx.188: We then examined paired pulse facilitation (PPF), a phenomenon whereby the second pulse of a pair applied in rapid succession elicits increased EPSP when the interval is sufficiently short (<500ms). 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "paired pulse facilitation (PPF),"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0234112:Facilitation [Organ or Tissue Function]
   827   C0391850:Pulse [Physiologic Function]
   827   C1709450:Paired [Qualitative Concept]
   827   C1947910:Pulse [Phenomenon or Process]
   743 E C0034107:Pulses [Health Care Activity]

Phrase: "a phenomenon whereby"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "the second pulse of a pair"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C1947910:Pulse [Phenomenon or Process]
   742   C0556967:pulses/second [Quantitative Concept]

Phrase: "applied in rapid succession"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C0439831:Rapid [Qualitative Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "increased EPSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524913:EPSP [Organ or Tissue Function]

Phrase: "when"

Phrase: "the interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1272706:Interval [Temporal Concept]
  1000   C1552654:Interval [Idea or Concept]
  1000   C1552713:Interval [Intellectual Product]

Phrase: "is"

Phrase: "sufficiently short"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1282927:short [Qualitative Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]

Phrase: "("

Phrase: "<500ms"

Phrase: ")."
Processing 00000000.tx.189: This phenomenon reflects neurotransmitter release (35). 

Phrase: "This phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "neurotransmitter release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0598964:neurotransmitter release [Cell Function]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.190: We observed a slight increase in PPF in parkin mutant animals (Fig.7C). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a slight increase in PPF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in parkin mutant animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "(Fig.7C"

Phrase: ")."
Processing 00000000.tx.191: We therefore activated the pathway in a more sustained manner by applying trains of 30 pulses at a fixed frequency of 14Hz. 

Phrase: "We therefore"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the pathway in a more sustained manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "by applying trains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0336809:Train [Manufactured Object]
   827   C1552514:Train [Manufactured Object]

Phrase: "of 30 pulses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0034107:Pulses [Health Care Activity]
   861   C0391850:PULSES [Physiologic Function]
   827 E C0232117:PULSE [Clinical Attribute]
   827 E C1947910:Pulse [Phenomenon or Process]

Phrase: "at a fixed frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "of 14Hz."
Processing 00000000.tx.192: Under these conditions of low-frequency stimulation, the size of the EPSPs in the parkin mutant animals were further increased (Fig.7D). 

Phrase: "Under these conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of low-frequency stimulation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0205213:Low frequency [Temporal Concept]

Phrase: "the size of the EPSPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0456389:size [Spatial Concept]

Phrase: "in the parkin mutant animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(Fig.7D"

Phrase: ")."
Processing 00000000.tx.193: Previous studies have established that manipulations that decrease neurotransmitter release result in increased synaptic facilitation in the hippocampal slice (3537). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that manipulations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
  1000   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "neurotransmitter release result in increased synaptic facilitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "in the hippocampal slice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519355:Slice [Substance]

Phrase: "(3537"

Phrase: ")."
Processing 00000000.tx.194: Therefore, the observation of a decreased EPSP size in response to single stimulation, together with an enhanced facilitation upon repeated stimulation, suggests that deletion of parkin results in decreased presynaptic glutamate release. 

Phrase: "Therefore,"

Phrase: "the observation of a decreased EPSP size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0302523:Observation [Research Activity]
   748   C0700325:observation [Health Care Activity]
   748   C1964257:Observation [Diagnostic Procedure]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to single stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "together with an enhanced facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "upon repeated stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that deletion of parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "results in decreased presynaptic glutamate release."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0030685:Release [Health Care Activity]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0391871:Release [Functional Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1274040:Result [Functional Concept]
   753   C1283071:Release [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   753   C2825142:Result [Finding]
   719 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.195: By contrast, there was no difference in the ability to induce long-term potentiation (LTP) in slices from wild-type and parkin mutant groups (Fig.7E), suggesting that postsynaptic glutamate-mediated events are not altered in this brain region.  

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "there"

Phrase: "was"

Phrase: "no difference in the ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "long-term potentiation (LTP) in slices"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   862   C2984294:Long-term potentiation [Functional Concept]
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2826302:TERM [Intellectual Product]

Phrase: "from wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "parkin mutant groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "(Fig.7E"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that postsynaptic glutamate-mediated events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441471:Events [Event]
   812   C3541888:Events [Classification]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered in this brain region."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1273723:Brain region [Body Location or Region]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0392747:Altered [Functional Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.196: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We have generated and characterized a knock out mouse model in which exon 3 of the parkin gene has been deleted by homologous recombination. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "a knock out mouse model in which exon 3 of the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C1517490:Gene Knock-Out Model [Experimental Model of Disease]
   750   C2986594:Mouse Model [Experimental Model of Disease]
   735   C3161035:Model [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "deleted by homologous recombination."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599773:Homologous Recombination [Genetic Function]
   833   C2984295:Homologous recombination [Functional Concept]
   770   C0034865:Recombination [Genetic Function]
   770   C1334043:Homologous [Gene or Genome]
   770   C1880274:Deleted [Activity]
Processing 00000000.tx.197: Deletion of exon 3 has been shown to be one of the most common parkin mutations found in patients with autosomal recessive early-onset parkinsonism (17,19). 

Phrase: "Deletion of exon 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "one of the most common parkin mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "found in patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "with autosomal recessive early-onset parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   911   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   884   C1838631:Parkinsonism, early-onset [Finding]
   804   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "(17,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.198: As in parkinsonian patients with parkin mutations, deletion of parkin exon 3 in mice abolishes their capacity to produce the parkin protein. 

Phrase: "As in parkinsonian patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "with parkin mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "deletion of parkin exon 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "abolishes"

Phrase: "their capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "produce"

Phrase: "the parkin protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.199: These mice therefore reproduce the key protein deficit that is responsible for the pathogenesis of the most frequent cause of autosomal recessive parkinsonism. 

Phrase: "These mice therefore"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "reproduce"

Phrase: "the key protein deficit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0162429:Deficit, NOS [Disease or Syndrome]
   827   C2987487:Deficit [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "responsible for the pathogenesis of the most frequent cause of autosomal recessive parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1273518:Responsible [Finding]
Processing 00000000.tx.200: The parkin mutant mice are viable and reproduce successfully, but display behavioural, biochemical and electrophysiological changes that could help explain some aspects of the pathogenesis of PD. 

Phrase: "The parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: "and"

Phrase: "reproduce"

Phrase: "successfully,"

Phrase: "but"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "behavioural, biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "electrophysiological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "explain"

Phrase: "some aspects of the pathogenesis of PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.201: In addition, parkin mutant mice display decreased body weight and temperature. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "decreased body weight"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0043096:Decreased body weight [Finding]
           Decreased weight
   901   C0005910:Body Weight [Organism Attribute]
           weight
   901   C1305866:body weight [Diagnostic Procedure]
           weight
   827   C0043100:Weight [Quantitative Concept]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1705104:Weight [Idea or Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "temperature."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]
Processing 00000000.tx.202: The significance of the body weight and temperature changes is unclear, since similar changes have been observed in other transgenic models. 

Phrase: "The significance of the body weight"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "and"

Phrase: "temperature changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C0450031:Temperature change [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "unclear,"

Phrase: "since"

Phrase: "similar changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "observed in other transgenic models."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1519606:Transgenic Model [Experimental Model of Disease]
   760   C0003069:Transgenic [Animal]
   760   C1441672:Observed [Functional Concept]
   760   C3161035:Models [Intellectual Product]
Processing 00000000.tx.203: However, it is noteworthy that both parkin and dopaminergic signalling have been implicated in the control of body weight and thermoregulation (3841). 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "both parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "dopaminergic signalling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C3537152:signalling [Biologic Function]
   827 E C1710082:Signal [Phenomenon or Process]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in the control of body weight"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0005910:Body Weight [Organism Attribute]
           weight
   778   C1305866:body weight [Diagnostic Procedure]
           weight
   774   C0920298:Weight control [Therapeutic or Preventive Procedure]
   748   C0043100:Weight [Quantitative Concept]
   748   C0242821:body [Human]
   748   C0243148:control [Qualitative Concept]
   748   C0460148:Body [Anatomical Structure]
   748   C1268086:Body [Anatomical Structure]
   748   C1550141:Control [Substance]
   748   C1705104:Weight [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "thermoregulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005905:Thermoregulation [Organism Function]
  1000   C0262758:thermoregulation [Therapeutic or Preventive Procedure]

Phrase: "(3841"

Phrase: ")."
Processing 00000000.tx.204: Loss of parkin function is associated with deregulation of dopamine handling. 

Phrase: "Loss of parkin function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "associated with deregulation of dopamine handling."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0018578:Handling [Behavior]
   753   C1832073:Handling [Finding]
   753   C1880287:Deregulation [Activity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.205: Thus, the endogenous levels of dopamine, but not the turnover of dopamine, are increased in brain areas rich in dopamine terminals and the ratio of the MAO-derived dopamine metabolite, DOPAC, over the COMT-derived dopamine metabolite, 3-MT, was significantly greater in parkin mutant mice. 

Phrase: "Thus,"

Phrase: "the endogenous levels of dopamine,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the turnover of dopamine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031227:turnover [Quantitative Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]

Phrase: "are"

Phrase: "increased in brain areas"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205146:areas [Spatial Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0017446:Area [Geographic Area]

Phrase: "rich in dopamine terminals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0699759:Rich [Qualitative Concept]

Phrase: "and"

Phrase: "the ratio of the MAO-derived dopamine metabolite,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: "DOPAC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000376:Dihydroxyphenylacetic acid [Biologically Active Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "over the COMT-derived dopamine metabolite,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0870883:Metabolite [Biologically Active Substance]

Phrase: "3-MT,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0047729:3-tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0886584:Methyl tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "significantly greater in parkin mutant mice."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.206: These changes suggest that abolition of parkin function interferes with dopamine release. 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that abolition of parkin function"

Phrase: "interferes with dopamine release."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0521102:Interferes with [Qualitative Concept]
           Interfere
   770   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.207: Since MAO-mediated metabolism of dopamine is considered to be mainly intracellular and COMT activity is mostly extracellular, these findings suggest that there is a shift towards increased intraneuronal dopamine metabolism by MAO in parkin mutant mice. 

Phrase: "Since"

Phrase: "MAO-mediated metabolism of dopamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1154437:dopamine metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mainly intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175996:intracellular [Cell Component]
   861   C0178719:Intracellular [Spatial Concept]

Phrase: "and"

Phrase: "COMT activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "mostly extracellular,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521119:Extracellular [Cell Component]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "a shift towards increased intraneuronal dopamine metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "by MAO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in parkin mutant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.208: The increase in the oxidative reduction of dopamine by MAO should result in enhanced production of H2O2, since MAO generates one molecule of DOPAC and H2O2 per molecule of dopamine metabolized. 

Phrase: "The increase in the oxidative reduction of dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "by MAO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "should"

Phrase: "result in enhanced production of H2O2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0033268:production [Occupational Activity]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2349975:Enhanced [Activity]
   753   C2825142:Result [Finding]

Phrase: "since"

Phrase: "MAO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "generates"

Phrase: "one molecule of DOPAC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "H2O2 per molecule of dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "metabolized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524026:Metabolized [Cell Function]
Processing 00000000.tx.209: Increasing the production of H2O2 could cause neuronal damage, due to excessive production of free radicals, if the normal scavenging systems are not able to cope with the excess of oxidative stress (42). 

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the production of H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "could"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "due to excessive production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "of free radicals,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "if"

Phrase: "the normal scavenging systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "are"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "cope with the excess of oxidative stress"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0009967:cope [Individual Behavior]
   748   C0038435:Stress [Finding]
   748   C0311404:Oxidative [Functional Concept]
   748   C1979886:Excess [Qualitative Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.210: Moreover, a number of studies have implicated oxidative stress in the neuronal death associated with PD (43) and severe reductions in the levels of GSH have been observed in the substantia nigra of PD patients (44,45). 

Phrase: "Moreover,"

Phrase: "a number of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "implicated oxidative stress in the neuronal death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0038435:Stress [Finding]
   748   C0311404:Oxidative [Functional Concept]

Phrase: "associated with PD (43"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "and"

Phrase: "severe reductions in the levels of GSH"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0301630:reductions [Natural Phenomenon or Process]
   748   C0441610:reductions [Therapeutic or Preventive Procedure]
   714 E C0392756:Reduction [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "observed in the substantia nigra of PD patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   770   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C1441672:Observed [Functional Concept]

Phrase: "(44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.211: Decreased GSH levels have also been reported in human neuroblastoma and human teratoma cells transfected with mutant parkin proteins through a mechanism that appears to be independent of parkin ubiquitin ligase activity (46). 

Phrase: "Decreased GSH levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1260386:GSH [Disease or Syndrome]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported in human neuroblastoma"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0027819:Neuroblastoma [Neoplastic Process]
   770   C0086418:Human [Human]
   770   C0684224:Reported [Intellectual Product]
   770   C0700095:neuroblastoma [Neoplastic Process]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   770   C3540583:Neuroblastoma [Intellectual Product]
   737 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "human teratoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0427861:Human cells [Laboratory or Test Result]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with mutant parkin proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   790   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "through a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be independent of parkin ubiquitin ligase activity"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C1150685:ubiquitin-ligase activity [Molecular Function]
   778   C0332291:Independent of [Functional Concept]
   778   C1150651:ligase activity [Molecular Function]
   774   C1325411:ubiquitin activity [Molecular Function]
   748   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0085862:Independent [Idea or Concept]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1299583:Independent [Finding]
   748   C1418270:PARKIN [Gene or Genome]
   748   C1561536:*Activity [Idea or Concept]
   748   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C2987476:Be [Conceptual Entity]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.212: In parkin mutant mice we have detected reduced levels of DAT in the striatum, which suggests an initial damage to the presynaptic terminals of nigrostriatal dopamine neurons. 

Phrase: "In parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "we"

Phrase: "have"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "reduced levels of DAT"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the striatum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an initial damage to the presynaptic terminals of nigrostriatal dopamine neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0010957:Damage [Injury or Poisoning]
   738   C1883709:Damage [Functional Concept]
Processing 00000000.tx.213: However, since there is no obvious loss of nigrostriatal dopamine neurons in parkin mutant mice, it is possible that these animals develop more powerful free radical protecting systems than the wild-type. 

Phrase: "However,"

Phrase: "since"

Phrase: "there"

Phrase: "is"

Phrase: "no obvious loss of nigrostriatal dopamine neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0598940:Loss of neurons [Finding]
           neuron loss
   748   C1517945:Loss [Quantitative Concept]
   732 E C1850496:Neuronal loss [Finding]

Phrase: "in parkin mutant mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "develop"

Phrase: "more powerful free radical protecting systems than the wild-type."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0449913:System [Functional Concept]
   706   C1553451:System [Manufactured Object]
   706   C1704459:System [Medical Device]
Processing 00000000.tx.214: Evidence supporting this possibility is provided by the observation that the levels of GSH are selectively increased in the striatum, the brain area with the highest dopamine levels, as well as in neuronal cultures from the dopamine rich ventral midbrain of parkin mutant mice. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "this possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "provided by the observation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]
   770   C1999230:Provided [Activity]

Phrase: "that"

Phrase: "the levels of GSH"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "selectively"

Phrase: "increased in the striatum,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0010097:Striatum [Body Part, Organ, or Organ Component]
   770   C0162512:Striatum [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "the brain area with the highest dopamine levels,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0017446:Area [Geographic Area]
   744   C0205146:Area [Spatial Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "as well as in neuronal cultures"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0010453:Cultures [Idea or Concept]
   753   C0205170:Well [Qualitative Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C3146287:Well [Manufactured Object]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "from the dopamine rich ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   812   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   812   C1704448:Ventral [Spatial Concept]

Phrase: "of parkin mutant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.215: GSH is a critical factor that regulates the neurotoxic or neurotrophic effects of catecholamines and other free radical donors on DA neurons (4749). 

Phrase: "GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "is"

Phrase: "a critical factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "regulates"

Phrase: "the neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "or"

Phrase: "neurotrophic effects of catecholamines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "other free radical donors on DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0013018:Donors [Population Group]
   748   C1527169:Donors [Finding]
   714 E C0040288:Donor [Population Group]

Phrase: "(4749"

Phrase: ")."
Processing 00000000.tx.216: For example, increasing catecholamine levels, similar to those observed in parkin mutant mice, also increases GSH levels and produces neuroprotective effects in both cultured fetal rat neurons and neuroblastoma cells and inhibition of this increased GSH formation switches the neuroprotective effects of catecholamines to a neurotoxic action (4749). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "catecholamine levels,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0428369:catecholamine levels [Laboratory or Test Result]
   966 E C0546632:Catecholamine level [Laboratory Procedure]
   861   C0007412:Catecholamine [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C3536742:Catecholamine [Pharmacologic Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed in parkin mutant mice,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1418270:PARKIN [Gene or Genome]
   760   C1441672:Observed [Functional Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "also"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "GSH levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1260386:GSH [Disease or Syndrome]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "produces"

Phrase: "neuroprotective effects in both cultured fetal rat neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0815279:Neuroprotective Effects [Functional Concept]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0815000:neuroblastoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "inhibition of this increased GSH formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "switches"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707719:SWITCHES [Manufactured Object]

Phrase: "the neuroprotective effects of catecholamines"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0815279:Neuroprotective Effects [Functional Concept]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "to a neurotoxic action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441472:Action [Functional Concept]
   861   C3266814:Action [Activity]

Phrase: "(4749"

Phrase: ")."
Processing 00000000.tx.217: Since we found increased GSH levels in both fetal neurons and brain regions of postnatal animals, this mechanism of neuroprotection appears to be active from the very early stages of dopamine cell development. 

Phrase: "Since"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "increased GSH levels in both fetal neurons"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1260386:GSH [Disease or Syndrome]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "brain regions of postnatal animals,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1273723:brain regions [Body Location or Region]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "this mechanism of neuroprotection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "active from the very early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205177:Active [Functional Concept]

Phrase: "stages of dopamine cell development."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0815089:cell development [Cell Function]
   762   C0870411:Developmental Stage [Temporal Concept]
   760   C0007634:Cell [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0205390:Stage [Temporal Concept]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   760   C1527148:Development [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.218: The parkin mutant mice also show a number of deficits in dopamine function, such as abnormal baseline motor activity, lack of amphetamine-induced increased locomotor activity, reduced amphetamine-induced dopamine release in fetal neuronal cultures, as well as decreased levels of VMAT2 and DAT protein and reduced [3H]-DA uptake. 

Phrase: "The parkin mutant mice also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a number of deficits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in dopamine function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "such as abnormal baseline motor activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0026606:Motor Activity [Daily or Recreational Activity]
   861   C1321502:motor activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "lack of amphetamine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332268:lack [Qualitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "increased locomotor activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0474395:increased activity [Finding]
   901   C0026606:Locomotor Activity [Daily or Recreational Activity]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "reduced amphetamine-induced dopamine release in fetal neuronal cultures,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]
   726   C1512035:dopamine neuron [Cell]

Phrase: "as well as"

Phrase: "decreased levels of VMAT2"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "DAT protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]

Phrase: "and"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "[3H]-DA uptake."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1657587:dopamine uptake [Cell Function]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.219: Amphetamine mainly increases the release of dopamine from the intracytoplasmic rather than the vesicular pool (5054). 

Phrase: "Amphetamine mainly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the release of dopamine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the intracytoplasmic"

Phrase: "rather than"

Phrase: "the vesicular pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "(5054"

Phrase: ")."
Processing 00000000.tx.220: Since the release of dopamine evoked by KCl, which is considered as an index of vesicular release, was unaffected in fetal neuronal cultures from mutant mice, this indicates that the reduction of amphetamine-induced dopamine release is mediated by alterations in the intracytoplasmic pool of dopamine. 

Phrase: "Since"

Phrase: "the release of dopamine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "evoked by KCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1444748:Evoked [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "considered as an index of vesicular release,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0030685:Release [Health Care Activity]
   748   C0205378:Vesicular [Qualitative Concept]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C0750591:considered [Idea or Concept]
   748   C0918012:Index [Intellectual Product]
   748   C1283071:Release [Functional Concept]
   748   C1552854:index [Idea or Concept]
   748   C1637833:% index [Quantitative Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "unaffected in fetal neuronal cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986417:Unaffected [Conceptual Entity]

Phrase: "from mutant mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "this"

Phrase: "indicates"

Phrase: "that"

Phrase: "the reduction of amphetamine-induced dopamine release"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "mediated by alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   756   C1515926:Alteration [Idea or Concept]

Phrase: "in the intracytoplasmic pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "of dopamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.221: The changes observed in VMAT2 and DAT protein levels and the reduction of [3H]-DA uptake may be related to the pathogenetic mechanisms of parkin dysfunction, or they could signal the first indication of initial damage to the dopamine nigrostriatal terminals. 

Phrase: "The changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "observed in VMAT2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
   833   C1529240:Vesicular Monoamine Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C3539788:Monoamine Transporter [Amino Acid, Peptide, or Protein]
   753   C0205378:Vesicular [Qualitative Concept]
   753   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0599682:monoamine [Organic Chemical]
   753   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "DAT protein levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the reduction of [3H]-DA uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1657587:dopamine uptake [Cell Function]
   804   C0243144:Uptake [Physiologic Function]
   804   C0347980:% uptake [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "related to the pathogenetic mechanisms of parkin dysfunction,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0031847:dysfunction [Functional Concept]
   744   C0277785:Dysfunction, NOS [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0441712:Mechanisms [Functional Concept]
   744   C0445223:Related [Finding]
   744   C1418270:PARKIN [Gene or Genome]
   744   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   711 E C0163712:Relate [Organic Chemical]
   711 E C1706376:Mechanism [Manufactured Object]

Phrase: "or"

Phrase: "they"

Phrase: "could"

Phrase: "signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "the first indication of initial damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392360:indication [Idea or Concept]
   753   C3146298:Indication [Functional Concept]

Phrase: "to the dopamine nigrostriatal terminals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205088:Terminal [Temporal Concept]
   793   C1705314:Terminal [Manufactured Object]
   793   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.222: However, we cannot exclude a contribution of adaptative modifications in response to other changes in DA metabolism. 

Phrase: "However,"

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "a contribution of adaptative modifications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to other changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in DA metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1154437:dopamine metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.223: Transgenic mice with reduced VMAT2 expression also show reduced amphetamine-induced DA release (55). 

Phrase: "Transgenic mice with reduced VMAT2 expression also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025936:Mice, Transgenic [Mammal]
   739   C0003069:Transgenic [Animal]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "reduced amphetamine-induced DA release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   804   C0030685:Release [Health Care Activity]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.224: Therefore, the abnormalities of DA release observed in the parkin mutant mice may be related to the reduction of VMAT2 levels. 

Phrase: "Therefore,"

Phrase: "the abnormalities of DA release"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "observed in the parkin mutant mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1441672:Observed [Functional Concept]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "related to the reduction of VMAT2 levels."
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   806   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
   782   C1529240:Vesicular Monoamine Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C3539788:Monoamine Transporter [Amino Acid, Peptide, or Protein]
   741   C0456948:Level 2 [Intellectual Product]
   739   C0205378:Vesicular [Qualitative Concept]
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0439849:Related [Qualitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]
   739   C0441889:Levels [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0599682:monoamine [Organic Chemical]
   706 E C0163712:Relate [Organic Chemical]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.225: Since VMAT2 controls the intraneuronal storage of DA, preventing its intracytoplasmic oxidation and preparing it for exocytotic release, the reduction of VMAT2 levels could enhance the neurotoxicity of high intracytoplasmic DA concentrations (56). 

Phrase: "Since"

Phrase: "VMAT2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
   923   C1529240:Vesicular Monoamine Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3539788:Monoamine Transporter [Amino Acid, Peptide, or Protein]
   812   C0205378:Vesicular [Qualitative Concept]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0599682:monoamine [Organic Chemical]
   741 E C0333262:VESICLES [Acquired Abnormality]
   741 E C1622418:vesicle [Cell Component]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the intraneuronal storage of DA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0337174:Storage [Spatial Concept]
   760   C1698986:Storage [Functional Concept]
   760   C1753314:storage [Cell Component]

Phrase: "preventing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "its intracytoplasmic oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "preparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "it for exocytotic release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the reduction of VMAT2 levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the neurotoxicity of high intracytoplasmic DA concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.226: There is a substantial amount of information indicating that VMAT2 and DAT are altered in patients with PD (57) and in presymptomatic individuals (58) and that their activity, as measured by modern neuroimaging techniques, can be used to measure the density of DA terminals while aging (59) and the severity of DA cell presynaptic terminal loss during the progression of PD (60). 

Phrase: "There"

Phrase: "is"

Phrase: "a substantial amount of information"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "indicating"

Phrase: "that VMAT2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
   923   C1529240:Vesicular Monoamine Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3539788:Monoamine Transporter [Amino Acid, Peptide, or Protein]
   812   C0205378:Vesicular [Qualitative Concept]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0599682:monoamine [Organic Chemical]
   741 E C0333262:VESICLES [Acquired Abnormality]
   741 E C1622418:vesicle [Cell Component]

Phrase: "and"

Phrase: "DAT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "altered in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0392747:Altered [Functional Concept]

Phrase: "with PD (57"

Phrase: ")"

Phrase: "and in presymptomatic individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1515981:And [Idea or Concept]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "(58"

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "their activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "measured by modern neuroimaging techniques,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025664:techniques [Intellectual Product]
   760   C0444706:Measured [Qualitative Concept]
   760   C0449851:Techniques [Functional Concept]
   760   C0679575:Neuroimaging [Diagnostic Procedure]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the density of DA terminals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178587:density [Quantitative Concept]

Phrase: "while"

Phrase: "aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "(59"

Phrase: ")"

Phrase: "and"

Phrase: "the severity of DA cell presynaptic terminal loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439793:Severity [Qualitative Concept]
   744   C2983285:Severity [Intellectual Product]

Phrase: "during the progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "of PD (60"

Phrase: ")."
Processing 00000000.tx.227: Examination of hippocampal electrophysiology demonstrates that abnormal neurotransmitter release in parkin mutant mice is not restricted to the nigrostriatal DA pathway but is also evident as significant deficits in glutamate neurotransmitter release at the level of the Schaffer collateral-CA1 synapses. 

Phrase: "Examination of hippocampal electrophysiology"

Phrase: "demonstrates"

Phrase: "that abnormal neurotransmitter release in parkin mutant mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0598964:neurotransmitter release [Cell Function]
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restricted to the nigrostriatal DA pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0443288:Restricted [Functional Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "but"

Phrase: "is"

Phrase: "also evident as significant deficits"

Phrase: "in glutamate neurotransmitter release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0598964:neurotransmitter release [Cell Function]
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "at the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of the Schaffer collateral-CA1 synapses."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0039062:Synapses [Body Space or Junction]
   779 E C0598501:Synapsis [Cell Function]
   779 E C1633000:Synapsis [Plant]
Processing 00000000.tx.228: Similar deficits in hippocampal electrophysiology have been observed in synuclein KO mice (61). 

Phrase: "Similar deficits in hippocampal electrophysiology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "have"

Phrase: "been"

Phrase: "observed in synuclein KO mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1416746:KO [Gene or Genome]
   760   C1441672:Observed [Functional Concept]
   760   C1862225:Ko [Body System]

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.229: The inhibition of neurotransmitter release in the absence of parkin is consistent with previous observations in which parkin has been shown to be localized to the interface between the synaptic vesicles and the cytoplasm (62) and to control the degradation of protein substrates, e.g. 

Phrase: "The inhibition of neurotransmitter release"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "consistent with previous observations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in which parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "localized to the interface"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392752:Localized [Spatial Concept]
   770   C1708533:Interface [Manufactured Object]
   770   C2698172:Interface [Intellectual Product]

Phrase: "between the synaptic vesicles"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0039065:Synaptic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "(62"

Phrase: ")"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the degradation of protein substrates,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0597297:Protein Degradation [Molecular Function]
   797   C0597304:Protein Degradation [Molecular Function]
   797   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "e.g."
Processing 00000000.tx.230: Cdcrel-1, that have been implicated in the inhibition of synaptic transmission (30). 

Phrase: "Cdcrel-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in the inhibition of synaptic transmission"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C2255939:inhibition of synaptic transmission [Organ or Tissue Function]
   778   C0027793:Synaptic Transmission [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0040722:transmission [Idea or Concept]
   748   C0242781:Transmission [Pathologic Function]
   748   C1521797:Transmission [Natural Phenomenon or Process]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.231: Dopamine neurotransmission is also altered in mice with mutations of -synuclein. 

Phrase: "Dopamine neurotransmission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027793:Neurotransmission [Cell Function]

Phrase: "is"

Phrase: "also"

Phrase: "altered in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0392747:Altered [Functional Concept]

Phrase: "with mutations of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.232: For example, similar to parkin mutant mice, mice lacking -synuclein develop normally, do not display loss of dopaminergic neurons, but have decreased locomotor responses to amphetamine and reduced striatal dopamine levels (63). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "similar to parkin mutant mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "develop"

Phrase: "normally,"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "loss of dopaminergic neurons,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C3550005:Loss of dopaminergic neurons [Finding]
   881   C0598940:Loss of neurons [Finding]
           neuron loss
   777 E C1850496:Neuronal loss [Finding]
   770   C1517945:Loss [Quantitative Concept]

Phrase: "but"

Phrase: "have"

Phrase: "decreased locomotor responses to amphetamine"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   851   C1621829:response to amphetamine [Organism Function]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "reduced striatal dopamine levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.233: By contrast, overexpression of A53T mutated -synuclein in mice induces a more pronounced phenotype characterized by a severe movement disorder leading to paralysis and death (64). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "overexpression of A53T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "mutated -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "synuclein in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a more pronounced phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "characterized by a severe movement disorder"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0026650:Movement disorder [Disease or Syndrome]
   783   C1836348:Severe disorder [Finding]
   753   C0012634:Disorder [Disease or Syndrome]
   753   C0026649:Movement [Organism Function]
   753   C0205082:Severe [Qualitative Concept]
   753   C1880022:Characterized [Activity]

Phrase: "leading to paralysis"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0332152:Leading [Temporal Concept]
   790   C0522224:Paralysis [Finding]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.234: Moreover, in contrast to mesencephalic neurons from parkin mutant mice where KCl-induced dopamine release is unaffected and amphetamine-induced dopamine release is decreased, in mesencephalic neurons overexpressing the A53T -synuclein mutation, KCl-induced dopamine release is decreased and amphetamine-induced dopamine release is increased (65). 

Phrase: "Moreover,"

Phrase: "in contrast to mesencephalic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "from parkin mutant mice where KCl-induced dopamine release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   793   C0030685:Release [Health Care Activity]
   793   C0391871:Release [Functional Concept]
   793   C0439180:% release [Quantitative Concept]
   793   C0680255:release [Health Care Activity]
   793   C1283071:Release [Functional Concept]
   793   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "unaffected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]

Phrase: "and"

Phrase: "amphetamine-induced dopamine release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "in mesencephalic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the A53T -synuclein mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "KCl-induced dopamine release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "amphetamine-induced dopamine release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.235: Expression of the A53T mutation in PC12 cells also produces loss of KCl-induced dopamine release and alterations of the ubiquitin-dependent degradation system (66). 

Phrase: "Expression of the A53T mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in PC12 cells also"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "produces"

Phrase: "loss of KCl-induced dopamine release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "alterations of the ubiquitin-dependent degradation system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "(66"

Phrase: ")."
Processing 00000000.tx.236: The alterations in dopamine and glutamate neurotransmission could be at the origin of some of the motor and cognitive deficits in parkin mutant mice, which are also present as presymptomatic symptoms in patients with PD prior to the development of overt clinical symptoms. 

Phrase: "The alterations in dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "glutamate neurotransmission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027793:Neurotransmission [Cell Function]

Phrase: "could"

Phrase: "be at the origin of some of the motor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0079946:origin [Classification]
   742   C0439659:Origin [Temporal Concept]
   742   C1513492:Motor [Functional Concept]
   742   C1550512:origin [Intellectual Product]
   742   C1705994:Motor [Manufactured Object]
   742   C2987476:Be [Conceptual Entity]

Phrase: "and"

Phrase: "cognitive deficits in parkin mutant mice,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   753   C2987487:deficits [Qualitative Concept]
   719 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "which"

Phrase: "are"

Phrase: "also"

Phrase: "present as presymptomatic symptoms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C0683368:symptoms [Functional Concept]
   770   C1457887:Symptoms [Sign or Symptom]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with PD"

Phrase: "prior to the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of overt clinical symptoms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0683368:symptoms [Functional Concept]
   827   C1457887:Symptoms [Sign or Symptom]
Processing 00000000.tx.237: For example, the decline in spatial working memory observed in mutant mice in the spontaneous alternation task has also been observed in PD patients with mild clinical symptoms (67). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the decline in spatial working memory"

Phrase: "observed in mutant mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   770   C1441672:Observed [Functional Concept]

Phrase: "in the spontaneous alternation task"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540678:Task [Occupational Activity]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "observed in PD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1441672:Observed [Functional Concept]

Phrase: "with mild clinical symptoms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1968569:Mild clinical symptoms [Finding]
   913   C0436343:mild symptoms [Finding]
   827   C0683368:symptoms [Functional Concept]
   827   C1457887:Symptoms [Sign or Symptom]

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.238: PD patients with severe clinical symptoms display impairment of spatial, verbal and visual working memory (67). 

Phrase: "PD patients with severe clinical symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1317600:patients symptoms [Finding]
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "impairment of spatial, verbal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0566027:Verbal impairment [Finding]
   770   C0684336:Impairment [Pathologic Function]

Phrase: "and"

Phrase: "visual working memory"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   913   C0542316:Visual memory [Mental Process]
   901   C0025265:Working Memory [Mental Process]
   827   C0025260:Memory [Mental Process]
   827   C0043227:Working [Occupational Activity]
   827   C0234621:Visual [Functional Concept]
   827   C0700327:memory [Finding]
   827   C1706377:Memory [Manufactured Object]
   771 E C0679055:mnemonic [Mental Process]

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.239: The reduced exploration observed in mutant mice in the open field studies is probably related to a lack of curiosity and novelty-seeking behaviour, rather than to akinesia or cognitive deficits, since other motor and behavioral deficits, such as akinesia or abnormal performance of routine activities were not observed. 

Phrase: "The reduced exploration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1280903:Exploration [Therapeutic or Preventive Procedure]

Phrase: "observed in mutant mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   770   C1441672:Observed [Functional Concept]

Phrase: "in the open field studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   867   C0596572:field study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "related to a lack of curiosity"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0010472:Curiosity [Individual Behavior]
   753   C0332268:lack [Qualitative Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "novelty-seeking behaviour,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0086716:Novelty-Seeking Behavior [Individual Behavior]
   827   C0004927:Behavior [Individual Behavior]
   827   C2707008:Behavior [Clinical Attribute]
   755 E C2986890:Behavioral [Idea or Concept]

Phrase: "rather than to akinesia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085623:Akinesia [Disease or Syndrome]

Phrase: "or"

Phrase: "cognitive deficits,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "since"

Phrase: "other motor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513492:Motor [Functional Concept]
  1000   C1705994:Motor [Manufactured Object]

Phrase: "and"

Phrase: "behavioral deficits,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "such as akinesia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085623:Akinesia [Disease or Syndrome]

Phrase: "or"

Phrase: "abnormal performance of routine activities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0597198:Performance [Individual Behavior]
   760   C1882330:Performance [Activity]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.240: In addition, it is possible that the cognitive deficit in the hanging grip test could be explained, at least in part, by the mutant mice having a more submissive character. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the cognitive deficit in the hanging grip test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0679466:cognitive deficit [Mental or Behavioral Dysfunction]
   744   C0162429:Deficit, NOS [Disease or Syndrome]
   744   C2987487:Deficit [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "explained"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by the mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "having"

Phrase: "a more submissive character."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007952:Character [Mental Process]
   827   C0486537:Character [Organism Attribute]
   827   C2350015:Character [Qualitative Concept]
Processing 00000000.tx.241: The presence of similar personality traits, including industriousness, punctuality, inflexibility, cautiousness and lack of novelty seeking have been observed to predate the onset of motor illness in presymptomatic PD patients (68,69). 

Phrase: "The presence of similar personality traits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "industriousness,"

Phrase: "punctuality,"

Phrase: "inflexibility,"

Phrase: "cautiousness"

Phrase: "and"

Phrase: "lack of novelty seeking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "predate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699540:Predate [Pharmacologic Substance,Steroid]

Phrase: "the onset of motor illness"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0277793:Onset of illness [Temporal Concept]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "in presymptomatic PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "(68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.242: Moreover, a high degree of submissive behaviour has been observed in depressed patients (70) and depression is frequently a complicating factor in patients with PD (71). 

Phrase: "Moreover,"

Phrase: "a high degree of submissive behaviour"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "observed in depressed patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0344315:Depressed [Finding]
   770   C0549249:DEPRESSED [Finding]
   770   C1441672:Observed [Functional Concept]

Phrase: "(70"

Phrase: ")"

Phrase: "and"

Phrase: "depression"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "is"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "a complicating factor in patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   797   C0960756:factor A [Organic Chemical]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "with PD (71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.243: These behavioral patterns in PD patients and mutant mice are probably related to abnormalities of the phasic release of dopamine and other neurotransmitters when a high output is required from these neuronal systems, rather than to neuronal loss in these systems, with normal dopamine function being maintained during activities that do not require a high degree of activation. 

Phrase: "These behavioral patterns in PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "related to abnormalities of the phasic release of dopamine"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   742   C0000768:Abnormalities [Congenital Abnormality]
   742   C0000769:abnormalities [Functional Concept]
   742   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]
   708 E C0163712:Relate [Organic Chemical]
   708 E C1704258:Abnormality [Finding]

Phrase: "and"

Phrase: "other neurotransmitters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]

Phrase: "when"

Phrase: "a high output"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709366:Output [Conceptual Entity]

Phrase: "is"

Phrase: "required from these neuronal systems,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1514873:Required [Functional Concept]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]

Phrase: "rather than to neuronal loss"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C1850496:Neuronal loss [Finding]
   770 E C0598940:neuron loss [Finding]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1517945:Loss [Quantitative Concept]

Phrase: "in these systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0449913:System [Functional Concept]
   966   C1553451:System [Manufactured Object]
   966   C1704459:System [Medical Device]
   916 E C0205373:Systemic [Functional Concept]

Phrase: "with normal dopamine function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "being"

Phrase: "maintained during activities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0441655:Activities [Activity]
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]
   756 E C0205177:Activity [Functional Concept]
   756 E C0439167:% activity [Quantitative Concept]
   756 E C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "a high degree of activation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.244: It is clear from the above that the absence of parkin results in abnormal processing of dopamine, deficits in glutamate synaptic transmission and impairment of certain aspects of motor activity and memory. 

Phrase: "It"

Phrase: "is"

Phrase: "clear from the above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "the absence of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "results in abnormal processing of dopamine,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0459424:Abnormal result [Finding]
   753   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0205161:Abnormal [Qualitative Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1709694:Processing [Activity]
   753   C2347472:% Abnormal [Quantitative Concept]
   753   C2699333:ABNORMAL [Intellectual Product]
   753   C2825142:Result [Finding]

Phrase: "deficits in glutamate synaptic transmission"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "and"

Phrase: "impairment of certain aspects of motor activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0684336:Impairment [Pathologic Function]

Phrase: "and"

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.245: However, in contrast to PD, all of these phenotypic changes occur in the absence of clear evidence of parkinsonism, cell loss in the nigrostriatal dopamine system or accumulation of ubiquitinated -synuclein aggregates. 

Phrase: "However,"

Phrase: "in contrast to PD,"

Phrase: "all of these phenotypic changes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0444868:All [Quantitative Concept]
   760   C3539085:All [Idea or Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "occur in the absence of clear evidence of parkinsonism,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0332120:Evidence of [Functional Concept]
           Evidence
   742   C0242422:Parkinsonism [Disease or Syndrome]
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]
   742   C1709305:Occur [Activity]
   742   C2745955:OCCUR [Temporal Concept]
   742   C2963144:Clear [Qualitative Concept]

Phrase: "cell loss in the nigrostriatal dopamine system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "or"

Phrase: "accumulation of ubiquitinated -synuclein aggregates."
Processing 00000000.tx.246: Locomotor defects have also been observed in the absence of general neuronal degeneration and dopaminergic neuron loss in Drosophila parkin mutants (34). 

Phrase: "Locomotor defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "observed in the absence of general neuronal degeneration"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0011164:Degeneration [Pathologic Function]
   744   C0205246:General [Spatial Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C0521390:Neuronal [Immunologic Factor]
   744   C1441672:Observed [Functional Concept]
   744   C1553889:General [Idea or Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   744   C1880269:Degeneration [Functional Concept]
   735   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "dopaminergic neuron loss in Drosophila parkin mutants"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0598940:neuron loss [Finding]
   748   C1517945:Loss [Quantitative Concept]
   743 E C1850496:Neuronal loss [Finding]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.247: In the Drosophila parkin model the locomotor defects are mediated by apoptotic muscle degeneration, which is not observed in our mouse model. 

Phrase: "In the Drosophila parkin model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "the locomotor defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "are"

Phrase: "mediated by apoptotic muscle degeneration,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0234958:MUSCLE DEGENERATION [Disease or Syndrome]
   760   C0011164:Degeneration [Pathologic Function]
   760   C0026845:Muscle [Tissue]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1516044:Apoptotic [Qualitative Concept]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in our mouse model."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C2986594:Mouse Model [Experimental Model of Disease]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1441672:Observed [Functional Concept]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.248: Absence of nigral cell loss, despite synuclein pathology and cell loss in other CNS areas, has also been observed in transgenic synuclein mice (64). 

Phrase: "Absence of nigral cell loss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "despite synuclein pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "cell loss in other CNS areas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "observed in transgenic synuclein mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0025936:Mice, Transgenic [Mammal]
   760   C0003069:Transgenic [Animal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1441672:Observed [Functional Concept]

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.249: This suggests that the nigrostriatal dopamine system in mice and Drosophila is less vulnerable to neuronal loss in the absence of parkin than humans. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the nigrostriatal dopamine system in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0815010:nigrostriatal system [Body Part, Organ, or Organ Component]
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "is"

Phrase: "less vulnerable to neuronal loss"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "than humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.250: This could be explained by the lack of neuromelanin formation in mice or the low levels of GSH in primates. 

Phrase: "This"

Phrase: "could"

Phrase: "be"

Phrase: "explained by the lack of neuromelanin formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0068608:neuromelanin [Organic Chemical]
   748   C0220781:formation [Biologic Function]
   748   C0332268:lack [Qualitative Concept]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "or"

Phrase: "the low levels of GSH"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in primates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033147:Primates [Mammal]
Processing 00000000.tx.251: In addition, parkin could work in concert with other factors to induce the degeneration of dopaminergic neurons and/or compensatory changes could protect against parkin loss of function. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "could"

Phrase: "work in concert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0043227:Work [Occupational Activity]

Phrase: "with other factors to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the degeneration of dopaminergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "and/or"

Phrase: "compensatory changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "could"

Phrase: "protect against parkin loss of function."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1517945:Loss [Quantitative Concept]
   753   C1705273:Function [Intellectual Product]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.252: A key role for such regulatory factors has been observed in dopaminergic neurons where L-DOPA and catecholamines can produce neurotoxic (72,73) or neurotrophic (47,7476) effects, depending on the concentration of GSH and other free radical scavengers (7779). 

Phrase: "A key role for such regulatory factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "observed in dopaminergic neurons where L-DOPA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0023570:L(-)-Dopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   778   C1512035:Dopaminergic Neurons [Cell]
   748   C0013023:Dopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   748   C0027882:Neurons [Cell]
   748   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   748   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "catecholamines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0007412:Catecholamines [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   966 E C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "can"

Phrase: "produce"

Phrase: "neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(72,"

Phrase: "73"

Phrase: ")"

Phrase: "or"

Phrase: "neurotrophic"

Phrase: "(47,"

Phrase: "7476"

Phrase: ")"

Phrase: "effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "depending on the concentration of GSH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086045:Concentration [Mental Process]
   753   C1260386:GSH [Disease or Syndrome]
   753   C1446561:Concentration [Quantitative Concept]
   719   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "other free radical scavengers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0079381:Free Radical Scavengers [Chemical Viewed Functionally]
   827   C0017108:scavengers [Medical Device]
   827   C1003377:scavengers [Fish]
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]

Phrase: "(7779"

Phrase: ")."
Processing 00000000.tx.253: The presence of such compensatory mechanisms could explain, at least in part, the lack of a clear parkinsonian phenotype in parkin mutant mice and the large variability in age of onset and clinical severity of parkinsonism related to mutations of parkin, even in members of the same family (19,20). 

Phrase: "The presence of such compensatory mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "explain"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "the lack of a clear parkinsonian phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:lack [Qualitative Concept]

Phrase: "in parkin mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "the large variability in age of onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   822   C1846355:Variable age of onset [Finding]
   748   C2827666:Variability [Conceptual Entity]

Phrase: "and"

Phrase: "clinical severity of parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439793:Severity [Qualitative Concept]
   770   C2983285:Severity [Intellectual Product]

Phrase: "related to mutations of parkin,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0026882:Mutations [Genetic Function]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0163712:Relate [Organic Chemical]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "even in members of the same family"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   774   C0086282:Family Members [Family Group]
   757 E C1611821:Family Member [Intellectual Product]
   748   C0015576:Family [Family Group]
   748   C0445247:Same [Qualitative Concept]
   748   C0680022:members [Population Group]
   748   C1704727:Family [Conceptual Entity]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.254: In conclusion, this parkin mutant mouse model displays a number of behavioural and biochemical changes which reproduce some of the presymptomatic aspects of PD. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "this parkin mutant mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Model [Intellectual Product]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a number of behavioural"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "biochemical changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "which"

Phrase: "reproduce"

Phrase: "some of the presymptomatic aspects of PD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205392:Some [Quantitative Concept]
   748   C3540770:Some [Intellectual Product]
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.255: However, these mice do not display a clear parkinsonian phenotype. 

Phrase: "However,"

Phrase: "these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a clear parkinsonian phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.256: This model therefore provides a valuable tool to better understand some of the preclinical deficits observed in patients with PD and to further examine the potential compensatory mechanisms that prevent the onset of a parkinsonian phenotype and which could provide new strategies for neuroprotection.  

Phrase: "This model therefore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a valuable tool to better"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0332272:Better [Qualitative Concept]
   812   C0336791:Tool [Manufactured Object]
   812   C2827396:Tool [Manufactured Object]
   779 E C0205170:Well [Qualitative Concept]
   779 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "some of the preclinical deficits"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205392:Some [Quantitative Concept]
   760   C1709630:Pre-clinical [Qualitative Concept]
   760   C2987487:deficits [Qualitative Concept]
   760   C3540770:Some [Intellectual Product]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "observed in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "with PD"

Phrase: "and"

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "examine"

Phrase: "the potential compensatory mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the onset of a parkinsonian phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "which"

Phrase: "could"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "new strategies for neuroprotection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679199:strategies [Mental Process]
Processing 00000000.tx.257: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Inactivation of the parkin gene: cloning of the mouse parkin gene and creation of the targeting vector A genomic phage library from the 129SvJ mouse strain (Stratagene, lambda FIX II ref. 946313) was screened with a rat parkin cDNA probe. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inactivation of the parkin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0598496:Gene Inactivation [Genetic Function]
   760   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: ":"

Phrase: "cloning of the mouse parkin gene"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C1418270:parkin gene [Gene or Genome]
           PARKIN
   790   C2983548:Parkin Gene [Gene or Genome]
   783   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0009015:Cloning [Research Activity]
   753   C0017337:Gene [Gene or Genome]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0009013:Clone [Cell]
   719 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "creation of the targeting vector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441513:Creation [Therapeutic or Preventive Procedure]
   760   C1706214:Creation [Activity]

Phrase: "A genomic phage library from the 129SvJ mouse strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0017430:Genomic Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0023621:Library [Manufactured Object,Organization]
   742   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Stratagene,"

Phrase: "lambda FIX II ref. 946313"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0231441:Fix [Finding]
   804   C0926407:Lambda [Body Location or Region]
   804   C1425988:REF [Gene or Genome]
   804   C1706314:Lambda [Idea or Concept]
   804   C1720314:Lambda [Intellectual Product]
   804   C3539736:LAMBDA [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "screened with a rat parkin cDNA probe."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0182400:Probe [Medical Device]
   748   C1418270:PARKIN [Gene or Genome]
   748   C1704681:Probe [Gene or Genome]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C3536729:Probe [Manufactured Object]
   714   C0220908:screen [Health Care Activity]
   714   C1305399:screen [Functional Concept]
   714   C1705053:Screen [Medical Device]
Processing 00000000.tx.258: A clone containing a 12kb genomic fragment was identified and shown to contain exon 3 of the mouse parkin gene, plus about 2.4 kb of intron 2 at its 5' end. 

Phrase: "A clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a 12kb genomic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "exon 3 of the mouse parkin gene,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1418270:parkin gene [Gene or Genome]
           PARKIN
   778   C2983548:Parkin Gene [Gene or Genome]
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017337:Gene [Gene or Genome]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "plus about 2.4 kb of intron 2"

Phrase: "at its 5' end."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.259: Two oligonucleotides were synthesized to amplify a sequence of 1092bp containing 1030bp at the 3' end of intron 2 and 62bp at the 5' end of exon 3. 

Phrase: "Two oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "a sequence of 1092bp containing 1030bp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "at the 3' end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "of intron 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "62bp at the 5' end of exon 3."
Processing 00000000.tx.260: The oligonucleotide used at the 5' end carries an EcoRI cloning site (ccg gaa ttc gtg tcc ttg gtg gta gat tca), whereas that used at the 3' end carries a BamHI (cgc gga tcc tga ctt ctc ctc cgt ggt ctc). 

Phrase: "The oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used at the 5' end"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   760   C0444930:End [Spatial Concept]
   760   C1273517:used [Finding]
   760   C2746065:End [Temporal Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "an EcoRI cloning site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1705686:Cloning Site [Nucleotide Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "(ccg gaa ttc gtg tcc ttg gtg gta gat tca"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0041405:TCA [Geographic Area]
   790   C0085758:TCA [Congenital Abnormality]
   790   C1415587:TCA [Gene or Genome]
   790   C3536819:TCA [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "that"

Phrase: "used at the 3' end"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   760   C0444930:End [Spatial Concept]
   760   C1273517:used [Finding]
   760   C2746065:End [Temporal Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "a BamHI"

Phrase: "(cgc gga tcc tga ctt ctc ctc cgt ggt ctc"

Phrase: ")."
Processing 00000000.tx.261: The XhoI site on the PCR fragment was destroyed and then the fragment was cloned at sites EcoRI and BamHI in the pPN2T plasmid, provided by Dr E. 

Phrase: "The XhoI site on the PCR fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "destroyed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Destroy [Idea or Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cloned at sites EcoRI"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0009013:cloned [Cell]
   770   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C1522642:Clone [Tissue]
   737 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "BamHI in the pPN2T plasmid,"

Phrase: "provided by Dr E."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031831:DR [Professional or Occupational Group]
   770   C1707664:DR [Biomedical or Dental Material]
   770   C1999230:Provided [Activity]
   770   C2348314:Dr. [Conceptual Entity]
   770   C3540849:DR [Idea or Concept]
Processing 00000000.tx.262: Rubin's laboratory (Berkeley, CA, USA). 

Phrase: "Rubin's laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "(Berkeley,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.263: This plasmid contains a positive selection cassette (neomycin gene), plus two negative selection cassettes (TK gene). 

Phrase: "This plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a positive selection cassette"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450240:Cassette [Medical Device]
   827   C1706210:Cassette [Manufactured Object]
   734   C2347644:Positive Selection [Laboratory Procedure]

Phrase: "(neomycin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "plus two negative selection cassettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0450240:cassettes [Medical Device]
   771 E C1706210:Cassette [Manufactured Object]

Phrase: "(TK gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1336633:TK Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.264: The long arm of the homologous recombination vector was obtained by cloning a 7kb EcoRISalI fragment from the 12kb genomic fragment in a Bluescript plasmid. 

Phrase: "The long arm of the homologous recombination vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0575519:Long arm [Finding]
   744   C0446516:Arm [Body Location or Region]
   744   C1269078:Arm [Body Part, Organ, or Organ Component]
   744   C1269612:Arm [Body Location or Region]

Phrase: "was"

Phrase: "obtained by cloning"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0009015:Cloning [Research Activity]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "a 7kb EcoRISalI fragment from the 12kb genomic fragment"

Phrase: "in a Bluescript plasmid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.265: The EcoRI site is 179bp from the 5' extremity of the exon 3. 

Phrase: "The EcoRI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "179bp from the 5' extremity of the exon 3."
Processing 00000000.tx.266: The NotI site of this DNA fragment was then destroyed. 

Phrase: "The NotI site of this DNA fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "destroyed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Destroy [Idea or Concept]
Processing 00000000.tx.267: New sites of NotI and XhoI cloning were then introduced into the SalI site and the EcoRI site of the polylinker, respectively. 

Phrase: "New sites of NotI"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   816   C2945843:Site of [Qualitative Concept]
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "XhoI cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009015:Cloning [Research Activity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "introduced into the SalI site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   726   C1292748:introduce [Functional Concept]

Phrase: "and"

Phrase: "the EcoRI site of the polylinker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.268: Sequencing revealed that the EcoRI site was removed. 

Phrase: "Sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the EcoRI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "removed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]
Processing 00000000.tx.269: The 7kb genomic fragment was cloned in the previous plasmid containing the BamHIEcoRI fragment plus the Neo and TK genes by using NotIXhoI sites. 

Phrase: "The 7kb genomic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cloned in the previous plasmid"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0009013:cloned [Cell]
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205156:Previous [Temporal Concept]
   760   C1552607:previous [Temporal Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the BamHIEcoRI fragment plus the Neo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "TK genes by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   866   C1336633:TK Gene [Gene or Genome]
   790   C0017337:Genes [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NotIXhoI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.270: In this construction, the parkin gene was interrupted by the neomycin resistance cassette within exon 3. 

Phrase: "In this construction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "interrupted by the neomycin resistance cassette"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0027603:Neomycin [Antibiotic,Carbohydrate]
   753   C0237834:Resistance [Mental Process]
   753   C0443239:Interrupted [Qualitative Concept]
   753   C0450240:Cassette [Medical Device]
   753   C1512900:Interrupted [Temporal Concept]
   753   C1514892:Resistance [Physiologic Function]
   753   C1706210:Cassette [Manufactured Object]

Phrase: "within exon 3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.271: The first 62 nucleic acids of exon 3 were preserved. 

Phrase: "The first 62 nucleic acids of exon 3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0001128:Acids [Chemical]
   744   C0007610:Nucleic [Cell Component]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "preserved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033085:Preserved [Laboratory Procedure]
Processing 00000000.tx.272: The introduced deletion covers an area of 1097 bp, encompassing the last 179 nucleic acids of exon 3 and the first 918 nucleic acids of intron 3. 

Phrase: "The introduced deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "covers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0180153:cover [Medical Device]
  1000   C1707529:Cover [Medical Device]
  1000   C1999244:Cover [Functional Concept]

Phrase: "an area of 1097 bp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "encompassing"

Phrase: "the last 179 nucleic acids of exon 3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0001128:Acids [Chemical]
   744   C0007610:Nucleic [Cell Component]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "the first 918 nucleic acids of intron 3."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0001128:Acids [Chemical]
   744   C0007610:Nucleic [Cell Component]
   711 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.273: Tools for homologous recombination PCRs. 

Phrase: "Tools for homologous recombination PCRs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0336791:Tool [Manufactured Object]
   726   C2827396:Tool [Manufactured Object]
Processing 00000000.tx.274: Three oligonucleotide pairs were used to select the recombinant ES cells; 

Phrase: "Three oligonucleotide pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "the recombinant ES cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0596508:ES cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.275: pair A, tttccaaatgtgtcagtttc/tttgagtaagagccactaagg; 

Phrase: "pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "A,"

Phrase: "tttccaaatgtgtcagtttc/tttgagtaagagccactaagg"

Phrase: ";"
Processing 00000000.tx.276: pair B, tgttccacatacacttcattc/tttgagtaagagccactaagg; 

Phrase: "pair B,"

Phrase: "tgttccacatacacttcattc/tttgagtaagagccactaagg"

Phrase: ";"
Processing 00000000.tx.277: pair C, cagtattgttttgccaagttc/tttgagtaagagccactaagg. 

Phrase: "pair C,"

Phrase: "cagtattgttttgccaagttc/tttgagtaagagccactaagg."
Processing 00000000.tx.278: The PCR conditions were as follows: reaction mixture containing 50fg of DNA, 1.5l of four dNPTs 4x25mM, 4l of each oligonucleotide at 100ng/l, 10l of MgCl2 1mM, 10l of buffer Taq 10x, 0.5l of Taq polymerase in 5U/l (Perkin Elmer) and 100l of water QSP. 

Phrase: "The PCR conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "reaction mixture containing 50fg of DNA,"

Phrase: "1.5l of four dNPTs 4x25mM,"

Phrase: "4l of each oligonucleotide"

Phrase: "at 100ng/l,"

Phrase: "10l of MgCl2 1mM,"

Phrase: "10l of buffer Taq 10x,"

Phrase: "0.5l of Taq polymerase"

Phrase: "in 5U/l (Perkin Elmer"

Phrase: ")"

Phrase: "and"

Phrase: "100l of water QSP."
Processing 00000000.tx.279: Amplification cycles were 8min at 95C, then 50 cycles at 95C (0.5min), 53C (0.5min), 72C (1min) and finally 10min at 72C. 

Phrase: "Amplification cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "were"

Phrase: "8min at 95C,"

Phrase: "then 50 cycles at 95C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1511572:Cycle [Temporal Concept]

Phrase: "(0.5min"

Phrase: ")"

Phrase: ","

Phrase: "53C"

Phrase: "(0.5min"

Phrase: ")"

Phrase: ","

Phrase: "72C"

Phrase: "(1min"

Phrase: ")"

Phrase: "and"

Phrase: "finally 10min at 72C."
Processing 00000000.tx.280: Southern blots. 

Phrase: "Southern blots."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005862:Southern Blot [Molecular Biology Research Technique]
   966   C1148472:Blot, Southern [Laboratory or Test Result]
   861   C1710133:Southern [Spatial Concept]
Processing 00000000.tx.281: A 1.3kb probe, external to the recombination vector and located in the 5' of this, makes it possible to discriminate a wild allele of the Parkin gene from a mutated allele after having performed homologous recombination. 

Phrase: "A 1.3kb probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]

Phrase: "external to the recombination vector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205101:External [Spatial Concept]

Phrase: "and"

Phrase: "located in the 5' of this,"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "discriminate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205235:Discriminate [Qualitative Concept]

Phrase: "a wild allele of the Parkin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "from a mutated allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "after"

Phrase: "having"

Phrase: "performed homologous recombination."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599773:Homologous Recombination [Genetic Function]
   901   C2984295:Homologous recombination [Functional Concept]
   827   C0034865:Recombination [Genetic Function]
   827   C1334043:Homologous [Gene or Genome]
Processing 00000000.tx.282: After enzymatic digestion by the endonuclease BamHI, the marked probe revealed a fragment of 6kb for the wild allele and a fragment of 5kb for the mutated allele. 

Phrase: "After enzymatic digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]

Phrase: "by the endonuclease BamHI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011513:Endonuclease BamHI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the marked probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a fragment of 6kb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332255:fragment [Functional Concept]
   770   C1708096:Fragment [Qualitative Concept]

Phrase: "for the wild allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "a fragment of 5kb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332255:fragment [Functional Concept]
   770   C1708096:Fragment [Qualitative Concept]

Phrase: "for the mutated allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.283: The methods for Southern blots were as described by Sambrook et al. 

Phrase: "The methods for Southern blots"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "were"

Phrase: "as"

Phrase: "described by Sambrook et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.284: (80) Cell culture. 

Phrase: "(80"

Phrase: ")"

Phrase: "Cell culture."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.285: The homologous recombination vector was electroporated into 129SV ES CK35 cells obtained from the Pasteur Institute. 

Phrase: "The homologous recombination vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]
   734   C0599773:Homologous Recombination [Genetic Function]
   734   C2984295:Homologous recombination [Functional Concept]

Phrase: "was"

Phrase: "electroporated into 129SV ES CK35 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0596508:ES cell [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "obtained from the Pasteur Institute."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.286: 288 clones resistant to double selection (Neo/TK) were plated. 

Phrase: "288"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "resistant to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332325:Resistant to [Functional Concept]
           Resistant
   861   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036576:selection [Genetic Function]

Phrase: "(Neo/TK)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220928:TK [Geographic Area]

Phrase: "were"

Phrase: "plated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.287: Analysis of the genetic content of these cells by PCR and then by Southern blot made it possible to select 41 clones showing evidence of homologous recombination in the parkin gene. 

Phrase: "Analysis of the genetic content of these cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0679560:genetic analysis [Laboratory Procedure]
   767   C0681915:content analysis [Research Activity]
   767   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "then by Southern blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005862:Southern Blot [Molecular Biology Research Technique]
   833   C1148472:Blot, Southern [Laboratory or Test Result]
   770   C1710133:Southern [Spatial Concept]
   770   C1883708:Then [Temporal Concept]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "41 clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence of homologous recombination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the parkin gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.288: Mutant mice. 

Phrase: "Mutant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.289: Two clones were microinjected into blastocystes from C57BL6 mice. 

Phrase: "Two clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "microinjected into blastocystes"

Phrase: "from C57BL6 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.290: Germ line transmission was obtained from the chimera mice of the two microinjected clones. 

Phrase: "Germ line transmission"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C1521797:Transmission [Natural Phenomenon or Process]
   734   C0017473:Germ Line [Cell]

Phrase: "was"

Phrase: "obtained from the chimera mice of the two microinjected clones."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   739   C0008109:Chimera [Organism]
   739   C0009013:Clones [Cell]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0205448:Two [Quantitative Concept]
   739   C1262946:Chimaera [Fish]
   739   C1301820:Obtained [Functional Concept]
   739   C1318484:Chimera [Disease or Syndrome]
   706 E C1522642:Clone [Tissue]
   706 E C1706701:Obtain [Activity]
Processing 00000000.tx.291: The parkin mutation was maintained in a pure 129SV and in a mixed 129SV/C57BL6 (50/50) genetic background. 

Phrase: "The parkin mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "maintained in a pure 129SV"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1314677:Maintained [Functional Concept]
   760   C2247561:PurE [Molecular Function]
   726 E C0024501:Maintain [Activity]

Phrase: "and in a mixed 129SV/C57BL6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205430:Mixed [Functional Concept]
   753   C1515981:And [Idea or Concept]
   753   C3160715:Mixed [Finding]

Phrase: "(50/50"

Phrase: ")"

Phrase: "genetic background."
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]
Processing 00000000.tx.292: Analysis of parkin protein expression Antibody production. 

Phrase: "Analysis of parkin protein expression Antibody production."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1882495:Protein Expression Analysis [Laboratory Procedure]
   774   C1514534:Protein Analysis [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.293: An antibody to mouse parkin was raised in rabbits following the methods described by Stichel et al. 

Phrase: "An antibody to mouse parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "raised in rabbits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034493:Rabbit [Mammal]
   790   C0442818:Raised [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "described by Stichel et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.294: (81). 

Phrase: "(81"

Phrase: ")."
Processing 00000000.tx.295: Briefly, a peptide was synthesized corresponding to residues 7192 of the mouse parkin protein and this was coupled to GFAP. 

Phrase: "Briefly,"

Phrase: "a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "corresponding to residues 7192 of the mouse parkin protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1570553:parkin protein, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1418270:PARKIN [Gene or Genome]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "this"

Phrase: "was"

Phrase: "coupled to GFAP."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1415042:GFAP [Gene or Genome]
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]
Processing 00000000.tx.296: New Zealand White rabbits were injected s.c. with 150250g of protein emulsified in Keyhole Limpet Haemacyonin and then boosted nine times. 

Phrase: "New Zealand White rabbits"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0324547:New Zealand White Rabbits [Mammal]
           New Zealand Rabbits
           New Zealand White
   861   C0027978:New Zealand [Geographic Area]
   812   C0007457:White [Population Group]
   812   C0034493:Rabbit [Mammal]
   812   C0043157:White [Population Group]
   812   C0205314:New [Temporal Concept]
   812   C0220938:White [Qualitative Concept]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "s.c."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "with 150250g"

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "emulsified in Keyhole Limpet Haemacyonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0324030:Limpet [Eukaryote]
   760   C2350000:Limpet [Food]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "boosted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1511253:Boost [Functional Concept]
   966   C1874596:BOOST [Food]

Phrase: "nine times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.297: Rabbits were bled 2 weeks after the last boost and serum purified by affinity column and used for immunoblotting studies. 

Phrase: "Rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "were"

Phrase: "bled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0019080:bleed [Pathologic Function]

Phrase: "2 weeks after the last boost"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1442457:2 Weeks [Temporal Concept]
   753   C0439230:weeks [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]

Phrase: "and"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "purified by affinity column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C1706132:Column [Idea or Concept]
   770   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "used for immunoblotting studies."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   802   C0869040:Use studies [Research Activity]
   770   C0020985:Immunoblotting [Laboratory Procedure]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.298: Western blots. 

Phrase: "Western blots."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.299: Tissue samples from parkin mutant and wildtype control mice were homogenized with a tissue mincer in a lysis buffer composed of 50mM HEPES pH 7.5, 150mM NaCl, 1mM EGTA, 10% (w/v) glycerol, 1% Triton X-100 (v/v), 1.5mM MgCl2, and a protease inhibitor cocktail. 

Phrase: "Tissue samples from parkin mutant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292533:Tissue Sample [Tissue]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "wildtype control mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   896   C1520150:Wild Type Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "homogenized with a tissue mincer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "in a lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "composed of 50mM HEPES pH 7.5,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1882074:pH 7 [Qualitative Concept]
   748   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0020283:[pH] [Quantitative Concept]
   748   C0450400:50mm [Quantitative Concept]
   748   C0450407:ph+ [Finding]
   748   C0450408:ph++ [Finding]
   748   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "(v/v), 1.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "a protease inhibitor cocktail."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678420:Cocktail [Food]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]
Processing 00000000.tx.300: The protein concentration in the crude preparation was measured according to the standard Bradford assay. 

Phrase: "The protein concentration in the crude preparation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0427716:Protein concentration [Laboratory Procedure]
   778   C1304757:Protein concentration [Laboratory or Test Result]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "measured according to the standard Bradford assay."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   774   C0449768:Measured to [Quantitative Concept]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0680240:according [Social Behavior]
   748   C1442989:Standard [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C2828392:Standard [Intellectual Product]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.301: Blots were performed on homogenates from mouse brain on 10% acrylamide gels with MOPS running buffer (NuPAGE, Invitrogen). 

Phrase: "Blots"

Phrase: "were"

Phrase: "performed on homogenates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "on 10% acrylamide gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "with MOPS running buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(NuPAGE,"

Phrase: "Invitrogen"

Phrase: ")."
Processing 00000000.tx.302: Parkin antibody, as above, was used at 1/500 and revealed with peroxidase-conjugated goat anti-rabbit (Jackson ImmunoResearch) at 1/8000. 

Phrase: "Parkin antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "at 1/500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1412113:AT-1 [Gene or Genome]
   827   C1516077:At [Spatial Concept]

Phrase: "and"

Phrase: "revealed with peroxidase-conjugated goat"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0018019:goat [Mammal]
   760   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0443289:Revealed [Qualitative Concept]
   760   C0522529:Conjugated [Spatial Concept]
   760   C1265549:goat [Mammal]
   760   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   760   C1510458:Goat [Mammal]

Phrase: "anti-rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "(Jackson ImmunoResearch"

Phrase: ")"

Phrase: "at 1/8000."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1412113:AT-1 [Gene or Genome]
   827   C1516077:At [Spatial Concept]
Processing 00000000.tx.303: Protein was revealed with an ECL kit (Amersham-Pharmacia). 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "revealed with an ECL kit (Amersham-Pharmacia"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0331955:Pharmacia [Health Care Related Organization]
   748   C0443289:Revealed [Qualitative Concept]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1332684:ECL [Gene or Genome]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.304: Phenotype Breeding colonies were established on the 129SV background or on a mixed 50/50% 129SV/C57BL6 background and their offspring used for experimentation. 

Phrase: "Phenotype Breeding colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "established on the 129SV background"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C1706907:Background [Conceptual Entity]

Phrase: "or on a mixed 50/50% 129SV/C57BL6 background"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205430:Mixed [Functional Concept]
   742   C1706907:Background [Conceptual Entity]
   742   C3160715:Mixed [Finding]

Phrase: "and"

Phrase: "their offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "used for experimentation."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0678323:experimentation [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.305: Litter size and mortality were observed and recorded in the breeding colony. 

Phrase: "Litter size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023881:Litter Size [Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "recorded in the breeding colony."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0006159:Breeding [Organism Function]
   760   C0439158:colony [Quantitative Concept]
   760   C1947989:Colony [Cell]
   726   C0034869:Record [Intellectual Product]
   726 E C1704650:Breed [Classification]
Processing 00000000.tx.306: After weaning, mice were maintained in same-sex groups of four to six per cage under normal animal house conditions with constant temperature (211C) and a 12h light/dark cycle. 

Phrase: "After weaning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043084:Weaning [Organism Function]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "maintained in same-sex"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0009253:Sex [Organism Function]
   770   C0036864:Sex [Behavior]
   770   C0079399:sex [Organism Attribute]
   770   C0445247:Same [Qualitative Concept]
   770   C1314677:Maintained [Functional Concept]
   770   C1314687:Sex [Finding]
   770   C1522384:sex [Organism Attribute]
   737 E C0024501:Maintain [Activity]

Phrase: "groups of four"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0205450:Four [Quantitative Concept]
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]

Phrase: "to six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "per cage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337189:Cage [Manufactured Object]
  1000   C0441239:Cage [Medical Device]

Phrase: "under normal animal house"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442519:house [Conceptual Entity]
   827   C2003847:House [Manufactured Object]

Phrase: "conditions with constant temperature"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0005903:temperature [Organism Attribute]
   770   C0012634:condition [Disease or Syndrome]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0348080:Condition [Qualitative Concept]
   770   C1547014:*Constant [Quantitative Concept]
   770   C1705253:Condition [Conceptual Entity]
   770   C1948059:Constant [Qualitative Concept]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "(211C"

Phrase: ")"

Phrase: "and"

Phrase: "a 12h light/dark cycle."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C2718082:Light-Dark Cycle [Temporal Concept]
           Light Cycle
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0332582:Dark [Qualitative Concept]
   812   C1306462:Light [Functional Concept]
   812   C1511572:Cycle [Temporal Concept]
   812   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.307: Unless otherwise stated, animals of mixed background were used as these animals reproduced more prolifically. 

Phrase: "Unless"

Phrase: "otherwise"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: ","

Phrase: "animals of mixed background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "used as these animals"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0003062:Animals [Animal]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "reproduced"

Phrase: "more prolifically."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]
Processing 00000000.tx.308: Behaviour Behavioural studies were carried out by operators blinded to the genotype of the animals being tested: Long-term behavioural observationsboth male and female transgenic mice and wild-type animals were observed at monthly intervals, up to the age of 24 months. 

Phrase: "Behaviour Behavioural studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by operators"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   756   C1705273:Operator [Intellectual Product]
   756   C1705274:Operator [Human]
   756   C1705275:Operator [Human]
   756   C2827501:Operator [Intellectual Product]

Phrase: "blinded to the genotype of the animals"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0003062:Animals [Animal]
   748   C0017431:Genotype [Organism Attribute]
   748   C0150108:Blinded [Research Activity]
   714 E C0456909:Blind [Disease or Syndrome]
   714 E C0525065:blind [Patient or Disabled Group]

Phrase: "being"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ":"

Phrase: "Long-term behavioural observationsboth male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0024554:Male [Finding]
   804   C0086582:male [Population Group]
   804   C1706180:Male [Qualitative Concept]
   804   C1706428:Male [Qualitative Concept]
   804   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "female transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "wild-type animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003070:Animals, Wild [Animal]
   827   C0003062:Animals [Animal]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "observed at monthly intervals,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332177:Monthly [Temporal Concept]
   770   C0439507:Monthly [Temporal Concept]
   770   C1272706:intervals [Temporal Concept]
   770   C1441672:Observed [Functional Concept]
   737 E C1552654:Interval [Idea or Concept]
   737 E C1552713:Interval [Intellectual Product]

Phrase: "up to the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 24 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.309: Growth rate and body temperaturegroups of mice were monitored for changes in body weight at regular intervals using a Mettlar Toledo balance. 

Phrase: "Growth rate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0449249:Growth rate [Temporal Concept]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "body temperaturegroups of mice"

Phrase: "were"

Phrase: "monitored for changes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "at regular intervals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1272706:intervals [Temporal Concept]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Mettlar Toledo balance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0560184:Balance [Finding]
Processing 00000000.tx.310: Body temperature was measured via a rectal probe lubricated with saline. 

Phrase: "Body temperature"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0005903:Body Temperature [Organism Attribute]
           temperature
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "was"

Phrase: "measured via a rectal probe"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0182400:Probe [Medical Device]
   760   C0205052:rectal [Spatial Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "lubricated with saline."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036082:Saline [Substance]
Processing 00000000.tx.311: Open field activityanimals were placed in a Perspex box (41x28cm) with a cross dividing it into four equal compartments. 

Phrase: "Open field activityanimals"

Phrase: "were"

Phrase: "placed in a Perspex box"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0179400:Box [Manufactured Object]
   760   C0701416:Perspex [Biomedical or Dental Material,Organic Chemical]
   760   C1533124:Box [Medical Device]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "(41x28cm"

Phrase: ")"

Phrase: "with a cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:dividing [Functional Concept]

Phrase: "it into four equal compartments."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205163:Equal [Qualitative Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C1185625:Compartments [Body Space or Junction]
   760   C1382196:Compartments [Natural Phenomenon or Process]
   760   C1549782:Equal [Idea or Concept]
   726 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.312: The blinded operator sat at 2m distance from the cage and counted each time the animal traversed the lines of the cross over two consecutive periods of 3min. 

Phrase: "The blinded operator sat at 2m distance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705827:SAT [Gene or Genome]

Phrase: "from the cage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337189:Cage [Manufactured Object]
  1000   C0441239:Cage [Medical Device]

Phrase: "and"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "each time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "the animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "traversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828360:Traverse [Conceptual Entity]

Phrase: "the lines of the cross over two consecutive periods of 3min."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   738   C0205132:lines [Spatial Concept]
   704 E C1550648:Line [Substance]
   704 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.313: Spontaneous alternationanimals were placed in a T maze with one arm blocked and allowed 3min to explore the maze. 

Phrase: "Spontaneous alternationanimals"

Phrase: "were"

Phrase: "placed in a T maze"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0083355:MAZE [Therapeutic or Preventive Procedure]
   760   C0870866:maze [Manufactured Object]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "with one arm"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0446516:Arm [Body Location or Region]
   861   C1269078:Arm [Body Part, Organ, or Organ Component]
   861   C1269612:Arm [Body Location or Region]
   805 E C0445456:Brachial [Spatial Concept]
   777 E C0206655:ARMS [Neoplastic Process]
   777 E C2681631:ARMS [Gene or Genome]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "allowed 3min to"

Phrase: "explore"

Phrase: "the maze."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083355:MAZE [Therapeutic or Preventive Procedure]
  1000   C0870866:maze [Manufactured Object]
Processing 00000000.tx.314: Fifteen minutes later they were placed in the same maze, this time with both arms open, and allowed to enter into the arm of their choice and the latency and arm choice recorded. 

Phrase: "Fifteen minutes later"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0439232:minute [Temporal Concept]
   827   C0700321:minute [Quantitative Concept]
   827   C0702093:/minute [Temporal Concept]
   827   C1282918:Minute [Quantitative Concept]
   827   C2347166:Minute [Quantitative Concept]

Phrase: "they"

Phrase: "were"

Phrase: "placed in the same maze,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0083355:MAZE [Therapeutic or Preventive Procedure]
   760   C0445247:Same [Qualitative Concept]
   760   C0870866:maze [Manufactured Object]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "this time with both arms"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "open"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: ","

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enter into the arm of their choice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0008300:choice [Individual Behavior]
   748   C0446516:Arm [Body Location or Region]
   748   C1269078:Arm [Body Part, Organ, or Organ Component]
   748   C1269612:Arm [Body Location or Region]
   748   C1522196:ENTER [Functional Concept]
   748   C1707391:Choice [Activity]

Phrase: "and"

Phrase: "the latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205275:Latent [Qualitative Concept]

Phrase: "and"

Phrase: "arm choice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008300:choice [Individual Behavior]
   861   C1707391:Choice [Activity]

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.315: Where the animal had been allowed access to one arm in the first trial and they chose the other arm in the second trial, alternation was considered to have taken place. 

Phrase: "Where"

Phrase: "the animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "had"

Phrase: "been"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "access to one arm"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205447:One [Quantitative Concept]
   770   C0444454:Access [Spatial Concept]
   770   C0446516:Arm [Body Location or Region]
   770   C1269078:Arm [Body Part, Organ, or Organ Component]
   770   C1269612:Arm [Body Location or Region]
   770   C1554204:access [Idea or Concept]
   715 E C0445456:Brachial [Spatial Concept]

Phrase: "in the first trial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008976:Trial [Research Activity]

Phrase: "and"

Phrase: "they"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "the other arm in the second trial,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0446516:Arm [Body Location or Region]
   748   C1269078:Arm [Body Part, Organ, or Organ Component]
   748   C1269612:Arm [Body Location or Region]
   732   C1705538:Trial Arms [Idea or Concept]

Phrase: "alternation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919661:alternation [Pathologic Function]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "place."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.316: This is a valid cue for good working memory performance and normally, in almost 100% of cases, animals alternate, following a strong exploratory motivation. 

Phrase: "This"

Phrase: "is"

Phrase: "a valid cue for good working memory performance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0010439:cue [Idea or Concept]

Phrase: "and"

Phrase: "normally,"

Phrase: "in almost 100%"

Phrase: "of cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "alternate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332270:alternate [Functional Concept]
  1000   C1523987:Alternate [Conceptual Entity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a strong exploratory motivation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026605:Motivation [Mental Process]
Processing 00000000.tx.317: However, alternation is only possible if the subjects remember the exploration of the first arm (first trial). 

Phrase: "However,"

Phrase: "alternation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919661:alternation [Pathologic Function]

Phrase: "is"

Phrase: "only possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "if"

Phrase: "the subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "remember"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679062:remember [Mental Process]

Phrase: "the exploration of the first arm (first trial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1280903:Exploration [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.318: This is a test classically used to estimate spatial working memory in rodents using a motor task without food deprivation (no food motivation and reinforcement) (82), the only reinforcement being the strength of the animals' novel environment exploration. 

Phrase: "This"

Phrase: "is"

Phrase: "a test classically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "spatial working memory in rodents"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0025265:Working Memory [Mental Process]
   797   C0814087:spatial memory [Mental Process]
   760   C0025260:Memory [Mental Process]
   760   C0043227:Working [Occupational Activity]
   760   C0700327:memory [Finding]
   760   C1428114:spatial [Gene or Genome]
   760   C1706377:Memory [Manufactured Object]
   704 E C0679055:mnemonic [Mental Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a motor task without food deprivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3540678:Task [Occupational Activity]

Phrase: "("

Phrase: "no food motivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026605:Motivation [Mental Process]

Phrase: "and"

Phrase: "reinforcement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035007:Reinforcement [Mental Process]
  1000   C0678211:Reinforcement [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "(82"

Phrase: ")"

Phrase: ","

Phrase: "the only reinforcement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035007:Reinforcement [Mental Process]
   861   C0678211:Reinforcement [Therapeutic or Preventive Procedure]

Phrase: "being"

Phrase: "the strength of the animals' novel environment exploration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0237897:Strength [Quantitative Concept]
   744   C0808080:Strength [Idea or Concept]
   744   C1705922:Strength [Qualitative Concept]
Processing 00000000.tx.319: Grip strengthanimals were measured using the Columbus grip strength meter. 

Phrase: "Grip strengthanimals"

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Columbus grip strength meter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475209:Meter [Quantitative Concept]
   812   C1706378:METER [Manufactured Object]
Processing 00000000.tx.320: Animals were allowed three attempts to hold on while being pulled backwards across the grid attached to the force-meter. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "hold on"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1553387:Hold [Idea or Concept]
   833   C1948035:Hold [Activity]

Phrase: "while"

Phrase: "being"

Phrase: "pulled backwards across the grid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439781:backwards [Spatial Concept]

Phrase: "attached to the force-meter."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0231441:Attached [Finding]
   760   C0441722:Force [Phenomenon or Process]
   760   C0475209:Meter [Quantitative Concept]
   760   C0563538:Force [Phenomenon or Process]
   760   C1706378:METER [Manufactured Object]
   726 E C1314972:ATTACH [Intellectual Product]
   704 E C0729333:Dynamic [Functional Concept]
Processing 00000000.tx.321: The highest force obtained, normally the first reading, was recorded. 

Phrase: "The highest force obtained, normally"
Meta Candidates (Total=17; Excluded=12; Pruned=0; Remaining=5)
   812   C0441722:Force [Phenomenon or Process]
   812   C0563538:Force [Phenomenon or Process]
   812   C1301820:Obtained [Functional Concept]
   812   C1522410:Highest [Qualitative Concept]
   787   C0557899:Height increased [Finding]
   779 E C0205250:High [Qualitative Concept]
   779 E C1299351:High [Qualitative Concept]
   779 E C1706701:Obtain [Activity]
   779 E C2700149:HIGH [Intellectual Product]
   756 E C0729333:Dynamic [Functional Concept]
   741 E C1517378:Gain [Quantitative Concept]
   729 E C0489786:Height [Organism Attribute]
   719 E C0205217:Increased [Quantitative Concept]
   719 E C0439661:Acquired [Temporal Concept]
   719 E C0442805:Increase [Functional Concept]
   719 E C0442808:Increasing [Functional Concept]
   719 E C3245488:acquired [Intellectual Product]

Phrase: "the first reading,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034754:Reading [Daily or Recreational Activity]
   861   C1705179:Reading [Finding]

Phrase: "was"

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.322: Hanging threadanimals were placed on a 50cm cotton thread (in the middle of the thread, 25cm from each platform) suspended between two platforms 25cm from the ground. 

Phrase: "Hanging threadanimals"

Phrase: "were"

Phrase: "placed on a 50cm cotton thread"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0010196:Cotton [Plant]
   753   C0330523:cotton [Plant]
   753   C0330524:cotton [Plant]
   753   C1095832:Cotton [Substance]
   753   C1710394:Thread [Manufactured Object]
   753   C1882475:Thread [Intellectual Product]
   719   C0442504:Place [Spatial Concept]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]

Phrase: "("

Phrase: "in the middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: "of the thread,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710394:Thread [Manufactured Object]
  1000   C1882475:Thread [Intellectual Product]

Phrase: "25cm from each platform"

Phrase: ")"

Phrase: "suspended between two platforms 25cm"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205448:Two [Quantitative Concept]
   760   C1553389:suspended [Idea or Concept]
   760   C1553403:suspended [Idea or Concept]
   760   C1705537:Suspended [Functional Concept]
   726   C1710360:Platform [Research Device]

Phrase: "from the ground."
Processing 00000000.tx.323: The animal's forelegs were placed on the thread, immediately inducing a grasping behaviour. 

Phrase: "The animal's forelegs"

Phrase: "were"

Phrase: "placed on the thread,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1710394:Thread [Manufactured Object]
   770   C1882475:Thread [Intellectual Product]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "a grasping behaviour."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.324: To reach any of the two platforms, the mice had to place their back legs on the thread. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "any of the two platforms,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205448:Two [Quantitative Concept]
   760   C1552551:Any [Qualitative Concept]
   760   C3272371:ANY [Intellectual Product]
   726   C1710360:Platform [Research Device]

Phrase: "the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "their back legs on the thread."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1140621:Legs [Body Location or Region]
   719 E C0023216:Leg [Body Location or Region]
   719 E C1285009:Leg [Body Location or Region]
Processing 00000000.tx.325: Both the time on the wire and the time until a back leg was placed on the wire were recorded. 

Phrase: "Both"

Phrase: "the time on the wire"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "the time until a back leg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "was"

Phrase: "placed on the wire"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005978:Wire [Medical Device]
   770   C1705105:Wire [Manufactured Object]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "were"

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.326: Refusal to grip was also noted. 

Phrase: "Refusal to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1569452:Refusal [Organic Chemical,Pharmacologic Substance]

Phrase: "grip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021400:GRIP [Disease or Syndrome]
  1000   C0220843:Grip [Organism Function]

Phrase: "was"

Phrase: "also"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.327: Animals underwent three tests per session and were re-tested at 3 monthly intervals. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "underwent"

Phrase: "three tests per session"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0022885:Tests [Laboratory Procedure]
   770   C0392366:Tests [Intellectual Product]
   737 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "were"

Phrase: "re-tested at 3 monthly intervals."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0332177:Monthly [Temporal Concept]
   753   C0392366:tested [Intellectual Product]
   753   C0439507:Monthly [Temporal Concept]
   753   C1272706:intervals [Temporal Concept]
   753   C2986904:RE [Idea or Concept]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]
   719 E C1552654:Interval [Idea or Concept]
   719 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.328: Exploratory behaviour, social interaction and motor activity were measured in drug-naive animals and after pharmacological treatment with amphetamine. 

Phrase: "Exploratory behaviour,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0015328:Exploratory Behavior [Individual Behavior]
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]

Phrase: "social interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037420:Social Interaction [Finding]
   861   C0728831:Social [Functional Concept]
   861   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "motor activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0026606:Motor Activity [Daily or Recreational Activity]
  1000   C1321502:motor activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured in drug-naive animals"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   797   C0449844:Drug measured [Pharmacologic Substance]
   760   C0003062:Animals [Animal]
   760   C0013227:Drug [Pharmacologic Substance]
   760   C0444706:Measured [Qualitative Concept]
   760   C1254351:Drug [Pharmacologic Substance]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   704 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   704 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]

Phrase: "and after pharmacological treatment"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0013216:Pharmacological Treatment [Therapeutic or Preventive Procedure]
   770   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205464:pharmacological [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with amphetamine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.329: Spontaneous motor activity was measured over a 30min period, after 30min of adaptation, using automated activity cages with photoelectric cells without drug treatment and after amphetamine (0.5, 1 and 5mg/kg i.p.). 

Phrase: "Spontaneous motor activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0026606:Motor Activity [Daily or Recreational Activity]
   901   C1321502:motor activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0205359:Spontaneous [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1513492:Motor [Functional Concept]
   827   C1561536:*Activity [Idea or Concept]
   827   C1705994:Motor [Manufactured Object]

Phrase: "was"

Phrase: "measured over a 30min period,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0439531:/period [Temporal Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1948053:Period [Temporal Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "after"

Phrase: "30min of adaptation,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "automated activity cages with photoelectric cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0337189:cages [Manufactured Object]
   719 E C0441239:Cage [Medical Device]

Phrase: "without drug treatment"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and after amphetamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]

Phrase: "(0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "5mg/kg i.p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.330: In amphetamine treated mice, the animals were returned to the activity cages 40min after the treatment and then recorded. 

Phrase: "In amphetamine treated mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "returned to the activity cages 40min"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   773   C0332156:Return to [Qualitative Concept]
           Return
   753   C0205177:Activity [Functional Concept]
   753   C0337189:cages [Manufactured Object]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
   719 E C0441239:Cage [Medical Device]

Phrase: "after the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.331: Histology and western blots Male and female mice were used at different ages (224 months) for these experiments. 

Phrase: "Histology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019638:Histology [Biomedical Occupation or Discipline]
  1000   C0205462:histology [Functional Concept]
  1000   C0344441:Histology [Laboratory Procedure]

Phrase: "and"

Phrase: "western blots Male"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0024554:Male [Finding]
   827   C0086582:male [Population Group]
   827   C1706180:Male [Qualitative Concept]
   827   C1706428:Male [Qualitative Concept]
   827   C1706429:Male [Organism Attribute]
   734   C0949466:Western Blots [Laboratory Procedure]
   701 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "female mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used at different ages"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0699810:age difference [Age Group]
   770   C0001779:Age [Organism Attribute]
   770   C1273517:used [Finding]
   770   C1705242:Different [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(224 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "for these experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.332: Animals were anaesthetized with pentobarbital (130mg/kg; Sigma, St Quentin, France) and transcardially perfused with 4% paraformaldehyde in 0.1M phosphate buffer saline (PBS). 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "anaesthetized with pentobarbital"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]

Phrase: "(130mg/kg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]

Phrase: "; Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Quentin,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "transcardially"

Phrase: "perfused with 4% paraformaldehyde"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   737   C1549542:Perfuse [Functional Concept]

Phrase: "in 0.1M phosphate buffer saline (PBS)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0036082:Saline [Substance]
Processing 00000000.tx.333: Brains were removed, postfixed, and cryoprotected. 

Phrase: "Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "postfixed,"

Phrase: "and"

Phrase: "cryoprotected."
Processing 00000000.tx.334: Routine histological sections at the level of the striatum, hippocampus, brain stem and cerebellum were stained with haematoxylin and eosin. 

Phrase: "Routine histological sections at the level of the striatum,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   708   C0205155:Section [Spatial Concept]
   708   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   708   C1522472:Section [Substance]
   708   C1552923:Section [Quantitative Concept]
   708   C1705191:Section [Physical Object]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "were"

Phrase: "stained with haematoxylin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "eosin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.335: Immunohistochemistry was performed, as described previously (83), on free-floating cryomicrotome-cut sections (20m in thickness) from the whole brain. 

Phrase: "Immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(83"

Phrase: ")"

Phrase: ","

Phrase: "on free-floating cryomicrotome-cut sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]

Phrase: "(20m in thickness"

Phrase: ")"

Phrase: "from the whole brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.336: After incubation in 1% H2O2, followed by 0.2% Triton X-100 and then 2% normal goat serum in 0.1 PBS0.2% gelatin, the sections were stained overnight at 4C using a polyclonal antibody against tyrosine hydroxylase (TH) (1/1000; rabbit polyclonal; Pel Freez, Rogers, AR, USA), dopamine transporter (DAT) (1/10000; kindly provided by B. Giros), -synuclein (1/2000; affinity-purified rabbit polyclonal AB5038P; Chemicon International), ubiquitin (1/3000; rabbit polyclonal; Dako), synapsin (1/2000; polyclonal rabbit; Sigma), synaptophysin (1/1000; monoclonal mouse; Sigma), Map2 (1/500; monoclonal mouse; Sigma) or NeuN (1/2000; monoclonal mouse; Chemicon International). 

Phrase: "After incubation"

Phrase: "in 1% H2O2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "followed by 0.2% Triton X-100"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0242759:Triton [Geographic Area]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "then 2% normal goat serum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0018019:goat [Mammal]
   804   C0205307:Normal [Qualitative Concept]
   804   C0229671:Serum [Body Substance]
   804   C0439166:% normal [Quantitative Concept]
   804   C1265549:goat [Mammal]
   804   C1510458:Goat [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   804   C2347086:% Normal [Quantitative Concept]

Phrase: "in 0.1 PBS0.2% gelatin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   804   C1145617:Gelatin [Food]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a polyclonal antibody against tyrosine hydroxylase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(TH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]
   861   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "(1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "polyclonal"

Phrase: "; Pel Freez,"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986463:AR+ [Finding]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "dopamine transporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(DAT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(1/10000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; kindly"

Phrase: "provided by B. Giros"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: ")"

Phrase: ", -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1/2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; affinity-purified rabbit polyclonal AB5038P"

Phrase: "; Chemicon"

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1/3000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "polyclonal"

Phrase: "; Dako"

Phrase: ")"

Phrase: ","

Phrase: "synapsin (1/2000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0087044:Synapsin I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420543:SYNAPSIN I [Gene or Genome]
   827   C0085252:synapsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; polyclonal rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "synaptophysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "(1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; monoclonal mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "Map2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417006:MAP2 [Gene or Genome]
  1000   C1424480:MAP2 [Gene or Genome]

Phrase: "(1/500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; monoclonal mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "NeuN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146324:NeuN [Gene or Genome]

Phrase: "(1/2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; monoclonal mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "; Chemicon"

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.337: Sections were then treated with biotinylated anti-rabbit (1/200) secondary antibodies (Vectastain; Vector Laboratory, Burlingame, CA, USA), and subsequently incubated with avidinbiotinylated horseradish peroxidase complex. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with biotinylated anti-rabbit"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0034493:Rabbit [Mammal]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(1/200"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Vectastain"

Phrase: "; Vector Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Burlingame,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "subsequently"

Phrase: "incubated with avidinbiotinylated horseradish peroxidase complex."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0330510:Horseradish [Food]
   753   C0439855:Complex [Qualitative Concept]
   753   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   753   C1110641:Horseradish [Plant]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.338: The peroxidase was revealed by incubation with 0.05% 3,3'-diaminobenzidine tetrahydrochloride containing 0.015% hydrogen peroxide. 

Phrase: "The peroxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "revealed by incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443289:Revealed [Qualitative Concept]

Phrase: "with 0.05% 3,"

Phrase: "3'-diaminobenzidine tetrahydrochloride"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.015% hydrogen peroxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0020275:Hydrogen [Element, Ion, or Isotope]
   812   C0031180:Peroxide [Inorganic Chemical]
   812   C0523702:HYDROGEN [Laboratory Procedure]
   812   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.339: All sections were stained simultaneously for animals of the same age using the same solutions. 

Phrase: "All sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "simultaneously for animals of the same age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0001779:Age [Organism Attribute]
   748   C0003062:Animals [Animal]
   748   C0445247:Same [Qualitative Concept]
   748   C0521115:simultaneously [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same solutions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.340: The total number of TH-stained cells with clearly visible nuclear borders was estimated, using a previously described method and an image analysis system (84) (Visioscan 2000, Biocom, Les Ulis, France). 

Phrase: "The total number of TH-stained cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1441375:Cells.total [Cell]
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0237753:*Number [Quantitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "with clearly visible nuclear borders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205284:Border [Spatial Concept]
   812   C1522411:Border [Body Location or Region]
   812   C2828371:Border [Classification]

Phrase: "was"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a previously described method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "an image analysis system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0039152:analysis system [Occupational Activity]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C0200765:Image analysis [Laboratory Procedure]

Phrase: "(84"

Phrase: ")"

Phrase: "(Visioscan 2000,"

Phrase: "Biocom,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0308450:BIOCOM [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Les Ulis,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.341: All sections were coded and examined blind. 

Phrase: "All sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "coded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0009219:code [Occupational Activity]
   966   C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "examined blind."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0150108:Blind [Research Activity]
   861   C0456909:Blind [Disease or Syndrome]
   861   C0525065:blind [Patient or Disabled Group]
Processing 00000000.tx.342: In the striatum, measurement of optical density of TH immunostaining, as an index of the density of dopaminergic axons and nerve terminals, was performed using the same image analysis system. 

Phrase: "In the striatum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "measurement of optical density of TH immunostaining,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1266211:Optical density measurement [Laboratory Procedure]
   767   C0337446:Tyrosine measurement [Laboratory Procedure]
   744   C0242485:Measurement [Functional Concept]

Phrase: "as"

Phrase: "an index of the density of dopaminergic axons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0918012:Index [Intellectual Product]
   744   C1552854:index [Idea or Concept]
   744   C1637833:% index [Quantitative Concept]

Phrase: "and"

Phrase: "nerve terminals,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0027747:Nerve terminals [Cell Component]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same image analysis system."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0039152:analysis system [Occupational Activity]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.343: Muscle samples from five transgenic and five wild-type male mice at 20 months of age were embebbed in paraffin, cut on a microtome in 5m sections and mounted on 2x gelatinized slides. 

Phrase: "Muscle samples from five transgenic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026845:Muscle [Tissue]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "five wild-type male mice at 20 months of age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   761   C1520150:Wild Type Mouse [Mammal]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "embebbed in paraffin,"

Phrase: "cut on a microtome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0000925:Cut [Injury or Poisoning]
   770   C1883724:CUT [Phenomenon or Process]

Phrase: "in 5m sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "mounted on 2x gelatinized slides."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0444330:slides [Research Device]
   760   C0449878:mounted [Finding]
   726 E C0181909:Mount [Medical Device]
   726 E C1705201:Slide [Manufactured Object]
Processing 00000000.tx.344: A Masson Trichrome staining was performed, and slides were examined by optic microscopy. 

Phrase: "A Masson Trichrome staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1318478:Trichrome staining [Laboratory Procedure]
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "and"

Phrase: "slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "examined by optic microscopy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015392:Optic [Body Part, Organ, or Organ Component]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0029144:optic [Occupation or Discipline]
   770   C0332128:Examined [Finding]
Processing 00000000.tx.345: Samples (25g) of striatum, limbic region, diencephalon and brain stem were analyzed for TH and DAT proteins by western blots, according to Mena et al. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "(25g"

Phrase: ")"

Phrase: "of striatum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "limbic region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "diencephalon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012144:Diencephalon [Body Part, Organ, or Organ Component]
  1000   C1281065:Diencephalon [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "analyzed for TH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]
   770   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "DAT proteins by western blots,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0114838:Dopamine Transporter Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   773   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "according to Mena et al."
Processing 00000000.tx.346: (85). 

Phrase: "(85"

Phrase: ")."
Processing 00000000.tx.347: Samples (40g) of striatum were analysed for VMAT2 protein by western blots, according to Handler et al. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "(40g"

Phrase: ")"

Phrase: "of striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "analysed for VMAT2 protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
   814   C1529240:Vesicular Monoamine Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C3539788:Monoamine Transporter [Amino Acid, Peptide, or Protein]
   774   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205378:Vesicular [Qualitative Concept]
   748   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0599682:monoamine [Organic Chemical]

Phrase: "by western blots,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "according to Handler et al."
Processing 00000000.tx.348: (86). 

Phrase: "(86"

Phrase: ")."
Processing 00000000.tx.349: The membranes were incubated with mouse anti-TH from Chemicon (1:10000), mouse anti-DAT from Chemicon (1:5000), rabbit anti-VMAT2 from Chemicon (1:500) and mouse anti--actin from Sigma (1:10000), as a control of charge. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with mouse anti-TH"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]
   753   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "from Chemicon"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10000"

Phrase: ")"

Phrase: ","

Phrase: "mouse anti-DAT from Chemicon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]
   753   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000"

Phrase: ")"

Phrase: ","

Phrase: "rabbit anti-VMAT2 from Chemicon"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
   800   C1529240:Vesicular Monoamine Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C3539788:Monoamine Transporter [Amino Acid, Peptide, or Protein]
   744   C0034493:Rabbit [Mammal]
   744   C0205378:Vesicular [Qualitative Concept]
   744   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0599682:monoamine [Organic Chemical]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "and"

Phrase: "mouse anti--actin from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10000"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "a control of charge."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.350: For VMAT2 detection, an enchanced chemiluminescence (SuperSignal West Dura Extended Duration Substrate) kit from Pierce Chemical was used. 

Phrase: "For VMAT2 detection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1511790:Detection [Therapeutic or Preventive Procedure]
   771   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
   717   C1529240:Vesicular Monoamine Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an enchanced chemiluminescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   861   C1450278:Chemiluminescence [Natural Phenomenon or Process]

Phrase: "(SuperSignal West Dura"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013313:Dura [Body Part, Organ, or Organ Component]

Phrase: "Extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "Duration Substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: ")"

Phrase: "kit from Pierce"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0812225:KIT [Medical Device]
   790   C1150635:KIT [Molecular Function]
   790   C1705212:Kit [Medical Device]
   790   C1705213:KIT [Medical Device]
   790   C3273202:Kit [Manufactured Object]

Phrase: "Chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.351: Pharmacology Monoamines and their metabolites. 

Phrase: "Pharmacology Monoamines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599682:monoamines [Organic Chemical]

Phrase: "and"

Phrase: "their metabolites."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870883:Metabolites [Biologically Active Substance]
  1000   C2698672:METABOLITES [Regulation or Law]
Processing 00000000.tx.352: Endogenous monoamine and metabolite levels in brain regions: After decapitation, brain parts were dissected, according to Carlsson and Lindqvist (87) into the dopamine (DA)-rich limbic portion, the corpora striata, the rest of the cerebral hemispheres, the diencephalon and the lower brain stem. 

Phrase: "Endogenous monoamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599682:monoamine [Organic Chemical]

Phrase: "and"

Phrase: "metabolite levels in brain regions"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0441889:Levels [Qualitative Concept]
   739   C0683928:regional level [Spatial Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: ":"

Phrase: "After"

Phrase: "decapitation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0152232:Decapitation [Injury or Poisoning]
  1000   C0413398:Decapitation [Injury or Poisoning]

Phrase: "brain parts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0445620:brain parts [Body Location or Region]
   861   C0449719:parts [Spatial Concept]
   861   C1709471:PARTS [Quantitative Concept]

Phrase: "were"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: ","

Phrase: "according to Carlsson"

Phrase: "and"

Phrase: "Lindqvist"

Phrase: "(87"

Phrase: ")"

Phrase: "into the dopamine (DA)-rich limbic portion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449719:Portion [Spatial Concept]

Phrase: "the corpora striata,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0010097:Corpus Striatum [Body Part, Organ, or Organ Component]
           Striatum
   966   C1269581:Corpus striatum [Body Part, Organ, or Organ Component]
   827   C0162512:Striatum [Body Part, Organ, or Organ Component]
   827   C0227813:Corpus [Body Part, Organ, or Organ Component]

Phrase: "the rest of the cerebral hemispheres,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035253:Rest [Daily or Recreational Activity]
   753   C1622890:ResT [Molecular Function]

Phrase: "the diencephalon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012144:Diencephalon [Body Part, Organ, or Organ Component]
  1000   C1281065:Diencephalon [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the lower brain stem."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
   901   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.353: The brain parts were frozen on dry ice and the levels of DA and its metabolites, 3-methoxy-tyramine (3-MT), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), noradrenaline (NA) and its metabolite, 4-hydroxy-3-methoxy-phenyl-glycol (MHPG), serotonin (5-HT) and its metabolite, 5-hydroxy-indole-acetic acid (5-HIAA), were measured by HPLC with an ESA coulochem detector, according to Mena et al. 

Phrase: "The brain parts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0445620:brain parts [Body Location or Region]
   861   C0449719:parts [Spatial Concept]
   861   C1709471:PARTS [Quantitative Concept]

Phrase: "were"

Phrase: "frozen on dry ice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0013239:Dry Ice [Inorganic Chemical]
   770   C0011682:Dry [Natural Phenomenon or Process]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0020746:Ice [Inorganic Chemical]
   770   C0205222:Dry [Qualitative Concept]
   770   C0677542:Frozen [Functional Concept]
   770   C1512080:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "the levels of DA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "its metabolites,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870883:Metabolites [Biologically Active Substance]
  1000   C2698672:METABOLITES [Regulation or Law]

Phrase: "3-methoxy-tyramine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0047728:3-tyramine [Organic Chemical]
   827   C0041479:Tyramine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(3-MT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0047729:3-tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0886584:Methyl tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4-dihydroxyphenylacetic acid (DOPAC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0000376:Dihydroxyphenylacetic acid [Biologically Active Substance,Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "homovanillic acid (HVA),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019903:Homovanillic Acid [Biologically Active Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "noradrenaline (NA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028351:Noradrenalin [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "its metabolite,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870883:Metabolite [Biologically Active Substance]

Phrase: "4-hydroxy-3-methoxy-phenyl-glycol (MHPG),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0075349:phenyl glycol [Biologically Active Substance,Organic Chemical]
   799   C0017945:Glycol [Organic Chemical]
   799   C0017951:Glycol [Organic Chemical]
   799   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "serotonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "(5-HT)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036751:5-HT [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
  1000   C0048996:5 ht [Organic Chemical,Pharmacologic Substance]
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: "and"

Phrase: "its metabolite,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870883:Metabolite [Biologically Active Substance]

Phrase: "5-hydroxy-indole-acetic acid (5-HIAA),"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0020361:5-Hydroxy-indoleacetic acid [Organic Chemical]
   884   C0936060:Indoleacetic acid [Hormone,Organic Chemical]
   840   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   840   C0000985:Acetic acid [Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0021236:indole [Organic Chemical,Pharmacologic Substance]
   804   C0021242:Indole [Organic Chemical]
   804   C0202406:Acid [Laboratory Procedure]
   804   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   748 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by HPLC"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "with an ESA coulochem detector,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0180392:Detector [Medical Device]
   827   C1705235:Detector [Manufactured Object]

Phrase: "according to Mena et al."
Processing 00000000.tx.354: (85). 

Phrase: "(85"

Phrase: ")."
Processing 00000000.tx.355: Briefly, the tissue was sonicated in 8 vols (w/v) of 0.4 N perchloric acid with 0.5mM Na2S2O5 and 2% EDTA and then centrifuged for 10min. 

Phrase: "Briefly,"

Phrase: "the tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "sonicated in 8 vols"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0449468:VOL [Quantitative Concept]
   737   C0560268:vol% [Quantitative Concept]
   737   C1690016:% vol [Qualitative Concept]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "of 0.4 N perchloric acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0030981:Perchloric acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "with 0.5mM Na2S2O5"

Phrase: "and"

Phrase: "2% EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged for 10min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]
Processing 00000000.tx.356: Monoamine levels were determined from 20l of the resulting supernatant. 

Phrase: "Monoamine levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined from 20l of the resulting supernatant."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0678226:resulting [Functional Concept]
   748   C1550101:Supernatant [Body Substance]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]
Processing 00000000.tx.357: Catecholamine turnover. 

Phrase: "Catecholamine turnover."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.358: Endogenous whole brain levels of NA and DA, with and without catecholamine synthesis inhibition by alpha-methyltyrosine (-MT), were measured. 

Phrase: "Endogenous whole brain levels of NA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0441889:Levels [Qualitative Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "DA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "with"

Phrase: "and without catecholamine synthesis inhibition"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1156511:catecholamine synthesis [Molecular Function]
   760   C0007412:Catecholamine [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0220781:synthesis [Biologic Function]
   760   C1515981:And [Idea or Concept]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C1883254:Synthesis [Activity]
   760   C3463820:Inhibition [Activity]
   760   C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "by alpha-methyltyrosine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0051427:alpha-Methyltyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "(-MT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0886584:Methyl tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.359: Mice were sacrificed 1h after being injected with -MT (250mg/kg, i.p.) 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "sacrificed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]

Phrase: "1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "after"

Phrase: "being"

Phrase: "injected with -MT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0886584:Methyl tyrosine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   737   C1720154:Inject [Functional Concept]

Phrase: "(250mg/kg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]

Phrase: "i.p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"
Processing 00000000.tx.360: (88). 

Phrase: "(88"

Phrase: ")."
Processing 00000000.tx.361: Measurement of glutathione levels. 

Phrase: "Measurement of glutathione levels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0202053:Glutathione measurement [Laboratory Procedure]
   770   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.362: Total glutathione (GSH) levels were measured by the method of Tietze (89). 

Phrase: "Total glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(GSH) levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1260386:GSH [Disease or Syndrome]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by the method of Tietze"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0025663:Method [Intellectual Product]
   753   C0444706:Measured [Qualitative Concept]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "(89"

Phrase: ")."
Processing 00000000.tx.363: Briefly, cells from fetal midbrain cultures or brain samples were sonicated in 0.4N PCA and centrifuged, and the supernatants were neutralized with 4 vols of NaH2PO4, 0.1M (5mM EDTA), pH 7.5. 

Phrase: "Briefly,"

Phrase: "cells from fetal midbrain cultures"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   813   C0920515:fetal cell culture [Laboratory Procedure]
   797   C0007585:cells cultures [Laboratory Procedure]
   797   C0439170:% fetal cells [Quantitative Concept]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "brain samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "sonicated in 0.4N PCA"

Phrase: "and"

Phrase: "centrifuged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "neutralized with 4 vols of NaH2PO4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0449468:VOL [Quantitative Concept]
   719   C0560268:vol% [Quantitative Concept]
   719   C1690016:% vol [Qualitative Concept]

Phrase: "0.1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470296:1M [Quantitative Concept]

Phrase: "(5mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "pH 7.5."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.364: GSH content was measured in a P96 automatic reader by the addition of DTNB (0.6mM), NADPH (0.2mM), GSH reductase (1U) and the reaction monitored at 412nM for 6min. 

Phrase: "GSH content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1260386:GSH [Disease or Syndrome]

Phrase: "was"

Phrase: "measured in a P96 automatic reader"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0205554:Automatic [Functional Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1514743:Reader [Professional or Occupational Group]
   753   C1706461:Reader [Manufactured Object]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "by the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of DTNB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012788:DTNB [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1414177:DTNB [Gene or Genome]

Phrase: "(0.6mM"

Phrase: ")"

Phrase: ","

Phrase: "NADPH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027303:NADPH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(0.2mM"

Phrase: ")"

Phrase: ","

Phrase: "GSH reductase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1U"

Phrase: ")"

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "monitored at 412nM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "for 6min."
Processing 00000000.tx.365: Oxidized glutathione (GSSG) was measured in the cells by the method of Griffith (90). 

Phrase: "Oxidized glutathione"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061516:Glutathione, Oxidized [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(GSSG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0061516:GSSG [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "measured in the cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0444706:Measured [Qualitative Concept]
   770   C3282337:Cells [Cell]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Griffith"

Phrase: "(90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.366: Reduced GSH, after PCA extraction and pH neutralization, was derivatized with 2-vinylpyridine at room temperature for 1h and the reaction carried out as above. 

Phrase: "Reduced GSH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1260386:GSH [Disease or Syndrome]

Phrase: "after"

Phrase: "PCA extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "pH neutralization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1578828:Neutralization [Laboratory Procedure]
   861   C2987668:Neutralization [Functional Concept]

Phrase: "was"

Phrase: "derivatized with 2-vinylpyridine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0303984:Vinyl pyridine [Organic Chemical]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out as above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.367: GSH was obtained by subtracting GSSG levels from total GSH levels (47). 

Phrase: "GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "was"

Phrase: "obtained by subtracting GSSG levels"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0061516:GSSG [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C1706701:Obtain [Activity]
   726   C1719767:Subtract [Intellectual Product]
   726   C2348589:Subtract [Phenomenon or Process]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "from total GSH levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1260386:GSH [Disease or Syndrome]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.368: DA uptake and release in fetal midbrain neuronal cultures. 

Phrase: "DA uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1657587:dopamine uptake [Cell Function]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "release in fetal midbrain neuronal cultures."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.369: Neuronal-enriched cultures from embryonic wild type and parkin mutant mice midbrain E-13 (crownrump length 1012mm) were obtained and prepared, according to Mena et al. 

Phrase: "Neuronal-enriched cultures from embryonic wild type"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0010453:Cultures [Idea or Concept]
   714 E C0220814:culture [Functional Concept]
   714 E C0430400:Culture [Laboratory Procedure]
   714 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "parkin mutant mice midbrain E-13"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0596988:Mutant [Cell or Molecular Dysfunction]
   799   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   799   C1418270:PARKIN [Gene or Genome]
   799   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(crownrump length 1012mm"

Phrase: ")"

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "prepared,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1318963:Preparedness [Finding]

Phrase: "according to Mena et al."
Processing 00000000.tx.370: (91). 

Phrase: "(91"

Phrase: ")."
Processing 00000000.tx.371: The cells were seeded in B27/Neurobasal TM medium with 15% fetal calf serum (B27/NBL-FCS) at a density of 2x105 cells/cm2 in multiwells or glass cover slides coated with poly-D-lysine (4.5g/cm2) in 0.1M borate buffer, pH 8.4. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in B27/Neurobasal TM medium"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0009458:Medium [Intellectual Product]
   753   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   753   C0439536:Medium [Quantitative Concept]
   753   C1537935:B27 [Gene or Genome]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   753   C3540468:TM [Gene or Genome]
   719   C0036563:Seed [Plant]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]

Phrase: "with 15% fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "(B27/NBL-FCS"

Phrase: ")"

Phrase: "at a density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of 2x105 cells/cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439479:cm2 [Quantitative Concept]
   827   C0555206:CM2 [Congenital Abnormality]

Phrase: "in multiwells"

Phrase: "or"

Phrase: "glass cover slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0444330:slides [Research Device]
   793 E C1705201:Slide [Manufactured Object]

Phrase: "coated with poly-"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0747726:POLY [Conceptual Entity]
   790   C1522408:Coated [Qualitative Concept]
   756 E C0453946:Coat [Manufactured Object]
   756 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "D-"

Phrase: "lysine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(4.5g/cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439479:cm2 [Quantitative Concept]
   827   C0555206:CM2 [Congenital Abnormality]

Phrase: ")"

Phrase: "in 0.1M borate buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0991799:BORATE BUFFER [Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 8.4."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C2678549:PH-4 [Gene or Genome]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.372: The cultures were kept in a humidified chamber at 37C in a 5% CO2 atmosphere for 67 days in vitro. 

Phrase: "The cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "kept in a humidified chamber"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   726   C0333118:Keep [Functional Concept]

Phrase: "at 37C"

Phrase: "in a 5% CO2 atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004178:Atmosphere [Natural Phenomenon or Process]
   827   C0678214:atmosphere [Quantitative Concept]

Phrase: "for 67 days in vitro."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.373: Twenty-four hours after plating, the cells were changed to serum-free defined medium (B27/NBL), as previously reported (91). 

Phrase: "Twenty-four hours after plating,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "changed to serum-free defined medium"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   753   C0009458:Medium [Intellectual Product]
   753   C0229671:Serum [Body Substance]
   753   C0332296:free [Functional Concept]
   753   C0392747:Changed [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0443172:Changed [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1704788:Defined [Conceptual Entity]
   753   C1705217:Medium [Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]
   753   C3539106:Defined [Intellectual Product]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "(B27/NBL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417891:NBL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(91"

Phrase: ")."
Processing 00000000.tx.374: Basal and K+- and amphetamine-induced [3H]-DA release was investigated in cells after 67 days in culture. 

Phrase: "Basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "K+-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "amphetamine-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[3H]-DA release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "investigated in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1292732:investigated [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "after 67 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.375: Each culture was washed once with 0.5ml of KrebsRingerHEPES buffer (KRH), and then loaded with [3H]-DA by incubating them for 20min at 37C with KRH containing [3H]-DA (5x10-8M) and desipramine (5x10-5M). 

Phrase: "Each culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with 0.5ml of KrebsRingerHEPES buffer (KRH),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C1720092:Once [Intellectual Product]
   748   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "loaded with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708715:Loaded [Activity]
   799 E C1550025:Load [Idea or Concept]
   799 E C1704782:Load [Manufactured Object]

Phrase: "[3H]-DA by incubating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   770   C1442460:3H [Temporal Concept]

Phrase: "them for 20min"

Phrase: "at 37C"

Phrase: "with KRH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "[3H]-DA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C1442460:3H [Temporal Concept]

Phrase: "(5x10-8M"

Phrase: ")"

Phrase: "and"

Phrase: "desipramine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011685:Desipramine [Organic Chemical,Pharmacologic Substance]

Phrase: "(5x10-5M"

Phrase: ")."
Processing 00000000.tx.376: After loading, the cells were rinsed four times with KRH. 

Phrase: "After loading,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0231290:After [Temporal Concept]
   861   C0687676:After [Temporal Concept]
   861   C1708715:Loading [Activity]
   827 E C1550025:Load [Idea or Concept]
   827 E C1704782:Load [Manufactured Object]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "four times with KRH."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.377: The basal release of [3H]-DA was measured in cultures incubated for 5 min at 23C with 0.5ml of KRB. 

Phrase: "The basal release of [3H]-DA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   804   C1442460:3H [Temporal Concept]

Phrase: "was"

Phrase: "measured in cultures"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0010453:Cultures [Idea or Concept]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0220814:culture [Functional Concept]
   756 E C0242485:Measure [Functional Concept]
   756 E C0430400:Culture [Laboratory Procedure]
   756 E C2242979:Culture [Laboratory Procedure]

Phrase: "incubated for 5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 23C"

Phrase: "with 0.5ml"

Phrase: "of KRB."
Processing 00000000.tx.378: K+- or amphetamine-induced [3H]-DA release was measured in similarly treated cultures, but with added KCl (50mM) or amphetamine (10M). 

Phrase: "K+-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "or"

Phrase: "amphetamine-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[3H]-DA release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "measured in similarly treated cultures,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   760   C0010453:Cultures [Idea or Concept]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C1522326:Treated [Functional Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C1292734:TREAT [Functional Concept]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "but with added KCl"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "(50mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450400:50mm [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "amphetamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.379: The radioactivity in the media was measured by liquid scintillation spectrometry. 

Phrase: "The radioactivity in the media"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured by liquid scintillation spectrometry."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0597425:scintillation spectrometry [Diagnostic Procedure]
   760   C0302908:Liquid [Substance]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.380: At the end of the experiment, residual intracellular radioactivity was extracted from the cells by incubating them for 30min with 0.2ml of NaOH (0.4N), and then counted. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "residual intracellular radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "extracted from the cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   770   C3541890:EXTRACTED [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2828366:Extract [Substance]

Phrase: "by incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:incubating [Laboratory Procedure]

Phrase: "them for 30min"

Phrase: "with 0.2ml"

Phrase: "of NaOH"

Phrase: "(0.4N"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "counted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.381: [3H]-DA release is expressed as a percentage of the total intracellular content of [3H]-DA present in each culture at the time of the release incubation, to correct for variations in the amount of [3H]-DA taken up by different cultures. 

Phrase: "[3H]-DA release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "expressed as a percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "of the total intracellular content of [3H]-DA present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0150312:Present [Quantitative Concept]
   795   C0449450:Present [Idea or Concept]

Phrase: "in each culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of the release incubation,"

Phrase: "to correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for variations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variations [Qualitative Concept]

Phrase: "in the amount of [3H]-DA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C1442460:3H [Temporal Concept]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by different cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.382: High affinity [3H]-DA uptake was measured after incubation of the cells with 10-8M [3H]-DA (70Ci/mmol), in the presence of pargyline 10-5M and ascorbic acid 10-3M, at 37C for 20min. 

Phrase: "High affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "[3H]-DA uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1657587:dopamine uptake [Cell Function]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "measured after incubation of the cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0444706:Measured [Qualitative Concept]
   753   C3282337:Cells [Cell]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with 10-8M"

Phrase: "[3H]-DA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C1442460:3H [Temporal Concept]

Phrase: "(70Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of pargyline 10-5M"

Phrase: "and"

Phrase: "ascorbic acid 10-3M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0332060:3M [Health Care Related Organization]

Phrase: "at 37C"

Phrase: "for 20min."
Processing 00000000.tx.383: Non-specific uptake/binding was calculated in the presence of 10-5M mazindol (77). 

Phrase: "Non-specific uptake/binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "calculated in the presence of 10-5M mazindol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0024977:Mazindol [Organic Chemical,Pharmacologic Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0444686:Calculated [Functional Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]

Phrase: "(77"

Phrase: ")."
Processing 00000000.tx.384: Proteins were measured according to the BCA assay. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "measured according to the BCA assay."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   783   C0449768:Measured to [Quantitative Concept]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C0680240:according [Social Behavior]
   753   C1332420:bca [Gene or Genome]
   753   C1510438:Assay [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.385: Hippocampal electrophysiology. 

Phrase: "Hippocampal electrophysiology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013865:Electrophysiology [Biomedical Occupation or Discipline]
   861   C1446476:Electrophysiology [Diagnostic Procedure]
Processing 00000000.tx.386: Hippocampal slices (500M thick) were prepared from male parkin mutant mice of 6468 weeks. 

Phrase: "Hippocampal slices"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519355:Slice [Substance]

Phrase: "(500M"

Phrase: "thick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "prepared from male parkin mutant mice of 6468 weeks."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   742   C0024554:Male [Finding]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0086582:male [Population Group]
   742   C0439230:weeks [Temporal Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1418270:PARKIN [Gene or Genome]
   742   C1706180:Male [Qualitative Concept]
   742   C1706428:Male [Qualitative Concept]
   742   C1706429:Male [Organism Attribute]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   708 E C0332174:/week [Temporal Concept]
   708   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.387: Age- and sex-matched wild-type mice were used as controls. 

Phrase: "Age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex-matched wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C1520150:Wild Type Mouse [Mammal]
   840   C1883559:Wild Type [Organism Attribute]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.388: Slices were incubated in a submersion-type recording chamber through which artificial cerebrospinal fluid (ACSF: 124mM NaCl, 3mM KCl, 1.25mM NaH2PO4, 1.3mM MgSO4, 2mM CaCl2, 26mM NaHCO3 and 10mM glucose) was continuously perfused at 2.53ml/min. 

Phrase: "Slices"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519355:Slice [Substance]

Phrase: "were"

Phrase: "incubated in a submersion-type recording chamber"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0585753:Record type [Intellectual Product]
   748   C0038561:Submersion [Injury or Poisoning]
   748   C0332307:Type [Qualitative Concept]
   748   C0935616:Chamber [Body Part, Organ, or Organ Component]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1547052:*Type [Quantitative Concept]
   714   C0034869:Record [Intellectual Product]

Phrase: "through which artificial cerebrospinal fluid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007806:Cerebrospinal Fluid [Body Substance]
   901   C0007807:cerebrospinal fluid [Functional Concept]
   827   C0005889:FLUID [Body Substance]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   827   C2004457:Artificial [Qualitative Concept]

Phrase: "(ACSF"

Phrase: ":"

Phrase: "124mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "3mM KCl,"

Phrase: "1.25mM NaH2PO4,"

Phrase: "1.3mM MgSO4,"

Phrase: "2mM CaCl2,"

Phrase: "26mM NaHCO3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "10mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "continuously"

Phrase: "perfused"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549542:Perfuse [Functional Concept]

Phrase: "at 2.53ml/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]
Processing 00000000.tx.389: ACSF was bubbled with a mixture of 95% O2/5% CO2 and maintained at 31.50.5C. 

Phrase: "ACSF"

Phrase: "was"

Phrase: "bubbled with a mixture of 95% O2/5% CO2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0439962:Mixture [Substance]
   742   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "maintained at 31.50.5C."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0450355:31 [Intellectual Product]
   760   C1314677:Maintained [Functional Concept]
   726 E C0024501:Maintain [Activity]
Processing 00000000.tx.390: Test stimulations (0.1ms duration) were delivered at constant intensity through bipolar stainless steel electrodes placed in the stratum radiatum of the CA1 area. 

Phrase: "Test stimulations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C1292856:stimulations [Therapeutic or Preventive Procedure]
   827 E C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(0.1ms duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449238:Duration [Temporal Concept]
   827   C2926735:Duration [Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "delivered at constant intensity"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0522510:Intensity [Qualitative Concept]
   770   C1547014:*Constant [Quantitative Concept]
   770   C1705822:Delivered [Activity]
   770   C1948059:Constant [Qualitative Concept]
   737 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   737 E C1874964:DELIVER [Pharmacologic Substance]

Phrase: "through bipolar stainless steel electrodes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013812:Electrodes [Medical Device]
   779 E C1705652:Electrode [Medical Device]

Phrase: "placed in the stratum radiatum of the CA1 area."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C2340164:Stratum radiatum [Body Part, Organ, or Organ Component]
   742   C0017446:Area [Geographic Area]
   742   C0205146:Area [Spatial Concept]
   708   C0442504:Place [Spatial Concept]
   708   C1704765:Place [Functional Concept]
   708   C1882509:Place [Activity]
   708   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.391: Extracellular field excitatory post-synaptic potentials (EPSPs) were recorded with a monopolar tungsten electrode placed in the same region on the trajectory of the Schaffer collaterals. 

Phrase: "Extracellular field excitatory post-synaptic potentials"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   841   C0234121:Excitatory potential [Organ or Tissue Function]
   827   C0205855:Synaptic Potentials [Organ or Tissue Function]
   799   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   799   C0687676:Post [Temporal Concept]
   799   C1521738:Field [Conceptual Entity]
   799   C1704687:Post [Manufactured Object]
   799   C2346620:Field [Conceptual Entity]
   799   C2349184:Field [Conceptual Entity]
   799   C3245505:potentials [Qualitative Concept]
   799   C3539073:FIELD [Spatial Concept]
   727 E C1514253:Postal [Functional Concept]

Phrase: "(EPSPs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   841   C0234121:Excitatory potential [Organ or Tissue Function]
   827   C0205855:Synaptic Potentials [Organ or Tissue Function]
   799   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   799   C0687676:Post [Temporal Concept]
   799   C1521738:Field [Conceptual Entity]
   799   C1704687:Post [Manufactured Object]
   799   C2346620:Field [Conceptual Entity]
   799   C2349184:Field [Conceptual Entity]
   799   C3245505:potentials [Qualitative Concept]
   799   C3539073:FIELD [Spatial Concept]
   727 E C1514253:Postal [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "recorded with a monopolar tungsten electrode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0013812:electrode [Medical Device]
   753   C0041383:Tungsten [Element, Ion, or Isotope]
   753   C1705652:Electrode [Medical Device]
   719   C0034869:Record [Intellectual Product]

Phrase: "placed in the same region"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0445247:Same [Qualitative Concept]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "on the trajectory"

Phrase: "of the Schaffer collaterals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C3544403:Schaffer collateral [Cell Component]
   827   C1275670:Collateral [Body Part, Organ, or Organ Component]
   827   C1948058:Collateral [Spatial Concept]
Processing 00000000.tx.392: The following features of synaptic physiology were assessed: basal transmission, paired-pulse facilitation, repetitive low-frequency stimulation and long-term potentiation. 

Phrase: "The following features of synaptic physiology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "were"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: ":"

Phrase: "basal transmission,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040722:transmission [Idea or Concept]
   861   C0242781:Transmission [Pathologic Function]
   861   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "paired-pulse facilitation,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0234112:Facilitation [Organ or Tissue Function]
   827   C0391850:Pulse [Physiologic Function]
   827   C1709450:Paired [Qualitative Concept]
   827   C1947910:Pulse [Phenomenon or Process]
   743 E C0034107:Pulses [Health Care Activity]

Phrase: "repetitive low-frequency stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "long-term potentiation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]
Processing 00000000.tx.393: The latter three properties were evaluated at a stimulation strength eliciting EPSPs of approximately half the maximal size. 

Phrase: "The latter three properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "were"

Phrase: "evaluated at a stimulation strength"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0220825:Evaluated [Functional Concept]
   760   C0237897:Strength [Quantitative Concept]
   760   C0808080:Strength [Idea or Concept]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1705922:Strength [Qualitative Concept]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "eliciting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449265:elicit [Qualitative Concept]

Phrase: "EPSPs of approximately half"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0205855:Synaptic Potentials [Organ or Tissue Function]
   762   C0439727:Half field [Spatial Concept]
   745   C0234121:Excitatory potential [Organ or Tissue Function]
   742   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   742   C0687676:Post [Temporal Concept]
   742   C1521738:Field [Conceptual Entity]
   742   C1704687:Post [Manufactured Object]
   742   C2346620:Field [Conceptual Entity]
   742   C2349184:Field [Conceptual Entity]
   742   C3245505:potentials [Qualitative Concept]
   742   C3539073:FIELD [Spatial Concept]

Phrase: "the maximal size."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]
Processing 00000000.tx.394: Analysis of paired-pulse facilitation was performed by delivering five pairs of stimuli at decreasing intervals (400, 200, 100, 50 and 25ms). 

Phrase: "Analysis of paired-pulse facilitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2825412:Paired Analysis [Idea or Concept]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by delivering five pairs of stimuli"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C1550369:Performed By [Qualitative Concept]
   748   C0205451:Five [Quantitative Concept]
   748   C0234402:Stimuli [Phenomenon or Process]
   748   C0884358:Performed [Functional Concept]
   748   C1709450:Pair [Qualitative Concept]
   732   C0597163:paired stimuli [Organ or Tissue Function]
   714   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   714   C1705822:Deliver [Activity]
   714   C1874964:DELIVER [Pharmacologic Substance]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at decreasing intervals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1272706:intervals [Temporal Concept]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]

Phrase: "(400,"

Phrase: "200,"

Phrase: "100,"

Phrase: "50"

Phrase: "and"

Phrase: "25ms"

Phrase: ")."
Processing 00000000.tx.395: Response to low-frequency stimulation was explored by delivering two sets of 30 stimuli at 70ms intervals repeated 30s apart and averaged. 

Phrase: "Response to low-frequency stimulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0237629:Response Frequency [Temporal Concept]
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "explored by delivering two sets of 30 stimuli"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0036849:Set [Mental Process]
   744   C0205448:Two [Quantitative Concept]
   744   C0234402:Stimuli [Phenomenon or Process]
   744   C1442518:Set [Functional Concept]
   744   C1705195:Set [Conceptual Entity]
   711   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   711   C1705822:Deliver [Activity]
   711   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "at 70ms intervals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1272706:intervals [Temporal Concept]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "30s apart"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0227073:30S [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "averaged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.396: To induce long-term potentiation, repeated brief trains of high frequency stimulation were delivered following a protocol consisting of five bursts of five pulses, each burst at 100Hz, with 200ms between bursts (theta-burst stimulation). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "long-term potentiation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "brief trains of high frequency stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0336809:Train [Manufactured Object]
   719   C1552514:Train [Manufactured Object]

Phrase: "were"

Phrase: "delivered"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705822:Delivered [Activity]
   966 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   966 E C1874964:DELIVER [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "consisting of five bursts of five pulses,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0034107:Pulses [Health Care Activity]
   748   C0205451:Five [Quantitative Concept]
   748   C0391850:PULSES [Physiologic Function]
   748   C0439818:bursts [Qualitative Concept]
   714 E C0232117:PULSE [Clinical Attribute]
   714   C0332529:CONSIST [Qualitative Concept]
   714 E C1881705:BURST [Phenomenon or Process]
   714 E C1947910:Pulse [Phenomenon or Process]

Phrase: "each"

Phrase: "burst at 100Hz,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439818:burst [Qualitative Concept]
   790   C1881705:BURST [Phenomenon or Process]

Phrase: "with 200ms"

Phrase: "between bursts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439818:bursts [Qualitative Concept]
   966 E C1881705:BURST [Phenomenon or Process]

Phrase: "(theta-burst stimulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0439101:Theta [Intellectual Product]
   827   C0439818:burst [Qualitative Concept]
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1422662:THETA [Gene or Genome]
   827   C1881705:BURST [Phenomenon or Process]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.397: Data analysis All data presented are expressed as the meanSEM. 

Phrase: "Data analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as the meanSEM."
Processing 00000000.tx.398: The results were statistically evaluated for significance by using one-way analysis of variance, followed by Student's t-test, the NewmanKeuls multiple comparison test or Bonferoni post hoc test. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "statistically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038215:Statistically [Occupation or Discipline]

Phrase: "evaluated for significance"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0220825:Evaluated [Functional Concept]
   790   C0237881:Significance [Quantitative Concept]
   790   C0750502:Significance [Idea or Concept]
   718 E C1546944:Significant [Qualitative Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "one-way analysis of variance,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1709320:One-way Analysis of Variance [Quantitative Concept]
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "followed by Student's t-test,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "the NewmanKeuls multiple comparison test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "or"

Phrase: "Bonferoni post hoc test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
Processing 00000000.tx.399: Means among groups were considered significantly different when P<0.05.  

Phrase: "Means among groups"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1704970:Means [Conceptual Entity]
   756 E C0444504:Mean [Quantitative Concept]
   756 E C2347634:Mean [Quantitative Concept]
   756 E C2348143:Mean [Quantitative Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "when"

Phrase: "P<0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.400: ACKNOWLEDGEMENTS  This work was supported by grants from the Comunidad Autonoma de Madrid, grant CAM 8.5/49/2001 and Fondo de Investigaciones Sanitarias, FIS 2002/PI20265 to J.G.Y. and M.A.M., and from the Association France Parkinson to A.B. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Comunidad Autonoma de Madrid,"

Phrase: "grant CAM 8.5/49/2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0018173:Grant [Quantitative Concept]
   799   C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "Fondo de Investigaciones Sanitarias,"

Phrase: "FIS 2002/PI20265 to J.G.Y."

Phrase: "and"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "M."

Phrase: ","

Phrase: "and from the Association France Parkinson"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0004083:Association [Mental Process]
   753   C0016674:France [Geographic Area]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]
   753   C1515981:And [Idea or Concept]

Phrase: "to A.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]
Processing 00000000.tx.401: The authors thank Mrs Rosario Villaverde and Elodie Martn for technical help and Thomas Debeir, Rita Raisman, Patrick Michel and Etienne Hirsch for helpful discussions. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Mrs Rosario Villaverde"

Phrase: "and"

Phrase: "Elodie Martn for technical"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "Thomas Debeir,"

Phrase: "Rita Raisman,"

Phrase: "Patrick Michel"

Phrase: "and"

Phrase: "Etienne Hirsch for helpful discussions."
Processing 00000000.tx.402: This paper is dedicated to the memory of Nacer Abbas.  

Phrase: "This paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "is"

Phrase: "dedicated to the memory of Nacer Abbas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025260:Memory [Mental Process]
   748   C0700327:memory [Finding]
   748   C1706377:Memory [Manufactured Object]
Processing 00000000.tx.403: FOOTNOTES  * To whom correspondence should be addressed. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.404: Tel: +33 158932645; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+33 158932645"

Phrase: ";"
Processing 00000000.tx.405: Fax: +33 158933685; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+33 158933685"

Phrase: ";"
Processing 00000000.tx.406: Email: thomas.rooney{at}aventis.com The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "thomas.rooney{at}aventis.com"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that,"

Phrase: "in their opinion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871010:opinion [Mental Process]

Phrase: "the first two authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0221193:Authors [Professional or Occupational Group]

Phrase: "should"

Phrase: "be"

Phrase: "regarded as joint First Authors."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0022417:Joint [Body Space or Junction]
   760   C0205435:First [Quantitative Concept]
   760   C0221193:Authors [Professional or Occupational Group]
   760   C0392905:Joint, NOS [Body System]
   760   C1269611:Joint [Body Space or Junction]
   760   C1279901:First [Qualitative Concept]
   760   C1706309:Joint [Medical Device]
   704 E C0521339:Articular [Functional Concept]
Processing 00000000.tx.407: Deceased.  

Phrase: "Deceased."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011065:deceased [Organism Function]
Processing 00000000.tx.408: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  de Rijk, M.C., Launer, L.J., Berger, K., Breteler, M.M., Dartigues, J.F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C. and Hofman, A. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "de Rijk,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Launer,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Berger,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Breteler,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Dartigues,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Baldereschi,"

Phrase: "M."

Phrase: ","

Phrase: "Fratiglioni,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lobo,"

Phrase: "A.,"

Phrase: "Martinez-Lage,"

Phrase: "J.,"

Phrase: "Trenkwalder,"

Phrase: "C."

Phrase: "and"

Phrase: "Hofman,"

Phrase: "A."
Processing 00000000.tx.409: (2000) Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Prevalence of Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "in Europe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]

Phrase: ":"

Phrase: "A collaborative study of population-based cohorts."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C1709599:Population Based Study [Research Activity]
   778   C0681804:collaborative study [Research Activity]
   774   C0681876:Population Study [Research Activity]
   774   C2348561:Study Population [Population Group]
   757   C0009247:Cohort Study [Quantitative Concept]
   748   C0282116:collaborative [Social Behavior]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]
Processing 00000000.tx.410: Neurologic Diseases in the Elderly Research Group, Neurology, 54, S2123. 

Phrase: "Neurologic Diseases in the Elderly Research Group,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0027765:Neurologic Diseases [Disease or Syndrome]
   748   C0012634:Diseases [Disease or Syndrome]

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "54,"

Phrase: "S2123."
Processing 00000000.tx.411: Elbaz, A., Bower, J.H., Maraganore, D.M., McDonnell, S.K., Peterson, B.J., Ahlskog, J.E., Schaid, D.J. and Rocca, W.A. 

Phrase: "Elbaz,"

Phrase: "A.,"

Phrase: "Bower,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "McDonnell,"

Phrase: "S."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Peterson,"

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Ahlskog,"

Phrase: "J.E.,"

Phrase: "Schaid,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Rocca,"

Phrase: "W."

Phrase: "A."
Processing 00000000.tx.412: (2002) Risk tables for parkinsonism and Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Risk tables for parkinsonism"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0039224:tables [Manufactured Object]
   770   C1706074:Tables [Intellectual Product]
   737 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.413: J. 

Phrase: "J."
Processing 00000000.tx.414: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.415: Epidemiol., 55, 2531.[CrossRef][ISI][Medline] Jankovic, J. 

Phrase: "Epidemiol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "2531."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jankovic,"

Phrase: "J."
Processing 00000000.tx.416: (1992) Pathophysiology and clinical assessment of motor symptoms in Parkinson's disease. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Pathophysiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031847:pathophysiology [Functional Concept]
  1000   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "and"

Phrase: "clinical assessment of motor symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C3494437:Symptom Assessment [Health Care Activity]
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.417: In Koller, W.C. 

Phrase: "In Koller,"

Phrase: "W.C."
Processing 00000000.tx.418: (ed.), Handbook of Parkinson's Disease. 

Phrase: "(ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Handbook of Parkinson's Disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596654:handbook [Intellectual Product]
Processing 00000000.tx.419: Marcel Dekker, New York, pp. 

Phrase: "Marcel Dekker,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "pp."
Processing 00000000.tx.420: 129157. 

Phrase: "129157."
Processing 00000000.tx.421: Louis, E.D., Levy, G., Cote, L.J., Mejia, H., Fahn, S. and Marder, K. 

Phrase: "Louis,"

Phrase: "E."

Phrase: "D."

Phrase: ","

Phrase: "Levy,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cote,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Mejia,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fahn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823105:FAHN [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Marder,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.422: (2002) Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Diagnosing Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "videotaped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0042655:videotape [Manufactured Object]
   966   C1548939:Videotape [Health Care Activity]

Phrase: "neurological examinations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027853:Neurological Examinations [Diagnostic Procedure]
   861   C0031809:examinations [Health Care Activity]

Phrase: ":"

Phrase: "validity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2349101:Validity [Quantitative Concept]
   928 E C2349099:Valid [Qualitative Concept]

Phrase: "and"

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "contribute to incorrect diagnoses."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0011900:Diagnoses [Finding]
   770   C1880177:Contribute [Activity]
   737 E C1704338:diagnosis [Qualitative Concept]
   737 E C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.423: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.424: Disord., 17, 513517.[CrossRef][ISI][Medline] Forno, L.S. 

Phrase: "Disord.,"

Phrase: "17,"

Phrase: "513517."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Forno,"

Phrase: "L.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.425: (1996) Neuropathology of Parkinson's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuropathology of Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1540677:neuropathology disease [Pathologic Function]
           neuropathology
   770   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   770   C1555824:Neuropathology [Intellectual Product]
Processing 00000000.tx.426: J. 

Phrase: "J."
Processing 00000000.tx.427: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.428: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.429: Neurol., 55, 259272.[ISI][Medline] Dickson, D.W. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "259272."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dickson,"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.430: (2001) Alpha-synuclein and the Lewy body disorders. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "the Lewy body disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012634:Disorders [Disease or Syndrome]
   734   C0085200:Lewy Body [Cell Component]
Processing 00000000.tx.431: Curr. 

Phrase: "Curr."
Processing 00000000.tx.432: Opin. 

Phrase: "Opin."
Processing 00000000.tx.433: Neurol., 14, 423432.[CrossRef][ISI][Medline] Schneider, J.A., Bienias, J.L., Gilley, D.W., Kvarnberg, D.E., Mufson, E.J. and Bennett, D.A. 

Phrase: "Neurol.,"

Phrase: "14,"

Phrase: "423432."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schneider,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Bienias,"

Phrase: "J.L., Gilley,"

Phrase: "D.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kvarnberg,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Mufson,"

Phrase: "E.J."

Phrase: "and"

Phrase: "Bennett,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.434: (2002) Improved detection of substantia nigra pathology in Alzheimer's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Improved detection of substantia nigra pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.435: J. 

Phrase: "J."
Processing 00000000.tx.436: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.437: Cytochem., 50, 99106.[Abstract/Free FullText] Beal, M.F. 

Phrase: "Cytochem.,"

Phrase: "50,"

Phrase: "99106."

Phrase: "[Abstract/Free FullText"

Phrase: "] Beal,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.438: (2002) Oxidatively modified proteins in aging and disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Oxidatively modified proteins in aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.439: Free Radic. 

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.440: Biol. 

Phrase: "Biol."
Processing 00000000.tx.441: Med., 32, 797803.[CrossRef][ISI][Medline] Schapira, A.H., Gu, M., Taanman, J.W., Tabrizi, S.J., Seaton, T., Cleeter, M. and Cooper, J.M. 

Phrase: "Med.,"

Phrase: "32,"

Phrase: "797803."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schapira,"

Phrase: "A.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gu,"

Phrase: "M."

Phrase: ","

Phrase: "Taanman,"

Phrase: "J.W., Tabrizi,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Seaton,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cleeter,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.442: (1998) Mitochondria in the etiology and pathogenesis of Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mitochondria in the etiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "pathogenesis of Parkinson's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.443: Ann. 

Phrase: "Ann."
Processing 00000000.tx.444: Neurol., 44, S8998.[ISI][Medline] Betarbet, R., Sherer, T.B. and Greenamyre, J.T. 

Phrase: "Neurol.,"

Phrase: "44,"

Phrase: "S8998."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Betarbet,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherer,"

Phrase: "T.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Greenamyre,"

Phrase: "J.T."
Processing 00000000.tx.445: (2002) Animal models of Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Animal models of Parkinson's disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   888   C0012644:Animal Model of Disease [Experimental Model of Disease]
           Animal Disease Models
   806   C0599779:Models, Animal [Animal]
   797   C0003047:animal disease [Disease or Syndrome]
   797   C0683033:disease models [Intellectual Product]
   797   C0684309:disease models [Experimental Model of Disease]
   760   C0003062:Animal [Animal]
   760   C3161035:Models [Intellectual Product]
Processing 00000000.tx.446: Bioessays, 24, 308318.[CrossRef][ISI][Medline] Feger, J., Pessiglione, M., Francois, C., Tremblay, L. and Hirsch, E. 

Phrase: "Bioessays,"

Phrase: "24,"

Phrase: "308318."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Feger,"

Phrase: "J.,"

Phrase: "Pessiglione,"

Phrase: "M."

Phrase: ","

Phrase: "Francois,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Tremblay,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hirsch,"

Phrase: "E."
Processing 00000000.tx.447: (2002) Experimental models of Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Experimental models of Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0086272:Models, Experimental [Intellectual Product]
   797   C0683033:disease models [Intellectual Product]
   797   C0684309:disease models [Experimental Model of Disease]
   760   C3161035:Models [Intellectual Product]
Processing 00000000.tx.448: Ann. 

Phrase: "Ann."
Processing 00000000.tx.449: Pharm. 

Phrase: "Pharm."
Processing 00000000.tx.450: Fr., 60, 321.[Medline] Gerlach, M. and Riederer, P. 

Phrase: "Fr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348513:Fr. [Conceptual Entity]
  1000   C3538902:FR [Gene or Genome]

Phrase: "60,"

Phrase: "321."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gerlach,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Riederer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.451: (1996) Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Animal models of Parkinson's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   888   C0012644:Animal Model of Disease [Experimental Model of Disease]
           Animal Disease Models
   806   C0599779:Models, Animal [Animal]
   797   C0003047:animal disease [Disease or Syndrome]
   797   C0683033:disease models [Intellectual Product]
   797   C0684309:disease models [Experimental Model of Disease]
   760   C0003062:Animal [Animal]
   760   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "an empirical comparison with the phenomenology of the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]

Phrase: "in man."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024554:MAN [Finding]
  1000   C0025266:Man [Population Group]
  1000   C0086418:Man [Human]
Processing 00000000.tx.452: J. 

Phrase: "J."
Processing 00000000.tx.453: Neural Transm., 103, 9871041.[ISI][Medline] Grunblatt, E., Mandel, S. and Youdim, M.B. 

Phrase: "Neural Transm.,"

Phrase: "103,"

Phrase: "9871041."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Grunblatt,"

Phrase: "E.,"

Phrase: "Mandel,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Youdim,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.454: (2000) Neuroprotective strategies in Parkinson's disease using the models of 6- hydroxydopamine and MPTP. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neuroprotective strategies in Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679199:strategies [Mental Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the models of 6- hydroxydopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "MPTP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000097:MPTP [Hazardous or Poisonous Substance,Organic Chemical]
Processing 00000000.tx.455: Ann. 

Phrase: "Ann."
Processing 00000000.tx.456: NY Acad. 

Phrase: "NY Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.457: Sci., 899, 262273.[Abstract/Free FullText] Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "899,"

Phrase: "262273."

Phrase: "[Abstract/Free FullText"

Phrase: "] Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. et al."
Processing 00000000.tx.458: (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the alpha-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.459: Science, 276, 20452047.[Abstract/Free FullText] Le, W.D., Xu, P., Jankovic, J., Jiang, H., Appel, S.H., Smith, R.G. and Vassilatis, D.K. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Le,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439090:LE [Idea or Concept]
  1000   C1423767:LE [Gene or Genome]

Phrase: "W."

Phrase: "D."

Phrase: ","

Phrase: "Xu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jankovic,"

Phrase: "J.,"

Phrase: "Jiang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Appel,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Vassilatis,"

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.460: (2003) Mutations in NR4A2 associated with familial Parkinson disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mutations in NR4A2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with familial Parkinson disease."
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   797   C0243083:associated disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.461: Nat. 

Phrase: "Nat."
Processing 00000000.tx.462: Genet., 33, 8589.[CrossRef][ISI][Medline] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "33,"

Phrase: "8589."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.463: (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.464: Nature, 392, 605608.[CrossRef][ISI][Medline] Lucking, C.B., Durr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B.S., Meco, G., Denefle, P., Wood, N.W. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "392,"

Phrase: "605608."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Vaughan,"

Phrase: "J.,"

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harhangi,"

Phrase: "B.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Meco,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Denefle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W. et al."
Processing 00000000.tx.465: (2000) Association between early-onset Parkinson's disease and mutations in the parkin gene. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Association between early-onset Parkinson's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1511978:Disease Association [Temporal Concept]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "mutations in the parkin gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.466: French Parkinson's Disease Genetics Study Group. 

Phrase: "French Parkinson's Disease Genetics Study Group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]
Processing 00000000.tx.467: New Engl. 

Phrase: "New Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.468: J. 

Phrase: "J."
Processing 00000000.tx.469: Med., 342, 15601567.[Abstract/Free FullText] Periquet, M., Latouche, M., Lohmann, E., Rawal, N., De Michele, G., Ricard, S., Teive, H., Fraix, V., Vidailhet, M., Nicholl, D. et al. 

Phrase: "Med.,"

Phrase: "342,"

Phrase: "15601567."

Phrase: "[Abstract/Free FullText"

Phrase: "] Periquet,"

Phrase: "M."

Phrase: ","

Phrase: "Latouche,"

Phrase: "M."

Phrase: ","

Phrase: "Lohmann,"

Phrase: "E.,"

Phrase: "Rawal,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ricard,"

Phrase: "S."

Phrase: ","

Phrase: "Teive,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fraix,"

Phrase: "V.,"

Phrase: "Vidailhet,"

Phrase: "M."

Phrase: ","

Phrase: "Nicholl,"

Phrase: "D. et al."
Processing 00000000.tx.470: (2003) Parkin mutations are frequent in patients with isolated early-onset parkinsonism. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "frequent in patients"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0332183:Frequent [Temporal Concept]
   718 E C0376249:frequency [Quantitative Concept]
   718 E C0439603:Frequencies [Temporal Concept]
   718 E C0871396:Frequency [Quantitative Concept]
   718 E C1561548:Frequency [Qualitative Concept]
   718 E C1705502:Frequency [Quantitative Concept]

Phrase: "with isolated early-onset parkinsonism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1838631:Parkinsonism, early-onset [Finding]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.471: Brain, 126, 12711278.[Abstract/Free FullText] Abbas, N., Lucking, C.B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J.R., Gasser, T., Marconi, R. et al. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "126,"

Phrase: "12711278."

Phrase: "[Abstract/Free FullText"

Phrase: "] Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Ricard,"

Phrase: "S."

Phrase: ","

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bouley,"

Phrase: "S."

Phrase: ","

Phrase: "Vaughan,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Marconi,"

Phrase: "R. et al."
Processing 00000000.tx.472: (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A wide variety of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "in the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "responsible for autosomal recessive parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in Europe."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]
Processing 00000000.tx.473: French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. 

Phrase: "French Parkinson's Disease Genetics Study Group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the European Consortium on Genetic Susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1513822:Consortium [Professional or Occupational Group]
   753   C1880171:Consortium [Professional or Occupational Group]

Phrase: "in Parkinson's Disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.474: Hum. 

Phrase: "Hum."
Processing 00000000.tx.475: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.476: Genet., 8, 567574.[Abstract/Free FullText] Hoenicka, J., Vidal, L., Morales, B., Ampuero, I., Jimenez-Jimenez, F.J., Berciano, J., del Ser, T., Jimenez, A., Ruiz, P.G. and de Yebenes, J.G. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "567574."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoenicka,"

Phrase: "J.,"

Phrase: "Vidal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Morales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026530:Morales [Individual Behavior]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ampuero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jimenez-Jimenez,"

Phrase: "F.J.,"

Phrase: "Berciano,"

Phrase: "J.,"

Phrase: "del Ser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jimenez,"

Phrase: "A.,"

Phrase: "Ruiz,"

Phrase: "P.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "de Yebenes,"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.477: (2002) Molecular findings in familial Parkinson disease in Spain. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Molecular findings in familial Parkinson disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]

Phrase: "in Spain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]
Processing 00000000.tx.478: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.479: Neurol., 59, 966970.[Abstract/Free FullText] Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S. and Takahashi, H. 

Phrase: "Neurol.,"

Phrase: "59,"

Phrase: "966970."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ishikawa,"

Phrase: "A.,"

Phrase: "Nagai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Maruyama,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ozawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.480: (2000) An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. 

Phrase: "(2000"

Phrase: ")"

Phrase: "An autopsy case of autosomal-recessive juvenile parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004398:Autopsy [Diagnostic Procedure]
   744   C0868928:Case [Functional Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]

Phrase: "with a homozygous exon 4 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "in the parkin gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.481: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.482: Disord., 15, 884888.[CrossRef][ISI][Medline] Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K. and Mizuno, Y. 

Phrase: "Disord.,"

Phrase: "15,"

Phrase: "884888."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakagawa-Hattori,"

Phrase: "Y.,"

Phrase: "Miyake,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suda,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mizuno,"

Phrase: "Y."
Processing 00000000.tx.483: (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Pathologic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1521733:Pathologic [Functional Concept]
   928 E C0030664:Pathologies [Biomedical Occupation or Discipline]
   928 E C0205469:pathology [Functional Concept]
   928 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "biochemical studies of juvenile parkinsonism"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C2699049:JUVENILE STUDIES [Regulation or Law]
   760   C0205474:Biochemical [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "linked to chromosome 6q."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008633:Chromosome [Cell Component]
   770   C1521554:6q [Nucleotide Sequence]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.484: Neurology, 51, 890892.[Abstract] Takahashi, H., Ohama, E., Suzuki, S., Horikawa, Y., Ishikawa, A., Morita, T., Tsuji, S. and Ikuta, F. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "51,"

Phrase: "890892."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Takahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ohama,"

Phrase: "E.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "S."

Phrase: ","

Phrase: "Horikawa,"

Phrase: "Y.,"

Phrase: "Ishikawa,"

Phrase: "A.,"

Phrase: "Morita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Ikuta,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.485: (1994) Familial juvenile parkinsonism: clinical and pathologic study in a family. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Familial juvenile parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752104:Familial Juvenile Parkinsonism [Disease or Syndrome]
   901   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ":"

Phrase: "clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathologic study in a family."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0199236:Family study, NOS [Diagnostic Procedure]
   770   C0551718:Pathology study [Clinical Attribute]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.486: Neurology, 44, 437441.[Abstract] Van de Warrenburg, B.P., Lammens, M., Lucking, C.B. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "44,"

Phrase: "437441."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Van de Warrenburg,"

Phrase: "B.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Lammens,"

Phrase: "M."

Phrase: ","

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.487: Denefle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A. and Horstink, M.W. 

Phrase: "Denefle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wesseling,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Booij,"

Phrase: "J.,"

Phrase: "Praamstra,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Quinn,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Horstink,"

Phrase: "M."

Phrase: "W."
Processing 00000000.tx.488: (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathologic abnormalities in a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "with parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "and"

Phrase: "parkin gene mutations."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0596611:gene mutations [Genetic Function]
   901   C1418270:parkin gene [Gene or Genome]
   901   C2983548:Parkin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.489: Neurology, 56, 555557.[Abstract/Free FullText] Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn-Hardy, K., Petrucelli, L. et al. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "56,"

Phrase: "555557."

Phrase: "[Abstract/Free FullText"

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Chan,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Hernandez,"

Phrase: "D."

Phrase: ","

Phrase: "Forno,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Petrucelli,"

Phrase: "L. et al."
Processing 00000000.tx.490: (2001) Lewy bodies and parkinsonism in families with parkin mutations. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "parkinsonism in families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "with parkin mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.491: Ann. 

Phrase: "Ann."
Processing 00000000.tx.492: Neurol., 50, 293300.[CrossRef][ISI][Medline] Klein, C., Pramstaller, P.P., Kis, B., Page, C.C., Kann, M., Leung, J., Woodward, H., Castellan, C.C., Scherer, M., Vieregge, P. et al. 

Phrase: "Neurol.,"

Phrase: "50,"

Phrase: "293300."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klein,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pramstaller,"

Phrase: "P.P.,"

Phrase: "Kis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1540160:KIS [Gene or Genome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Kann,"

Phrase: "M."

Phrase: ","

Phrase: "Leung,"

Phrase: "J.,"

Phrase: "Woodward,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Castellan,"

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Scherer,"

Phrase: "M."

Phrase: ","

Phrase: "Vieregge,"

Phrase: "P. et al."
Processing 00000000.tx.493: (2000) Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin deletions in a family"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "with adult-onset,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1836537:Adult onset [Finding]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "tremor-dominant parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ":"

Phrase: "expanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expanding [Spatial Concept]

Phrase: "the phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.494: Ann. 

Phrase: "Ann."
Processing 00000000.tx.495: Neurol., 48, 6571.[CrossRef][ISI][Medline] Morales, B., Martnez, A., Gonzalo I. 

Phrase: "Neurol.,"

Phrase: "48,"

Phrase: "6571."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Morales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026530:Morales [Individual Behavior]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Martnez,"

Phrase: "A.,"

Phrase: "Gonzalo I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.496: Vidal, L., Gomez-Tortosa, E., Rabano, A., Ampuero, I., Snchez, M., Hoenicka, J. and Garcia de Yebenes, J. 

Phrase: "Vidal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gomez-Tortosa,"

Phrase: "E.,"

Phrase: "Rabano,"

Phrase: "A.,"

Phrase: "Ampuero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Snchez,"

Phrase: "M."

Phrase: ","

Phrase: "Hoenicka,"

Phrase: "J."

Phrase: "and"

Phrase: "Garcia de Yebenes,"

Phrase: "J."
Processing 00000000.tx.497: (2002) SteeleRichardsonOlzewsky syndrome in a patient with a single C212Y mutation in the parkin protein. 

Phrase: "(2002"

Phrase: ")"

Phrase: "SteeleRichardsonOlzewsky syndrome in a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0039082:Syndrome [Disease or Syndrome]

Phrase: "with a single C212Y mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the parkin protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.498: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.499: Disord., 17, 13741380.[CrossRef][ISI][Medline] Lohmann, E., Periquet, M., Bonifati, V., Wood, N.W., De Michele, G., Bonnet, A.M., Fraix, V., Broussolle, E., Horstink, M.W., Vidailhet, M., Verpillat, P. et al. 

Phrase: "Disord.,"

Phrase: "17,"

Phrase: "13741380."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lohmann,"

Phrase: "E.,"

Phrase: "Periquet,"

Phrase: "M."

Phrase: ","

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W., De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bonnet,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fraix,"

Phrase: "V.,"

Phrase: "Broussolle,"

Phrase: "E.,"

Phrase: "Horstink,"

Phrase: "M."

Phrase: "W., Vidailhet,"

Phrase: "M."

Phrase: ","

Phrase: "Verpillat,"

Phrase: "P. et al."
Processing 00000000.tx.500: (2003) How much phenotypic variation can be attributed to parkin genotype? 

Phrase: "(2003"

Phrase: ")"

Phrase: "How"

Phrase: "much phenotypic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1836717:Phenotypic variation [Finding]
   861   C0205419:Variation [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "to parkin genotype?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.501: The French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. 

Phrase: "The French Parkinson's Disease Genetics Study Group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the European Consortium on Genetic Susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1513822:Consortium [Professional or Occupational Group]
   753   C1880171:Consortium [Professional or Occupational Group]

Phrase: "in Parkinson's Disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.502: Ann. 

Phrase: "Ann."
Processing 00000000.tx.503: Neurol., 54, 176185.[CrossRef][ISI][Medline] West, A., Periquet, M., Lincoln, S., Lucking, C.B., Nicholl, D., Bonifati, V., Rawal, N., Gasser, T., Lohmann, E., Deleuze J.F. et al. 

Phrase: "Neurol.,"

Phrase: "54,"

Phrase: "176185."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.,"

Phrase: "Periquet,"

Phrase: "M."

Phrase: ","

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Nicholl,"

Phrase: "D."

Phrase: ","

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Rawal,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lohmann,"

Phrase: "E.,"

Phrase: "Deleuze J.F. et al."
Processing 00000000.tx.504: (2002) Complex relationship between Parkin mutations and Parkinson disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Complex relationship between Parkin mutations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "Parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.505: Am. 

Phrase: "Am."
Processing 00000000.tx.506: J. 

Phrase: "J."
Processing 00000000.tx.507: Med. 

Phrase: "Med."
Processing 00000000.tx.508: Genet., 114, 584591.[CrossRef][ISI][Medline] Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "114,"

Phrase: "584591."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang,"

Phrase: "Y.,"

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.509: (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "functions as an E2-dependent ubiquitin-protein ligase"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1442769:ubiquitin-protein ligase [Gene or Genome]
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   744   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031843:function [Physiologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1705273:Function [Intellectual Product]
   744   C3244310:dependent [Functional Concept]
   744   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of the synaptic vesicle-associated protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1623036:Protein Degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "CDCrel-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]
Processing 00000000.tx.510: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.511: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.512: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.513: USA, 97, 1335413359.[Abstract/Free FullText] Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "1335413359."

Phrase: "[Abstract/Free FullText"

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Inoue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.514: (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "An unfolded putative transmembrane polypeptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "can"

Phrase: "lead to endoplasmic reticulum stress,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a substrate of Parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.515: Cell, 105, 891902.[CrossRef][ISI][Medline] Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "105,"

Phrase: "891902."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chung,"

Phrase: "K.K.,"

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Tanaka,"

Phrase: "Y.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.516: (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ubiquitinates"

Phrase: "the alpha-synuclein-interacting protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3541909:Alpha-Synuclein-Interacting Protein [Amino Acid, Peptide, or Protein]
   902   C1158819:alpha protein [Genetic Function]
   902   C2362546:Alpha protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "implications for Lewy-body formation"

Phrase: "in Parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.517: Nat. 

Phrase: "Nat."
Processing 00000000.tx.518: Med., 7, 11441150.[CrossRef][ISI][Medline] Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. 

Phrase: "Med.,"

Phrase: "7,"

Phrase: "11441150."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Frosch,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trockenbacher,"

Phrase: "A.,"

Phrase: "Schneider,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Kosik,"

Phrase: "K.S."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.519: (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Ubiquitination of a new form of alpha-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1519751:Ubiquitination [Molecular Function]

Phrase: "by parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "implications for Parkinson's disease."
Processing 00000000.tx.520: Science, 293, 263269.[Abstract/Free FullText] Greene, J.C., Whitworth, A.J., Kuo, I., Andrews, L.A., Feany, M.B. and Pollanck, L.J. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "293,"

Phrase: "263269."

Phrase: "[Abstract/Free FullText"

Phrase: "] Greene,"

Phrase: "J.C., Whitworth,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Kuo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Andrews,"

Phrase: "L.A.,"

Phrase: "Feany,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Pollanck,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.521: (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mitochondrial pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "apoptotic muscle degeneration in Drosophila parkin mutants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0234958:MUSCLE DEGENERATION [Disease or Syndrome]
   748   C0011164:Degeneration [Pathologic Function]
   748   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.522: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.523: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.524: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.525: USA, 100, 40784083.[Abstract/Free FullText] Zucker, R.S. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "100,"

Phrase: "40784083."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zucker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700303:Zucker [Mammal]

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.526: (1989). 

Phrase: "(1989"

Phrase: ")."
Processing 00000000.tx.527: Short-term synaptic plasticity. 

Phrase: "Short-term synaptic plasticity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0678558:Plasticity [Natural Phenomenon or Process]
   741 E C0032167:Plastic [Substance]
Processing 00000000.tx.528: A. 

Phrase: "A."
Processing 00000000.tx.529: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.530: Neurosci., 12, 1331.[CrossRef][ISI][Medline] Creager, R., Dunwiddie, T. and Lynch, G. 

Phrase: "Neurosci.,"

Phrase: "12,"

Phrase: "1331."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Creager,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dunwiddie,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lynch,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.531: (1980) Paired-pulse and frequency facilitation in the CA1 region of the in vitro rat hippocampus. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Paired-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Paired [Qualitative Concept]

Phrase: "pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0232117:PULSE [Clinical Attribute]
  1000   C0391850:Pulse [Physiologic Function]
  1000   C1947910:Pulse [Phenomenon or Process]
   916 E C0034107:Pulses [Health Care Activity]

Phrase: "and"

Phrase: "frequency facilitation in the CA1 region of the in vitro rat hippocampus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0234112:Facilitation [Organ or Tissue Function]
Processing 00000000.tx.532: J. 

Phrase: "J."
Processing 00000000.tx.533: Physiol., 299, 409424.[ISI][Medline] Dunwiddie, T.V. and Haas, H.L. 

Phrase: "Physiol.,"

Phrase: "299,"

Phrase: "409424."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dunwiddie,"

Phrase: "T.V."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039461:t.v. [Manufactured Object]

Phrase: "and"

Phrase: "Haas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1828470:HAA [Cell Component]

Phrase: "H.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346686:h l [Quantitative Concept]
Processing 00000000.tx.534: (1985) Adenosine increases synaptic facilitation in the in vitro rat hippocampus: evidence for a presynaptic site of action. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Adenosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "synaptic facilitation in the in vitro rat hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0234112:Facilitation [Organ or Tissue Function]

Phrase: ":"

Phrase: "evidence for a presynaptic site of action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.535: J. 

Phrase: "J."
Processing 00000000.tx.536: Physiol., 369, 365377.[Abstract] Beites, C.L., Xie, H., Bowser, R. and Trimble, W.S. 

Phrase: "Physiol.,"

Phrase: "369,"

Phrase: "365377."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Beites,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Xie,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bowser,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Trimble,"

Phrase: "W.S."
Processing 00000000.tx.537: (1999) The septin CDCrel-1 binds syntaxin and inhibits exocytosis. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The septin CDCrel-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1414049:SEPTIN 1 [Gene or Genome]
   901   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
   901   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   827   C1539748:CDCREL [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "syntaxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "exocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.538: Nat. 

Phrase: "Nat."
Processing 00000000.tx.539: Neurosci., 2, 434439.[CrossRef][ISI][Medline] Diaz-Torga, G., Feierstein, C., Libertun, C., Gelman, D., Kelly, M.A., Low, M.J., Rubinstein, M. and Becu-Villalobos, D. 

Phrase: "Neurosci.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "434439."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Diaz-Torga,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Feierstein,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Libertun,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gelman,"

Phrase: "D."

Phrase: ","

Phrase: "Kelly,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "M."

Phrase: "J.,"

Phrase: "Rubinstein,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Becu-Villalobos,"

Phrase: "D."
Processing 00000000.tx.540: (2002) Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Disruption of the D2 dopamine receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "GH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539616:GH [Gene or Genome]

Phrase: "and"

Phrase: "IGF-I secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   734   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334089:IGF I [Gene or Genome]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "dwarfism in male mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013336:Dwarfism [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.541: Endocrinology, 143, 12701279.[Abstract/Free FullText] Lipton, J.M. and Clark, W.G. 

Phrase: "Endocrinology,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   928 E C0694557:endocrinologic [Functional Concept]

Phrase: "143,"

Phrase: "12701279."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lipton,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Clark,"

Phrase: "W.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.542: (1986) Neurotransmitters in temperature control. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Neurotransmitters in temperature control."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.543: A. 

Phrase: "A."
Processing 00000000.tx.544: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.545: Physiol., 48, 613623.[CrossRef][ISI][Medline] Boulay, D., Depoortere, R., Perrault, G., Borrelli, E. and Sanger, D.J. 

Phrase: "Physiol.,"

Phrase: "48,"

Phrase: "613623."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Boulay,"

Phrase: "D."

Phrase: ","

Phrase: "Depoortere,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perrault,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borrelli,"

Phrase: "E."

Phrase: "and"

Phrase: "Sanger,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.546: (1999) Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Dopamine D2 receptor knock-out mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0206745:Knock-out Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "insensitive to the hypolocomotor"

Phrase: "and"

Phrase: "hypothermic effects of dopamine D2/D3 receptor agonists."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C3179498:Dopamine Effects [Physiologic Function]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.547: Neuropharmacology, 38, 13891396.[CrossRef][ISI][Medline] Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S. and Andersen, J.K. 

Phrase: "Neuropharmacology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027896:Neuropharmacology [Biomedical Occupation or Discipline]

Phrase: "38,"

Phrase: "13891396."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bharath,"

Phrase: "S."

Phrase: ","

Phrase: "Hsu,"

Phrase: "M."

Phrase: ","

Phrase: "Kaur,"

Phrase: "D."

Phrase: ","

Phrase: "Rajagopalan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Andersen,"

Phrase: "J.K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.548: (2002) Glutathione, iron and Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Glutathione,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.549: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.550: Pharmac., 64, 10371048.[CrossRef][ISI][Medline] Adams, J.D., Chang, M.L. and Klaidman, L.K. 

Phrase: "Pharmac.,"

Phrase: "64,"

Phrase: "10371048."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Chang,"

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Klaidman,"

Phrase: "L.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.551: (2001) Parkinsons Disease-redox mechanisms. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkinsons Disease-redox mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.552: Curr. 

Phrase: "Curr."
Processing 00000000.tx.553: Med. 

Phrase: "Med."
Processing 00000000.tx.554: Chem., 8, 809814.[ISI][Medline] Riederer, P., Sofic, E., Rausch, W.D., Schmidt, B., Reynolds, G.P., Jellinger, K. and Youdim, M.B. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "8,"

Phrase: "809814."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Riederer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sofic,"

Phrase: "E.,"

Phrase: "Rausch,"

Phrase: "W."

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Reynolds,"

Phrase: "G.P.,"

Phrase: "Jellinger,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Youdim,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.555: (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Transition metals,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0682906:transition metal [Element, Ion, or Isotope]
   861   C0025552:Metals [Inorganic Chemical]
   861   C0599156:Transition [Cell or Molecular Dysfunction]
   861   C2700061:Transition [Activity]
   789 E C1182674:Transitional [Spatial Concept]
   789 E C1548597:Transitional [Idea or Concept]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "ferritin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "glutathione,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ascorbic acid in parkinsonian brains."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   751 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   751 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   751 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   723 E C2349136:Vitamin C [Organic Chemical,Vitamin]
Processing 00000000.tx.556: J. 

Phrase: "J."
Processing 00000000.tx.557: Neurochem., 52, 515520.[ISI][Medline] Sofic, E., Lange, K.W., Jellinger, K. and Riederer, P. 

Phrase: "Neurochem.,"

Phrase: "52,"

Phrase: "515520."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sofic,"

Phrase: "E.,"

Phrase: "Lange,"

Phrase: "K.W., Jellinger,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Riederer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.558: (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "oxidized glutathione in the substantia nigra of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0061516:Glutathione, Oxidized [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.559: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.560: Lett., 142, 128130.[CrossRef][ISI][Medline] Hyun, D-H., Lee, M.H., Hattori, N., Kubo, S. 

Phrase: "Lett.,"

Phrase: "142,"

Phrase: "128130."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hyun,"

Phrase: "D-"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.561: I., Mizuno, Y., Halliwell, B. and Jenner, P. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Halliwell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jenner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.562: (2002) Effect of wild-type or mutant parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Effect of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "mutant parkin on oxidative damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "nitric oxide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "antioxidant defenses,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003402:Antioxidant [Pharmacologic Substance]
   861   C1880266:Defense [Conceptual Entity]

Phrase: "and"

Phrase: "the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.563: J. 

Phrase: "J."
Processing 00000000.tx.564: Biol. 

Phrase: "Biol."
Processing 00000000.tx.565: Chem., 277, 2857228577.[Abstract/Free FullText] Mena, M.A., Davila, V., Bogaluvsky, J. and Sulzer, D. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "2857228577."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Davila,"

Phrase: "V.,"

Phrase: "Bogaluvsky,"

Phrase: "J."

Phrase: "and"

Phrase: "Sulzer,"

Phrase: "D."
Processing 00000000.tx.566: (1998) A synergistic neurotrophic response to l-dihydroxyphenylalanine and nerve growth factor. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A synergistic neurotrophic response to l-dihydroxyphenylalanine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "nerve growth factor."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]
Processing 00000000.tx.567: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.568: Pharmac., 54, 678686.[Abstract/Free FullText] Rodriguez-Marn, E., Canals, S., Casarejos, M.J., de Bernardo, S., Handler, A. and Mena, M.A. 

Phrase: "Pharmac.,"

Phrase: "54,"

Phrase: "678686."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rodriguez-Marn,"

Phrase: "E.,"

Phrase: "Canals,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0442636:canals [Geographic Area]
  1000   C1550227:canals [Body Part, Organ, or Organ Component]
   966 E C0086881:Canal [Body Space or Junction]

Phrase: "S."

Phrase: ","

Phrase: "Casarejos,"

Phrase: "M."

Phrase: "J.,"

Phrase: "de Bernardo,"

Phrase: "S."

Phrase: ","

Phrase: "Handler,"

Phrase: "A."

Phrase: "and"

Phrase: "Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.569: (2001) L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells. 

Phrase: "(2001"

Phrase: ")"

Phrase: "L-DOPA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023570:L(-)-Dopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0013023:Dopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "and"

Phrase: "glia-conditioned medium"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
   901   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0009647:Conditioned [Mental Process]
   827   C0027836:Glia [Cell]
   827   C0439536:Medium [Quantitative Concept]
   827   C1087003:Glia [Plant]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]
   755 E C0012634:condition [Disease or Syndrome]
   755 E C0040607:Training [Educational Activity]
   755 E C0220931:Training [Educational Activity]
   755 E C0336809:Train [Manufactured Object]
   755 E C0348080:Condition [Qualitative Concept]
   755 E C1552514:Train [Manufactured Object]
   755 E C1705253:Condition [Conceptual Entity]
   755 E C2673163:training [Qualitative Concept]
   727 E C1701901:Conditional [Qualitative Concept]
   727 E C1963686:Conditional [Functional Concept]
   711 E C1519605:Conditionality [Conceptual Entity]

Phrase: "have"

Phrase: "additive effects on tyrosine hydroxylase expression"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0442796:Additive [Qualitative Concept]
   753   C1280500:effects [Qualitative Concept]
   753   C1550602:Additive [Substance]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in human catecholamine-rich neuroblastoma NB69 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   895   C0427861:Human cells [Laboratory or Test Result]
   822   C0815000:neuroblastoma cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.570: J. 

Phrase: "J."
Processing 00000000.tx.571: Neurochem., 78, 535545.[CrossRef][ISI][Medline] Canals, S., Casarejos, M.J., de Bernardo, S., Rodriguez-Marn, E. and Mena, M.A. 

Phrase: "Neurochem.,"

Phrase: "78,"

Phrase: "535545."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Canals,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0442636:canals [Geographic Area]
  1000   C1550227:canals [Body Part, Organ, or Organ Component]
   966 E C0086881:Canal [Body Space or Junction]

Phrase: "S."

Phrase: ","

Phrase: "Casarejos,"

Phrase: "M."

Phrase: "J.,"

Phrase: "de Bernardo,"

Phrase: "S."

Phrase: ","

Phrase: "Rodriguez-Marn,"

Phrase: "E."

Phrase: "and"

Phrase: "Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.572: (2001) Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Glutathione depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "switches"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707719:SWITCHES [Manufactured Object]

Phrase: "nitric oxide neurotrophic effects to cell death"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "in midbrain cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: ":"

Phrase: "implications for Parkinson's disease."
Processing 00000000.tx.573: J. 

Phrase: "J."
Processing 00000000.tx.574: Neurochem., 79, 11831195.[CrossRef][ISI][Medline] Di Chiara, G. and Imperato, A. 

Phrase: "Neurochem.,"

Phrase: "79,"

Phrase: "11831195."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Di Chiara,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Imperato,"

Phrase: "A."
Processing 00000000.tx.575: (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "abused by humans preferentially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086418:Humans [Human]
   737   C0013146:ABUSE [Mental or Behavioral Dysfunction]
   737   C0562381:Abuse [Finding]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "synaptic dopamine concentrations in the mesolimbic system of freely moving rats."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0086045:Concentrations [Mental Process]
   704 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.576: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.577: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.578: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.579: USA, 85, 52745278.[Abstract] Rudnick, G. and Wall, S.C. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "85,"

Phrase: "52745278."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rudnick,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0677535:Wall [Manufactured Object]

Phrase: "S.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.580: (1992) The molecular mechanism of ecstasy [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. 

Phrase: "(1992"

Phrase: ")"

Phrase: "The molecular mechanism of ecstasy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "[3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4-methylenedioxy-methamphetamine (MDMA)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025611:Methamphetamine [Hazardous or Poisonous Substance,Organic Chemical]
   827   C0202419:Methamphetamine [Laboratory Procedure]

Phrase: "]"

Phrase: ":"

Phrase: "serotonin transporters"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0170657:serotonin transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1420214:SEROTONIN TRANSPORTER [Gene or Genome]
   861   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
   861   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "targets for MDMA-induced serotonin release."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521840:Target [Functional Concept]
   719   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.581: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.582: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.583: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.584: USA, 89, 18171821.[Abstract] Sulzer, D., Maidment, N.T. and Rayport, S. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "89,"

Phrase: "18171821."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "Maidment,"

Phrase: "N.T."

Phrase: "and"

Phrase: "Rayport,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.585: (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Amphetamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "other weak bases"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   861   C0178499:bases [Chemical Viewed Functionally]
   861   C1626935:Bases [Quantitative Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C1527178:Basis [Functional Concept]
   827 E C1874451:Basis [Pharmacologic Substance]
   827 E C1880279:Base [Biomedical or Dental Material]
   777 E C0205112:Basal [Spatial Concept]
   768 E C0016617:Foundation [Organization]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "reverse transport of dopamine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1159717:dopamine transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "in ventral midbrain neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.586: J. 

Phrase: "J."
Processing 00000000.tx.587: Neurochem., 60, 527535.[ISI][Medline] Sulzer, D., Chen, T.K., Lau, Y.Y., Kristensen, H., Rayport, S. and Ewing, A. 

Phrase: "Neurochem.,"

Phrase: "60,"

Phrase: "527535."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "T.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lau,"

Phrase: "Y.Y.,"

Phrase: "Kristensen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rayport,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Ewing,"

Phrase: "A."
Processing 00000000.tx.588: (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Amphetamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "redistributes"

Phrase: "dopamine from synaptic vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "to the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "reverse transport."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
Processing 00000000.tx.589: J. 

Phrase: "J."
Processing 00000000.tx.590: Neurosci., 15, 41024108.[Abstract] Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. and Caron, M.G. 

Phrase: "Neurosci.,"

Phrase: "15,"

Phrase: "41024108."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Giros,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jaber,"

Phrase: "M."

Phrase: ","

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "S.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Wightman,"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Caron,"

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.591: (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Hyperlocomotion"

Phrase: "and"

Phrase: "indifference to cocaine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085632:Indifference [Sign or Symptom]
   718 E C0332238:Indifferent [Qualitative Concept]

Phrase: "and"

Phrase: "amphetamine in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0002658:Amfetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C0002667:amphetamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the dopamine transporter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.592: Nature, 379, 606612.[CrossRef][ISI][Medline] Patel, J., Mooslehner, K.A., Chan, P.M. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "379,"

Phrase: "606612."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Patel,"

Phrase: "J.,"

Phrase: "Mooslehner,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chan,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.593: Emson, P.C. and Stamford, J.A. 

Phrase: "Emson,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Stamford,"

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.594: (2003) Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Presynaptic control of striatal dopamine neurotransmission"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "in adult vesicular monoamine transporter 2 (VMAT2) mutant mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]
   710   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
Processing 00000000.tx.595: J. 

Phrase: "J."
Processing 00000000.tx.596: Neurochem., 85, 898910.[CrossRef][ISI][Medline] Shuldinger, S. 

Phrase: "Neurochem.,"

Phrase: "85,"

Phrase: "898910."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shuldinger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.597: (1994) A molecular glimpse of vesicular monoamine transporters. 

Phrase: "(1994"

Phrase: ")"

Phrase: "A molecular glimpse of vesicular monoamine transporters."
Processing 00000000.tx.598: J. 

Phrase: "J."
Processing 00000000.tx.599: Neurochem., 62, 20672078.[ISI][Medline] Miller, G.W., Erickson, J.D., Perez, J.T., Penland, S.N., Mash, D.C., Rye, D.B. and Levey, A.I. 

Phrase: "Neurochem.,"

Phrase: "62,"

Phrase: "20672078."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "G.W., Erickson,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Perez,"

Phrase: "J.T.,"

Phrase: "Penland,"

Phrase: "S."

Phrase: "N., Mash,"

Phrase: "D.C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rye,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035984:Rye [Food]
  1000   C0086964:Rye [Plant]
  1000   C0684317:rye [Food]

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Levey,"

Phrase: "A.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.600: (1999) Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Immunochemical analysis of vesicular monoamine transporter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "(VMAT2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0246932:Vesicular Monoamine Transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420115:VESICULAR MONOAMINE TRANSPORTER 2 [Gene or Genome]
   923   C1529240:Vesicular Monoamine Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3539788:Monoamine Transporter [Amino Acid, Peptide, or Protein]
   812   C0205378:Vesicular [Qualitative Concept]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0599682:monoamine [Organic Chemical]
   741 E C0333262:VESICLES [Acquired Abnormality]
   741 E C1622418:vesicle [Cell Component]

Phrase: ")"

Phrase: "protein in Parkinson's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.601: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.602: Neurol., 156, 138148.[CrossRef][ISI][Medline] Fernandez, H.H., Friedman, J.H., Fischman, A.J., Noto, R.B. and Lannon, M.C. 

Phrase: "Neurol.,"

Phrase: "156,"

Phrase: "138148."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fernandez,"

Phrase: "H.H.,"

Phrase: "Friedman,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Fischman,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Noto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538482:NOTO [Gene or Genome]

Phrase: "R.B."

Phrase: "and"

Phrase: "Lannon,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.603: (2001) Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease? 

Phrase: "(2001"

Phrase: ")"

Phrase: "Is"

Phrase: "altropane SPECT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040399:SPECT [Diagnostic Procedure]
   861   C1830198:SPECT [Clinical Attribute]

Phrase: "more sensitive to fluoroDOPA PET"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "for detecting early Parkinson's disease?"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   875   C0679245:early disease [Temporal Concept]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.604: Med. 

Phrase: "Med."
Processing 00000000.tx.605: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.606: Monit., 7, 13391343.[Medline] Moll, G.H., Mehnert, C., Wicker, M., Bock, N., Rothenberger, A., Ruther, E. and Huether, G. 

Phrase: "Monit.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0590695:Monit [Organic Chemical,Pharmacologic Substance]

Phrase: "7,"

Phrase: "13391343."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moll,"

Phrase: "G.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mehnert,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wicker,"

Phrase: "M."

Phrase: ","

Phrase: "Bock,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678387:bock [Food]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rothenberger,"

Phrase: "A.,"

Phrase: "Ruther,"

Phrase: "E."

Phrase: "and"

Phrase: "Huether,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.607: (2000) Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Age-associated changes in the densities of presynaptic monoamine transporters"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   777   C0541594:Changes in Densities [Qualitative Concept]
           changes density
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   706 E C1705241:Change [Quantitative Concept]

Phrase: "in different regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of the rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from early juvenile life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: "to late adulthood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700597:Adulthood [Temporal Concept]
Processing 00000000.tx.608: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.609: Dev. 

Phrase: "Dev."
Processing 00000000.tx.610: Brain Res., 7, 251257. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "7,"

Phrase: "251257."
Processing 00000000.tx.611: Parkinson Study Group (2002) Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. 

Phrase: "Parkinson Study Group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0441833:Group [Idea or Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C2603343:Study [Research Activity]

Phrase: "(2002"

Phrase: ")"

Phrase: "Dopamine transporter brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effects of pramipexole"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "vs"

Phrase: "levodopa on Parkinson disease progression."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0023570:Levodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   704 E C0699991:Larodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   704 E C0720022:Dopar [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.612: JAMA, 3, 16531661. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "16531661."
Processing 00000000.tx.613: Cabin, D.E., Shimazu, K., Murphy, D., Cole, N.B., Gottschalk, W., McIlwain, K.L., Orrison, B., Chen, A., Ellis, C.E., Paylor, R. et al. 

Phrase: "Cabin,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Shimazu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murphy,"

Phrase: "D."

Phrase: ","

Phrase: "Cole,"

Phrase: "N.B.,"

Phrase: "Gottschalk,"

Phrase: "W.,"

Phrase: "McIlwain,"

Phrase: "K.L., Orrison,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "A.,"

Phrase: "Ellis,"

Phrase: "C.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Paylor,"

Phrase: "R. et al."
Processing 00000000.tx.614: (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Synaptic vesicle depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333668:Depletion [Functional Concept]
   734   C0039065:Synaptic vesicle [Cell Component]

Phrase: "correlates with attenuated synaptic responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0332161:Attenuated [Qualitative Concept]
   760   C0599946:Attenuated [Activity]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "to prolonged repetitive stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "alpha-synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.615: J. 

Phrase: "J."
Processing 00000000.tx.616: Neurosci., 22, 87978807.[Abstract/Free FullText] Kubo, S.I., Kitami, T., Noda, S., Shimura, H., Uchiyama, Y., Asakawa, S., Minoshima, S., Shimizu, N., Mizuno, Y. and Hattori, N. 

Phrase: "Neurosci.,"

Phrase: "22,"

Phrase: "87978807."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kubo,"

Phrase: "S.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Kitami,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Noda,"

Phrase: "S."

Phrase: ","

Phrase: "Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Uchiyama,"

Phrase: "Y.,"

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Hattori,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.617: (2001) Parkin is associated with cellular vesicles. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "associated with cellular vesicles."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1622418:vesicle [Cell Component]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.618: J. 

Phrase: "J."
Processing 00000000.tx.619: Neurochem., 78, 4254.[CrossRef][ISI][Medline] Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W.H., Castillo, P.E., Shinsky, N., Verdugo, J.M., Armanini, M., Ryan, A. et al. 

Phrase: "Neurochem.,"

Phrase: "78,"

Phrase: "4254."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Abeliovich,"

Phrase: "A.,"

Phrase: "Schmitz,"

Phrase: "Y.,"

Phrase: "Farinas,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Choi-Lundberg,"

Phrase: "D."

Phrase: ","

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "W.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Castillo,"

Phrase: "P.E.,"

Phrase: "Shinsky,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Verdugo,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Armanini,"

Phrase: "M."

Phrase: ","

Phrase: "Ryan,"

Phrase: "A. et al."
Processing 00000000.tx.620: (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "functional deficits in the nigrostriatal dopamine system."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C2987487:deficits [Qualitative Concept]
   714 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.621: Neuron, 25, 239252.[ISI][Medline] Giasson, B.I., Duda, J.E., Quinn, S.M., Zhang, B., Trojanowski, J.Q. and Lee, V.M. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "25,"

Phrase: "239252."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Giasson,"

Phrase: "B.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Duda,"

Phrase: "J.E.,"

Phrase: "Quinn,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J.Q."

Phrase: "and"

Phrase: "Lee,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.622: (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuronal alpha-synucleinopathy with severe movement disorder"

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "A53T human alpha-synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439095:Alpha [Intellectual Product]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.623: Neuron, 34, 521533.[ISI][Medline] Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H.K. and Brundin, P. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "34,"

Phrase: "521533."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lotharius,"

Phrase: "J.,"

Phrase: "Barg,"

Phrase: "S."

Phrase: ","

Phrase: "Wiekop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lundberg,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Raymon,"

Phrase: "H.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Brundin,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.624: (2002) Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Effect of mutant alpha-synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on dopamine homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "in a new human mesencephalic cell line."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   888   C0682523:Human Cell Line [Cell]
   853   C0427861:human cell [Laboratory or Test Result]
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.625: J. 

Phrase: "J."
Processing 00000000.tx.626: Biol. 

Phrase: "Biol."
Processing 00000000.tx.627: Chem., 277, 3888438894.[Abstract/Free FullText] Stefanis, L., Larsen, K.E., Rideout, H.J., Sulzer, D. and Greene, L.A. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "3888438894."

Phrase: "[Abstract/Free FullText"

Phrase: "] Stefanis,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Larsen,"

Phrase: "K.E.,"

Phrase: "Rideout,"

Phrase: "H.J.,"

Phrase: "Sulzer,"

Phrase: "D."

Phrase: "and"

Phrase: "Greene,"

Phrase: "L.A."
Processing 00000000.tx.628: (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Expression of A53T mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "not wild-type alpha-synuclein in PC12 cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   750   C0030280:Alpha cell [Cell]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439095:Alpha [Intellectual Product]
   744   C2003941:Alpha [Intellectual Product]
   744   C2350010:Alpha [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "alterations of the ubiquitin-dependent degradation system,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "loss of dopamine release,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "autophagic cell death."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1326207:Autophagic Cell Death [Cell Function]
           autophagic death
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.629: J. 

Phrase: "J."
Processing 00000000.tx.630: Neurosci., 21, 95499560.[Abstract/Free FullText] Owen, A.M., Iddon, J.L., Hodges, J.R., Summers, B.A. and Robbins, T.W. 

Phrase: "Neurosci.,"

Phrase: "21,"

Phrase: "95499560."

Phrase: "[Abstract/Free FullText"

Phrase: "] Owen,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Iddon,"

Phrase: "J.L., Hodges,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Summers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0241301:Summer [Temporal Concept]

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Robbins,"

Phrase: "T.W."
Processing 00000000.tx.631: (1997) Spatial and non-spatial working memory at different stages of Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Spatial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428114:spatial [Gene or Genome]

Phrase: "and"

Phrase: "non-spatial working memory at different stages of Parkinson's disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025265:Working Memory [Mental Process]
   757   C0814087:spatial memory [Mental Process]
   739   C0025260:Memory [Mental Process]
   739   C0043227:Working [Occupational Activity]
   739   C0700327:memory [Finding]
   739   C1706377:Memory [Manufactured Object]
Processing 00000000.tx.632: Neuropsychologia, 35, 519532.[CrossRef][ISI][Medline] Heberlein, I., Ludin, H.P., Scholz, J. and Vieregge, P. 

Phrase: "Neuropsychologia,"

Phrase: "35,"

Phrase: "519532."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Heberlein,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ludin,"

Phrase: "H.P.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Scholz,"

Phrase: "J."

Phrase: "and"

Phrase: "Vieregge,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.633: (1998) Personality, depression, and premorbid lifestyle in twin pairs discordant for Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Personality,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003944:personality [Mental or Behavioral Dysfunction]
  1000   C0031208:Personality [Mental Process]

Phrase: "depression,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "and"

Phrase: "premorbid lifestyle in twin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023676:Life Style [Social Behavior]

Phrase: "pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "discordant for Parkinson's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3639994:Discordant [Conceptual Entity]
Processing 00000000.tx.634: J. 

Phrase: "J."
Processing 00000000.tx.635: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.636: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.637: Psychiat., 64, 262266.[Abstract/Free FullText] Menza, M. 

Phrase: "Psychiat.,"

Phrase: "64,"

Phrase: "262266."

Phrase: "[Abstract/Free FullText"

Phrase: "] Menza,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.638: (2000) The personality associated with Parkinson's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The personality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003944:personality [Mental or Behavioral Dysfunction]
  1000   C0031208:Personality [Mental Process]

Phrase: "associated with Parkinson's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.639: Curr. 

Phrase: "Curr."
Processing 00000000.tx.640: Psychiatry Rep., 2, 421426.[Medline] O'Connor, L., Berry, J., Weiss, J. and Gilbert, P. 

Phrase: "Psychiatry Rep., 2,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1413395:REP-2 [Gene or Genome]
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   827   C1744664:REP [Molecular Function]
   755 E C0205487:Psychiatric [Functional Concept]

Phrase: "421426."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] O'Connor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Berry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005135:Berry [Food]
  1000   C0982158:BERRY [Food]
  1000   C3495134:BERRY [Organic Chemical,Pharmacologic Substance]

Phrase: "J.,"

Phrase: "Weiss,"

Phrase: "J."

Phrase: "and"

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.641: (2002) Guilt, fear, submission, and empathy in depression. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Guilt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018379:Guilt [Mental Process]

Phrase: "fear,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015726:Fear [Mental Process]
   928 E C0458278:Fearful [Qualitative Concept]

Phrase: "submission,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515022:Submission [Functional Concept]
  1000   C1515023:Submission [Functional Concept]

Phrase: "and"

Phrase: "empathy in depression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013989:Empathy [Individual Behavior]
Processing 00000000.tx.642: J. 

Phrase: "J."
Processing 00000000.tx.643: Affect. 

Phrase: "Affect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]
Processing 00000000.tx.644: Disord., 71, 1319. 

Phrase: "Disord.,"

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "1319."
Processing 00000000.tx.645: Cummings, J.L. 

Phrase: "Cummings,"

Phrase: "J.L."
Processing 00000000.tx.646: (1992) Depression and Parkinson's disease. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Depression"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.647: Am. 

Phrase: "Am."
Processing 00000000.tx.648: J. 

Phrase: "J."
Processing 00000000.tx.649: Psychiat., 149, 443454.[Abstract] Michel, P.P. and Hefti, F. 

Phrase: "Psychiat.,"

Phrase: "149,"

Phrase: "443454."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Michel,"

Phrase: "P.P."

Phrase: "and"

Phrase: "Hefti,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.650: (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Toxicity of 6-hydroxydopamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "dopamine for dopaminergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1512035:dopamine neurons [Cell]
   770   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.651: J. 

Phrase: "J."
Processing 00000000.tx.652: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.653: Res., 26, 428435.[ISI][Medline] Mena, M.A., Pardo, B., Casarejos, M.J., Fahn, S. and Garcia de Yebenes, J. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "26,"

Phrase: "428435."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pardo,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Casarejos,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Fahn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823105:FAHN [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Garcia de Yebenes,"

Phrase: "J."
Processing 00000000.tx.654: (1992) Neurotoxicity of levodopa on catecholamine-rich neurons. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neurotoxicity of levodopa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "on catecholamine-rich neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.655: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.656: Disord., 7, 2331.[ISI][Medline] Murer, M.G., Dziewczapolski, G., Menalled, L.B., Garcia, M.C., Agid, Y., Gershanik, O. and Raisman-Vozari, R. 

Phrase: "Disord.,"

Phrase: "7,"

Phrase: "2331."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Murer,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dziewczapolski,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Menalled,"

Phrase: "L.B.,"

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Gershanik,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Raisman-Vozari,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.657: (1998) Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Chronic levodopa"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0023570:Levodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   805 E C0699991:Larodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   805 E C0720022:Dopar [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "not toxic for remaining dopamine neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0600688:toxic [Injury or Poisoning]
   753   C1407029:Toxic [Qualitative Concept]

Phrase: "but"

Phrase: "instead"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "their recovery,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "with moderate nigrostriatal lesions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.658: Ann. 

Phrase: "Ann."
Processing 00000000.tx.659: Neurol., 43, 561575.[ISI][Medline] Troadec, J.D., Marien, M., Darios, F., Hartmann, A., Ruberg, M., Colpaert, F. and Michel, P.P. 

Phrase: "Neurol.,"

Phrase: "43,"

Phrase: "561575."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Troadec,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Marien,"

Phrase: "M."

Phrase: ","

Phrase: "Darios,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hartmann,"

Phrase: "A.,"

Phrase: "Ruberg,"

Phrase: "M."

Phrase: ","

Phrase: "Colpaert,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Michel,"

Phrase: "P.P."
Processing 00000000.tx.660: (2001) Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Noradrenaline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028351:Noradrenalin [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "long-term protection to dopaminergic neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1545588:Protection [Finding]

Phrase: "by reducing oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.661: J. 

Phrase: "J."
Processing 00000000.tx.662: Neurochem., 79, 200210.[CrossRef][ISI][Medline] Troadec, J.D., Marien, M., Mourlevat, S., Debeir, T., Ruberg, M., Colpaert, F. and Michel, P.P. 

Phrase: "Neurochem.,"

Phrase: "79,"

Phrase: "200210."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Troadec,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Marien,"

Phrase: "M."

Phrase: ","

Phrase: "Mourlevat,"

Phrase: "S."

Phrase: ","

Phrase: "Debeir,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ruberg,"

Phrase: "M."

Phrase: ","

Phrase: "Colpaert,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Michel,"

Phrase: "P.P."
Processing 00000000.tx.663: (2002) Activation of the mitogen-activated protein kinase (ERK1/2) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Activation of the mitogen-activated protein kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1819041:protein kinase activation [Cell Function]
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "(ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "signaling pathway by cyclic AMP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0037083:signaling pathway [Cell Function]
   806   C0086982:Signaling Pathway [Molecular Function]
   797 E C0037080:pathway signaling [Molecular Function]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "potentiates"

Phrase: "the neuroprotective effect of the neurotransmitter noradrenaline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0815279:Neuroprotective Effect [Functional Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on dopaminergic neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:Dopaminergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.664: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.665: Pharmac., 62, 10431052.[Abstract/Free FullText] Mena, M.A., Casarejos, M.J., Carazo, A., Paino, C.L. and Garcia de Yebenes, J. 

Phrase: "Pharmac.,"

Phrase: "62,"

Phrase: "10431052."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Casarejos,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Carazo,"

Phrase: "A.,"

Phrase: "Paino,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Garcia de Yebenes,"

Phrase: "J."
Processing 00000000.tx.666: (1996) Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Glia conditioned medium"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
   901   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0009647:Conditioned [Mental Process]
   827   C0027836:Glia [Cell]
   827   C0439536:Medium [Quantitative Concept]
   827   C1087003:Glia [Plant]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]
   755 E C0012634:condition [Disease or Syndrome]
   755 E C0040607:Training [Educational Activity]
   755 E C0220931:Training [Educational Activity]
   755 E C0336809:Train [Manufactured Object]
   755 E C0348080:Condition [Qualitative Concept]
   755 E C1552514:Train [Manufactured Object]
   755 E C1705253:Condition [Conceptual Entity]
   755 E C2673163:training [Qualitative Concept]
   727 E C1701901:Conditional [Qualitative Concept]
   727 E C1963686:Conditional [Functional Concept]
   711 E C1519605:Conditionality [Conceptual Entity]

Phrase: "protects"

Phrase: "fetal rat midbrain neurones in culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0027882:Neurone [Cell]

Phrase: "from L-DOPA toxicity."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734   C0023570:L(-)-Dopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.667: Neuroreport, 7, 441445.[ISI][Medline] Mena, M.A., Casarejos, M.J. and Garcia de Yebenes, J. 

Phrase: "Neuroreport,"

Phrase: "7,"

Phrase: "441445."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Casarejos,"

Phrase: "M."

Phrase: "J."

Phrase: "and"

Phrase: "Garcia de Yebenes,"

Phrase: "J."
Processing 00000000.tx.668: (1999) The effect of glia-conditioned medium on dopamine neurons in culture. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The effect of glia-conditioned medium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on dopamine neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.669: Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity. 

Phrase: "Modulation of apoptosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443264:Modulation [Spatial Concept]

Phrase: "tyrosine hydroxylase expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]

Phrase: "and"

Phrase: "1-methyl-4-phenylpyridinium toxicity."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   804   C0040539:toxicity [Qualitative Concept]
   804   C0600688:Toxicity [Injury or Poisoning]
   771   C0000098:1-Methyl-4-phenylpyridinium [Hazardous or Poisonous Substance,Organic Chemical]
   733 E C1407029:Toxic [Qualitative Concept]
   711 E C0032346:Poison [Hazardous or Poisonous Substance]
   711 E C1548769:Poison [Intellectual Product]
   711 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.670: J. 

Phrase: "J."
Processing 00000000.tx.671: Neural Transm., 106, 11051123.[CrossRef][ISI] Pardo, B., Mena, M.A., Casarejos, M.J., Paino, C.L. and De Yebenes, J.G. 

Phrase: "Neural Transm.,"

Phrase: "106,"

Phrase: "11051123."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Pardo,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Casarejos,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Paino,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "De Yebenes,"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.672: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.673: Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants. 

Phrase: "Toxic effects of L-DOPA"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   760   C1280500:effects [Qualitative Concept]
   760   C1407029:Toxic [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on mesencephalic cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0007585:Cell Cultures [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Cultures [Idea or Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: ":"

Phrase: "protection with antioxidants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]
Processing 00000000.tx.674: Brain Res., 682, 133143.[CrossRef][ISI][Medline] Sambrook, J., Fritsch, E.F. and Maniatis, T. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "682,"

Phrase: "133143."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sambrook,"

Phrase: "J.,"

Phrase: "Fritsch,"

Phrase: "E.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.675: (1989) Molecular Cloning. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Molecular Cloning."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]
Processing 00000000.tx.676: A Laboratory Manual. 

Phrase: "A Laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "Manual."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024763:Manual [Intellectual Product,Manufactured Object]
  1000   C0175674:Manual [Functional Concept]
Processing 00000000.tx.677: Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 

Phrase: "Cold Spring Harbor Laboratory Press,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]
Processing 00000000.tx.678: Stichel, C., Augustin, M., Khn, K., Zhu, X., Engels, P., Ullmer, C. and Lbbert, H. 

Phrase: "Stichel,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Augustin,"

Phrase: "M."

Phrase: ","

Phrase: "Khn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhu,"

Phrase: "X.,"

Phrase: "Engels,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ullmer,"

Phrase: "C."

Phrase: "and"

Phrase: "Lbbert,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.679: (2000) Parkin expression in adult mouse brain. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin expression in adult mouse brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.680: Eur. 

Phrase: "Eur."
Processing 00000000.tx.681: J. 

Phrase: "J."
Processing 00000000.tx.682: Neurosci., 12, 115.[CrossRef][Medline] Jaffard, R., Dubois, M. and Galey, D. 

Phrase: "Neurosci.,"

Phrase: "12,"

Phrase: "115."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jaffard,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dubois,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Galey,"

Phrase: "D."
Processing 00000000.tx.683: (1981) Memory of a choice direction in a T maze as measured by spontaneous alternation in mice: effects of intertribal interval and reward. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Memory of a choice direction"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025260:Memory [Mental Process]
   760   C0700327:memory [Finding]
   760   C1706377:Memory [Manufactured Object]
   704 E C0679055:mnemonic [Mental Process]

Phrase: "in a T maze"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0083355:MAZE [Therapeutic or Preventive Procedure]
   827   C0870866:maze [Manufactured Object]
   734   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "measured by spontaneous alternation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205359:Spontaneous [Functional Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C0919661:alternation [Pathologic Function]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "effects of intertribal interval"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "reward."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035397:Reward [Mental Process]
Processing 00000000.tx.684: Behav. 

Phrase: "Behav."
Processing 00000000.tx.685: Proc., 6, 1121.[CrossRef][ISI] Hirsch, M.D. and Helke, C.J. 

Phrase: "Proc.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]

Phrase: "6,"

Phrase: "1121."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Hirsch,"

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Helke,"

Phrase: "C.J."
Processing 00000000.tx.686: (1988) Bulbospinal thyrotropin-releasing hormone projections to the intermediolateral cell column: a double fluorescence immunohistochemical-retrograde tracing study in the rat. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Bulbospinal thyrotropin-releasing hormone projections to the intermediolateral cell column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C1325523:cell projection [Cell Component]
   739   C0016538:projections [Intellectual Product]
   739   C0033363:projections [Mental Process]
   739   C0348018:projections [Spatial Concept]

Phrase: ":"

Phrase: "a double fluorescence immunohistochemical-retrograde tracing study in the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0557651:Study [Manufactured Object]
   739   C2603343:Study [Research Activity]
Processing 00000000.tx.687: Neuroscience, 25, 625637.[CrossRef][ISI][Medline] Hunot, S., Brugg, B., Ricard, D., Michel, P.P., Muriel, M.P., Ruberg, M., Faucheux, B.A., Agid, Y. and Hirsch, E.C. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "25,"

Phrase: "625637."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hunot,"

Phrase: "S."

Phrase: ","

Phrase: "Brugg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ricard,"

Phrase: "D."

Phrase: ","

Phrase: "Michel,"

Phrase: "P.P.,"

Phrase: "Muriel,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ruberg,"

Phrase: "M."

Phrase: ","

Phrase: "Faucheux,"

Phrase: "B.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Hirsch,"

Phrase: "E.C."
Processing 00000000.tx.688: (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nuclear translocation of NF-kappaB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1518440:Nuclear Translocation [Molecular Function]
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "is"

Phrase: "increased in dopaminergic neurons of patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1512035:Dopaminergic Neurons [Cell]
   753   C0027882:Neurons [Cell]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0205217:Increased [Quantitative Concept]
   753   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0442805:Increased [Functional Concept]

Phrase: "with parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.689: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.690: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.691: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.692: USA, 94, 75317536.[Abstract/Free FullText] Mena, M.A., Casarejos, M.J., Bonin, A., Ramos, J.A. and Garcia de Yebenes, J. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "94,"

Phrase: "75317536."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Casarejos,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Bonin,"

Phrase: "A.,"

Phrase: "Ramos,"

Phrase: "J."

Phrase: "A."

Phrase: "and"

Phrase: "Garcia de Yebenes,"

Phrase: "J."
Processing 00000000.tx.693: (1995) Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: prevention of cell death by dibutyryl cyclic AMP. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Effects of dibutyryl cyclic AMP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "retinoic acid on the differentiation of dopamine neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "prevention of cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "by dibutyryl cyclic AMP."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012054:Dibutyryl Cyclic AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   901   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0439596:Cyclic [Temporal Concept]
   827   C1511572:Cyclic [Temporal Concept]
   755 E C0031084:Cyclicities [Temporal Concept]
Processing 00000000.tx.694: J. 

Phrase: "J."
Processing 00000000.tx.695: Neurochem., 65, 26122620.[ISI][Medline] Handler, A., Lobo, M.V.T., Alonso, F.J., Paino, C.L. and Mena, M.A. 

Phrase: "Neurochem.,"

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "26122620."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Handler,"

Phrase: "A.,"

Phrase: "Lobo,"

Phrase: "M."

Phrase: "V.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040210:V T [Finding]

Phrase: "Alonso,"

Phrase: "F.J.,"

Phrase: "Paino,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.696: (2000) Functional implications of the noradrenergic-cholinergic switch induced by retinoic acid in NB69 neuroblastoma cells. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Functional implications of the noradrenergic-cholinergic switch"

Phrase: "induced by retinoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0205263:Induced [Functional Concept]

Phrase: "in NB69 neuroblastoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.697: J. 

Phrase: "J."
Processing 00000000.tx.698: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.699: Res., 60, 311320.[CrossRef][ISI][Medline] Carlsson, A. and Lindqvist, M. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "60,"

Phrase: "311320."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carlsson,"

Phrase: "A."

Phrase: "and"

Phrase: "Lindqvist,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.700: (1973) Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. 

Phrase: "(1973"

Phrase: ")"

Phrase: "Effect of ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the hydroxylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020365:Hydroxylation [Natural Phenomenon or Process]

Phrase: "of tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "tryptophan in rat brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.701: J. 

Phrase: "J."
Processing 00000000.tx.702: Pharm. 

Phrase: "Pharm."
Processing 00000000.tx.703: Pharmac., 25, 437440.[ISI][Medline] Garcia de Yebenes, J., Carlsson, A. and Mena, M.A. 

Phrase: "Pharmac.,"

Phrase: "25,"

Phrase: "437440."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Garcia de Yebenes,"

Phrase: "J.,"

Phrase: "Carlsson,"

Phrase: "A."

Phrase: "and"

Phrase: "Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.704: (1978) The effect of taurine on motor behavior, body temperature and monoamine metabolism in rat brain. 

Phrase: "(1978"

Phrase: ")"

Phrase: "The effect of taurine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on motor behavior,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0026606:Motor behavior [Daily or Recreational Activity]
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]

Phrase: "body temperature"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0005903:Body Temperature [Organism Attribute]
           temperature
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "monoamine metabolism in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0596215:brain metabolism [Organ or Tissue Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.705: Naunyn-Smiedeberg Archv. 

Phrase: "Naunyn-Smiedeberg Archv."
Processing 00000000.tx.706: Pharmac., 304, 9599. 

Phrase: "Pharmac.,"

Phrase: "304,"

Phrase: "9599."
Processing 00000000.tx.707: Tietze, F. 

Phrase: "Tietze,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.708: (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. 

Phrase: "(1969"

Phrase: ")"

Phrase: "Enzymic method for quantitative determination of nanogram amounts of total"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "oxidized glutathione"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061516:Glutathione, Oxidized [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "applications to mammalian blood"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0185125:applications [Health Care Activity]
   737 E C1947919:Application [Intellectual Product]
   737 E C2347934:Application [Intellectual Product]
   737 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "and"

Phrase: "other tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.709: Anal. 

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.710: Biochem., 27, 502522.[ISI][Medline] Griffith, O.W. 

Phrase: "Biochem.,"

Phrase: "27,"

Phrase: "502522."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Griffith,"

Phrase: "O.W."
Processing 00000000.tx.711: (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Determination of glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "glutathione disulfide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061516:Glutathione Disulfide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0012771:disulfide [Chemical Viewed Structurally]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "glutathione reductase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017824:Glutathione Reductase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415326:GLUTATHIONE REDUCTASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "2-vinylpyridine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0163671:2-vinylpyridine [Organic Chemical,Pharmacologic Substance]
   861   C0303984:Vinyl pyridine [Organic Chemical]
Processing 00000000.tx.712: Anal. 

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.713: Biochem., 106, 207212.[ISI][Medline] Mena, M.A., Casarejos, M.J., Carazo, A., Paino, C.L. and Garcia de Yebenes, J. 

Phrase: "Biochem.,"

Phrase: "106,"

Phrase: "207212."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Casarejos,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Carazo,"

Phrase: "A.,"

Phrase: "Paino,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Garcia de Yebenes,"

Phrase: "J."
Processing 00000000.tx.714: (1997) Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "protect"

Phrase: "fetal midbrain dopamine neurons in culture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1512035:dopamine neurons [Cell]
   753   C0027882:Neurons [Cell]

Phrase: "from L-DOPA toxicity"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734   C0023570:L(-)-Dopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "through multiple mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.715: J. 

Phrase: "J."
Processing 00000000.tx.716: Neural.Transm., 104, 317328.

Phrase: "Neural.Transm.,"

Phrase: "104,"

Phrase: "317328."

